Survival and replication of Group A Streptococcus in human macrophages by O'Neill, Alan
1 
 
  
 
Survival and replication of Group A Streptococcus 
in human macrophages 
 
 
Alan O’Neill 
2015 
 
 
Imperial College London 
 
Submitted for the degree of Doctor of Philosophy 
 
 
 
 
 
2 
 
Abstract 
 
As key components of innate immune defence, macrophages are essential in controlling 
bacterial pathogens, including Group A Streptococcus (GAS). Despite this, only a limited 
number of studies have analysed the recovery of GAS from within human neutrophils and 
macrophages. The purpose of this study was to determine the intracellular fate of GAS in 
human macrophages using several quantitative approaches. The first part of this work 
involved the set-up of a reliable and reproducible infection system for GAS. In both U937 
and primary human macrophages, the appearance over time of long GAS chains revealed 
replication that despite GAS-mediated cytotoxicity, occurred in viable macrophages. 
Whereas the major virulence factor M1 did not contribute to bacterial growth, a GAS 
mutant strain deficient in streptolysin O (Δslo) was impaired for intracellular replication. SLO 
was required for vacuolar rupture and bacterial escape into the host cytosol. Despite 
evidence of efficient cytosolic growth, up to half of cytosolic GAS were targeted by 
autophagy and decorated with ubiquitin and p62. Our studies reveal that GAS can replicate 
within the cytosol of viable human macrophages and that components of antibacterial 
autophagy machinery, despite being recruited to the bacteria, fail to restrict overall growth. 
To my knowledge, this study provides the first direct visualisation of GAS replication inside 
human cells.  
GAS is also persistent coloniser of the oropharynx. Persisters are a subpopulation of non- or 
slow-growing bacteria that are multidrug tolerant, and thought to be involved in the 
recalcitrance of chronic infections. In the final section of this study, I investigated the in vitro 
persister formation of clinical isolates of GAS in response to antibiotics. I found that GAS 
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produce a high level of persisters, but no significant difference was detected between 
different isolates. GAS isolates did not produce more persisters upon uptake in epithelial 
cells or by macrophages. I also characterized several putative toxin/antitoxin (TA) modules 
as candidate persister genes of GAS and a subset were shown to encode functional toxins, 
which when overexpressed in E. coli resulted in bacterial growth arrest.  
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Chapter 1 
 
Introduction  
 
1.1 Group A Streptococcus – general information 
 
1.1.1 Classification 
Streptococci belong to the Streptococcaceae family, within the phylum Firmicutes. 
Streptococci are Gram-positive, facultatively anaerobic, non-motile bacteria that can grow 
in pairs or chains (Chhatwal, 2014). Before the advent of modern molecular typing, 
streptococci were divided into four groups: pyogenic, viridians, lactic and enterococci, based 
on their haemolytic and phenotypic characteristics (Sherman, 1937). In 1933, pioneering 
work carried out by Rebecca Lancefield described a grouping system that distinguished β-
hemolytic streptococci (pyogenic) based on their group A carbohydrate (GAC) (Lancefield, 
1933). This group A antigen is a highly conserved cell wall carbohydrate composed of N-
acetylglucosamine linked to a polyrhamnose backbone (Mccarty, 1956). Lancefield’s 
classification recognises 20 serogroups of streptococci denoted by the letters A-H and K-V, 
of which GAS remains the most clinically relevant. In addition to the GAC division, Lancefield 
developed a serotyping system for Group A Streptococcus (GAS), based on the antigenic 
properties of the cell surface M protein (Lancefield, 1962). The M protein was extracted by 
boiling the bacteria in hydrochloric acid and differentiated by using type-specific antisera 
(Cunningham, 2000). Classical M-typing is now replaced with modern emm-sequence typing 
of the 5’ N-terminal hypervariable region of the M protein gene (emm) (Tewodros and 
Kronvall, 2005) . Roughly 225 distinct emm-types are currently listed in the United States 
Centres for Disease Control and Prevention online database 
(http://www.cdc.gov/streplab/index.html). In addition to M-typing, the cell surface T 
protein antigen can also be used as serological tool since certain T-types are specific for GAS 
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M-types (Jones et al., 1991). The combination of M- and T-typing is very useful in classifying 
GAS strain diversity. 
 
1.1.2 Global Burden 
It is estimated that up to 600 million GAS infections occur yearly worldwide, whereby most 
frequent manifestations are mild and non-invasive (Lynskey et al., 2011). GAS is primarily a 
community-acquired pathogen causing at least 500,000 deaths every year (Carapetis et al., 
2005a). Currently, no effective vaccine against disease is available and prevention is difficult 
as roughly 90% of reported cases occur sporadically (Pandey et al., 2009). An exclusively 
human-adapted pathogen, GAS causes a wide variety of diseases ranging from mild self-
limiting infections including pharyngitis, cellulitis and impetigo, to more life threatening 
invasive disease such as sepsis, streptococcal toxic shock syndrome (STSS) and necrotising 
fasciitis (NF), which can progress rapidly. A UK-based surveillance study found that 20% of 
patients with severe GAS infection died within 7 days after the initial diagnosis (Lamagni et 
al., 2008). Children are more susceptible to streptococcal infections but have a reduced rate 
of mortality compared to adults (Steer et al., 2007). GAS disease is therefore a global 
burden, whose virulence can be enhanced by common factors such as diabetes, viral 
infections, AIDS and cancer (Long et al., 2012). 
 
1.1.3 Epidemiology 
Since the advent of antibiotic therapy in the 1940’s, the incidence of invasive GAS infections 
decreased significantly worldwide, only to re-emerge during the 1980’s (Aziz and Kotb, 
2008). The resurgence of severe invasive disease is due in part to the global dissemination of 
an M1T1 hypervirulent clone. This M1T1 clone remains the most frequent serotype isolated 
not only from mild skin infections, but also from severe life threatening forms of the disease 
(Cole et al., 2006).  The M1T1 clone can be distinguished from other M1-types due to the 
acquisition of phage elements that contain virulence factors (Uchiyama et al., 2012). This 
special feature provides an advantage over host immune defences. Nevertheless, the 
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underlying factors that contribute to the success of the M1T1 serotype are multifaceted. 
Invasive isolates often constitute a wide diversity of emm-types (Luca-Harari et al., 2009; 
Imöhl et al., 2010), and common emm-types are found in both invasive and non-invasive 
infections (Steer et al., 2009a). Likewise, major differences in emm-type distribution are 
observed depending on the geographical location (Fig.1.1). Therefore, it has been proposed 
that the re-emergence of invasive GAS disease is not attributed to increased virulence 
potential of the M1 serotype, but rather a higher prevalence among the population (Rogers 
et al., 2007). 
It remains unknown whether host genetic or environmental factors predispose individuals 
to more serious invasive disease or whether the specific acquisition of additional virulence 
traits provide a competitive advantage for ‘hypervirulent’ serotypes (Basma et al., 1999; 
Chhatwal and McMillan, 2005; McMillan et al., 2006). Whatever the case, underlying host 
factors seem to contribute to disease severity and epidemiological evidence suggests that 
specific HLA types and B cell alloantigens can predispose some individuals to GAS infection 
(Bryant et al., 2009).  
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Figure 1.1. Geographical distribution of emm-type isolates. 
The 25 most common emm-type isolates from high-income countries (A), Africa (B) or the Pacific 
region (C). Data obtained from Steer et al. 2009. 
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1.1.4 GAS carriage 
GAS is a major coloniser of the oropharynx and has a high propensity to become pathogenic. 
School-aged children (5-12 years) are the primary reservoir of GAS and a major source of 
transmission to adults, either through direct contact or by respiratory droplets. The 
prevalence of GAS carriage in asymptomatic children is between 10-20% (Begovac et al., 
1993; Dumre et al., 2009; Steer et al., 2009b; Abdissa et al., 2011). However, this can vary 
substantially since GAS is a seasonal pathogen and is more prevalent during winter months 
(Danchin et al., 2007). 39% of children that present at a hospital or clinic with sore throat, 
test positive for GAS (Shaikh et al., 2010). In adults, GAS carriage rates are typically less than 
5%. However, adults presenting with sore throat are just as likely to test positive for GAS, 
compared to children. Young children who are GAS carriers also tend to acquire new emm-
types (Martin et al., 2004) which indicates an age-dependant distribution in emm-types 
during childhood (Jaggi et al., 2005). Ultimately, the development of immunity towards 
certain serotypes may reflect emm-type changes over time. 
 
1.1.5 Pharyngitis/tonsillitis 
Streptococcal sore throat (pharyngitis) is common and 10-25% of children will develop at 
least one case of GAS pharyngitis per year (Dingle et al., 1964; Begovac et al., 1993; Danchin 
et al., 2007; Steer et al., 2009b). However, the incidence rate can rise to 50% for children in 
developing countries. Likewise, outbreaks of pharyngitis and more severe GAS diseases are 
frequently reported for military recruits living in crowded conditions (Gray et al., 1999). In 
fact many cases of invasive GAS infections in adults originate from local pharyngitis isolates 
(Hoe et al., 2001; Shea et al., 2011). These cyclical outbreaks of invasive disease are often 
acquired from close contact with infected children (Cockerill et al., 1997). The six most 
prevalent pharyngeal emm-types in the US and Canada are 1, 2, 3, 4, 12 and 28 (Shulman et 
al., 2009). Comparably, the emm1 and emm3 are also the most frequently associated with 
invasive disease. The incidence of GAS pharyngitis is dependent on many factors including 
age, season, pollution and living conditions (Nandi et al., 2001). Scarlet fever is characterised 
by a red rash located on the tongue and is associated with throat infection of GAS isolates 
that produce pyrogenic exotoxins (Henningham et al., 2012). Scarlet fever was a major 
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cause of childhood morbidity and mortality in the preceding centuries. However, since the 
discovery of antibiotics, it has become a rare disease. Recently, scarlet fever has re-emerged 
in Hong Kong and it has been linked to the acquisition of prophage elements encoding the 
streptococcal superantigen A (ssa) gene, including antibiotic resistence genes in an emm12 
strain (Davies et al., 2015).  Acute pharyngotonsillitis is generally self-limiting but can 
become recurrent. Failure to eradicate chronic tonsillitis can manifest into more serious 
complications such as peritonsillar abscess, as well as causing sequelae like rheumatic heart 
disease and glomerulonephritis, which are debilitating and difficult to treat (Mazur et al., 
2015). In some cases recurrent bouts of tonsillitis may require tonsillectomy or 
adenotonsillectomy (Burton et al., 2014; Chung et al., 2014).  
 
1.1.6 GAS skin infections 
The strains of GAS which give rise to skin infections differ in serotype compared to those 
that cause pharyngitis. Skin infections caused by GAS (pyoderma or impetigo) are most 
common in the tropics, particularly in children. In aboriginal communities in northern 
Australia prevalence is high as 70% (Currie and Carapetis, 2000). Impetigo is characterised 
by the formation of skin lesions usually localised on the face or extremities, which evolve 
into pustules and are highly contagious (Cunningham, 2000). Although easily treatable, 
pyoderma can manifest into suppurative postinfectious disorders including erysipelas, 
cellulitis and gangrene which can disseminate into deep tissue and lead to systemic illness 
(Bisno and Stevens, 1996).  
 
1.1.7 Acute rheumatic fever  
Acute rheumatic fever (ARF) as a non-suppurative sequelae of GAS skin and throat 
infections that afflicts up to 15 million people worldwide, mostly in developing countries 
(Carapetis et al., 2005a). ARF can lead to rheumatic heart disease (RHD), a serious 
autoimmune disease that presents 4-8 weeks after infection in 30-45% of patients 
(Guilherme et al., 2005). The M protein represents the major GAS antigen and is structurally 
similar to several human heart proteins, like cardiac myosin and tropomyosin (Dale and 
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Beachey, 1985). Molecular mimicry forms the basis of RHD as the generation of protective 
antibodies against GAS results in an abnormal cross reactive response, leading to 
destruction of heart tissue (Cunningham, 2014).  More than 50% of individuals who acquire 
ARF develop RHD at a later stage (Carapetis et al., 2005b). According to the WHO, an 
estimated 233,000 people die every year due to ARF or RHD.  
 
1.1.8 Invasive GAS infection 
Penetration of GAS into deep tissue can lead to invasive disease such as STSS, NF and 
bacteremia. Although these infections are rare, they progress rapidly and are difficult to 
treat with antibiotics. In the case of NF, soft tissue necrosis can spread rapidly and patients 
often require surgical debridement.  It has been reported that 32% of patients with newly 
acquired invasive infections die within the first week. However, the likelihood of recovery is 
even worse during the onset of STSS, where the mortality rate rises to 60% for patients in 
the first 72 hours (Stevens, 2000). GAS is a major health burden with an estimated 663,000 
new cases of invasive disease reported each year (as of 2005) resulting in 163,000 deaths 
annually (Carapetis et al, 2005). 
 
 
1.2 Molecular determinants of pathogenesis 
GAS needs to overcome many obstacles to establish infection, including circumventing the 
innate immune defences, colonizing epithelial surfaces and penetrating the mucosal layer.  
It has developed an impressive array of surface and secreted virulence factors to exploit 
host immune defences to adapt, thrive and/or persist (Tart et al., 2007). Some of these 
virulence factors are strain specific and confer tissue tropism such as the Fibronectin-
binding proteins (Fbps), hyaluronic acid capsule and surface pili.  
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1.2.1 Surface virulence factors 
1.2.1.1 Pili 
Recently discovered in streptococci (Mora et al., 2005), the role of these long filamentous 
structures is becoming increasingly more important in terms of GAS pathogenesis. Pili from 
the M1 serotype have been shown to promote virulence by mediating attachment to human 
tonsil epithelium and primary human keratinocytes, but not to HeLa or A549 cell lines 
(Abbot et al., 2007). Despite promoting bacterial colonization, the presence of pili is 
reported to restrict the invasive potential of the M1T1 clone in a NF mouse model (Crotty 
Alexander et al., 2010). This is in direct contradiction to what has been previously described 
for pili in Group B Streptococcus (GBS) and Streptococcus pneumoniae. It was found that 
expression of pili promotes the release of neutrophil extracellular traps that can entrap and 
kill GAS. Alternatively, in the M6 serotype pili are reported to be essential for biofilm 
formation (Kimura et al., 2012).  
GAS pilus components have been proposed as promising vaccine candidates since they have 
been shown to elicit an immunoprotective response in mice (Soriani and Telford, 2010). 
 
1.2.1.2 M Protein 
The M protein is a dimeric coil-coiled fibrillar protein exposed on the surface of all GAS 
strains and remains one of the most widely studied GAS virulence factors to date 
(McNamara et al., 2008). The M protein has multifarious ways to contribute to disease. For 
instance, it can form a dynamic complex with multiple fibrinogen molecules that activate 
neutrophils to release heparin-binding proteins (HBP) causing vascular leakage and sepsis 
(Macheboeuf et al., 2011). The M protein can also be released from the surface of the 
bacterium to act as a toxin, inducing a myriad of downstream inflammatory effects at the 
cellular and tissue level (Påhlman et al., 2008; Herwald et al., 2004). It can interact with 
glycosaminoglycans in the extracellular matrix (ECM) to promote attachment and invasion 
of lung epithelial cells (Frick et al., 2003). Likewise, it can bind to fibronectin to promote 
bacterial uptake via β-integrins on the cell surface (Talay et al., 1992). In addition, the M 
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protein may also contribute to deep tissue invasive infection as it can trigger bacterial 
uptake into polarised human endothelial cells (Ochel et al., 2014).  
It has been well documented that GAS can survive in human blood and this was attributed 
partially to the antiphagocytic capacity of the surface M-protein (Lancefield, 1962). It is now 
known that M protein confers resistance to phagocytosis through the interaction with 
fibrinogen and the complement inhibitors factor H and C4b-binding protein (C4BP) 
(Horstmann et al., 1988; Carlsson et al., 2005; Sandin et al., 2006). Surface-bound fibrinogen 
and C4BP can block complement deposition on the bacteria whilst surface-bound Factor H 
has complement regulatory activity. However, a recent study has challenged the long held 
view that factor H mediates resistance to phagocytosis. During in vivo infection, factor H was 
not required for virulence in transgenic mice, and during whole human blood assays, factor 
H did not confer resistance to killing (Gustafsson et al., 2013).  
The N-terminal hypervariable region (HVR) of the M protein has a large sequence variability 
among different M-types but not within the same M-type, a feature used for serotype 
classification. This stipulates that antigenic variation of the HVR prevents effective immune 
protection during infection with different emm-type GAS.  This was the rationale for the 
development of a 30-valent-M-protein-based vaccine covering all the major serotypes of 
GAS (Dale et al., 2013) Antigenic variation is an important strategy in GAS pathogenesis 
since anti-HVR antibodies elicit strong protection against GAS infection and can outcompete 
binding to C4BP, thereby reducing its virulence capability (Fischetti and Windels, 1988;  
Persson et al., 2006; Gustafsson et al., 2013). Moreover, the sequence variability of the HVR 
also confers a weak immunogenic response, which could allow GAS time to prolong the 
infection and disseminate to different sites within the body (Lannergård et al., 2015). The 
negative consequence of using the M protein as a vaccine is that potentially the resultant 
antibodies can cross-react with the structurally homologous cardiac myosin, resulting in a 
harmful autoimmune response (McNamara et al., 2008). Therefore developing an effective 
vaccine against GAS is complicated and efforts in the field are still being made. 
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Figure 1.2. Architecture of the surface M protein 
The M protein forms a dimeric, parallel α-helical coiled coil structure. The coiled coil 
structure contains structural irregularities and instabilities, similar to that found in myosin 
and tropomysin, which might explain the antibody cross reactivity. The hypervariable and B-
repeat regions display low sequence similarity between M types, whereas domains C and D 
are conserved. The M protein has the ability to bind to many human plasma proteins (listed 
on the right), that facilitate colonisation, promote virulence and escape from antibody 
attack.  Taken from McArthur and Walker, 2006. 
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1.2.1.3 SpyCEP 
The presence of a GAS chemokine-degrading protease was first identified in 2004, from 
necrotic tissue obtained from patients with NF that had high bacterial load but lacked 
neutrophils (Hidalgo-Grass et al., 2004). The culprit was later identified as the GAS cell 
envelope SpyCEP, an autocatalytic serine protease that can be released in a soluble form 
(Edwards et al., 2005). SpyCEP promotes GAS virulence by degrading the neutrophil 
chemoattractant IL-8, which prevents neutrophil migration to the site of infection (Edwards 
et al., 2005), as well as promoting resistance to neutrophil killing (Zinkernagel et al., 2008). 
Both soluble and surface-bound SpyCEP have IL-8-cleaving activity (Chiappini et al., 2012). 
SpyCEP contains a LPXTG cell wall-anchoring motif, but is present in higher amounts in the 
stationary phase supernatant of invasive clinical isolates compared to non-invasive 
pharyngeal isolates (Turner et al., 2009). SpyCEP is also essential for systemic spread of GAS 
in mouse models of infection and SpyCEP knockout strains are severely attenuated for 
virulence (Zinkernagel et al., 2008; Kurupati et al., 2010). SpyCEP is also considered as a 
potential vaccine candidate (Bensi et al., 2012).  Surface-anchored SpyCEP is recognized by 
specific antibodies, which have been shown to counteract SpyCEP-mediated impairment of 
neutrophil recruitment (Chiappini et al., 2012).  
 
 
1.2.2 Secreted virulence factors 
The hallmark of invasive GAS disease, sepsis, toxic shock and soft tissue necrosis, is 
attributed to the actions of secreted extracellular factors. Two important secreted toxins 
involved in the pathogenesis of GAS are the haemolytic cytolysin streptolysin-S (SLS) and the 
cholesterol binding toxin streptolysin-O (SLO).  
 
1.2.2.1 Streptolysin S (SLS) 
SLS is a small 2.7 kDa cytolysin peptide, which is non-immunogenic and produced in 99% of 
all GAS strains (Molloy et al., 2011). SLS is the toxin responsible for red blood cell lysis, which 
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can be observed by the classical zone of β-haemolysis surrounding GAS colonies grown on 
blood agar plates. This feature was first observed in 1895 (Marmorek, 1985) but not 
attributed to SLS until 1938 (Todd, 1938).  
The streptolysin S-associated gene (sag) locus comprises 9 genes (A-I), all required for the 
processing and export of SLS (Nizet et al., 2000; Lee et al., 2008). However, only sagA-G is 
essential for the cytolytic activity of GAS. SLS is post-translationally modified and then 
exported to the cellular surface, where it displays its cytolytic activity (Ginsburg, 1999). 
Upon first contact of GAS with the target cell, SLS is released and delivered into the host, 
where it induces the formation of transmembrane pores and cell death. SLS-mediated 
cytotoxicity is thought to contribute to dissemination into deeper tissue. However, SLS has 
been reported to facilitate translocation of GAS through a para-cellular route (Sumitomo et 
al., 2011). SLS can degrade intercellular junctions, via recruitment of the host cysteine 
protease Calpain and E-cadherin to the plasma membrane. However, the precise 
mechanism is yet to be elucidated.   
SLS has been repeatedly demonstrated to promote virulence in mice (Betschel et al., 1998; 
Fontaine et al., 2003; Engleberg et al., 2004). In a NF mouse model of invasive infection with 
an M1T1 GAS strain, SLS was associated with enhanced tissue necrosis and dissemination, 
and impaired phagocytic clearance (Datta et al., 2005).  
 
1.2.2.2 Streptolysin O (SLO) 
SLO is part of the cholesterol-dependant cytolysin (CDC) family, which are classified based 
on conserved features such as the presence of the cholesterol recognition/binding motif 
(CRM), the undecapeptide signature sequence (ECTGLAWEWWR) and the ability to form 
pores in host cell membranes (Farrand et al., 2015). In the past, electron microscopy studies 
clearly showed that SLO pores exist as ring-like structures on the membranes of red blood 
cells (Dourmashkin and Rosse, 1966). SLO is secreted as a monomer, which binds to the 
cholesterol receptor via an undecapeptide-containing C-terminal domain 4, anchoring the 
SLO monomer to the membrane in an upright position (Bhakdi et al., 1985; Ramachandran 
et al., 2005). The membrane-anchored monomers make contact via domain 3 and undergo 
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oligomerisation to assemble a circular pre-pore complex consisting of 35-40 individual 
monomers (Hugo et al., 1986; Hotze and Tweten, 2012; Wade et al., 2015). The next step 
involves formation of transmembrane β-hairpins between adjacent monomers followed by 
the insertion of the complex into the membrane, generating a large circular pore with a 
diameter of 30 nm (Feil et al., 2014). 
Unexpectedly, it was recently revealed that SLO, despite being dependent on the presence 
of cholesterol, can also bind carbohydrate receptors on the surface of erythroyctes via a 
glycan-binding site on domain 4 (Shewell et al., 2014). Mutational studies of SLO found that 
this site was required for pore formation and lysis of erythroyctes but did not affect 
cytotoxicity during infection (Mozola and Caparon, 2015).  
SLO is required for the cytolysin-mediated translocation (CMT) of the GAS effector NAD+ 
glycohydrolase (SPN) into the host cell cytosol during infection (Madden et al., 2001). Upon 
translocation, SPN catalyses hydrolysis of β-NAD+ to deplete cellular energy stores, which 
contributes to SLO-mediated host cell death (Ghosh et al., 2010). It was initially reported 
that CMT could occur by simple diffusion through SLO pores (Madden et al., 2001). 
However, this idea has since been disproved as CMT requires the expression of SLO but is 
independent of pore formation (Magassa et al., 2010). Recent investigations suggest that 
CMT occurs by a co-dependent binding of SLO and SPN to cholesterol-insensitive regions at 
the host cell membrane (Mozola et al., 2014; Mozola and Caparon, 2015). However, the 
exact mechanism of CMT is not fully understood. 
 
1.2.2.3 Streptococcal pyrogenic exotoxin B (SpeB) 
SpeB is a secreted autocatalytic cysteine protease and represents a major virulence factor of 
GAS. The protein is secreted as a 40 kDa inactive zymogen, which undergoes autocatalytic 
processing, resulting in the 28 kDa mature active form (Carroll and Musser, 2011). SpeB is 
well conserved among different GAS serotypes and whilst 99% of GAS strains contain the 
speB gene, there are variations in the levels of expression between different emm-types 
(Cole et al., 2011). To establish infection, GAS must overcome the innate and adaptive 
immune response. SpeB has been demonstrated to degrade a wide variety of host proteins 
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through various stages of the infection cycle. SpeB cleaves several immunoglobulins (A, D, E, 
G and M) including a variety of complement factors including, C3b, C9, properdin and C1-
esterase inhibitor which provide resistance against complement activation and 
opsonophagocytosis (Tsao et al., 2006; Kuo et al., 2008; Honda-Ogawa et al., 2013). SpeB-
mediated degradation of C3b has been confirmed in sera from patients with STSS (Terao et 
al., 2008). In addition, SpeB may promote dissemination to deeper tissues by cleaving the 
host extracellular matrix protein fibronectin and degrading vitronectin (Kapur et al., 1993; 
Matsuka et al., 1999). 
SpeB has also proven proteolytic activity against GAS surface proteins, including M protein 
(Raeder et al., 1998), cell wall anchored fibronectin-binding proteins (Nyberg et al., 2004) 
and the C5a peptidase (Berge and Björck, 1995) which results in greater recruitment of 
neutrophils. Likewise, SpeB also cleaves the plasminogen activator streptokinase and the 
DNase Sda1 which promotes clearance from extracellular traps (Cole et al., 2006).  As a 
consequence, loss of SpeB is also associated with increased virulence of GAS (Raeder et al., 
2000; Sumby et al., 2006), since many essential GAS virulence factors are then spared from 
proteolytic degradation.   
Without active SpeB, plasminogen binds to the surface M protein and is converted to 
plasmin by the GAS streptokinase (Sanderson-Smith et al., 2008). Surface plasmin is 
essential for the destruction of tissue barriers and extracellular matrix proteins, facilitating 
the invasive spread of GAS in mice (Cole et al., 2006). The role of host plasmin in promoting 
GAS virulence has also been expanded to include protection against the antimicrobial 
peptide LL-37 (Hollands et al., 2012).  
Transition from localised GAS infection to invasive infection is associated with loss of SpeB 
expression (Cole et al., 2011). In vivo passaging of the bacteria through mice selects for low 
SpeB-producing bacteria, mainly due to mutations in CovRS (control of virulence regulator), 
that perturb SpeB expression (Mayfield et al., 2014). However, this may be different in 
humans since high amounts of SpeB were also found in biopsy tissue from patients suffering 
with NF (Thulin et al., 2006).  Likewise, in a group of patients with severe and non-severe 
GAS infection, the levels of SpeB did not correlate with disease severity (Chatellier et al., 
2000). In addition, a recent study carried out a molecular characterisation screen of multiple 
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GAS isolates in a patient that progressed from having non-severe infection to invasive 
disease (Flores et al., 2014). It was found that the transition to an invasive phenotype was 
not correlated with loss of SpeB. 
Often the reported activities of SpeB produce conflicting physiological findings (Nelson et 
al., 2011) and despite being one of the best studied GAS virulence factors, many of its 
reported functions remains controversial to date.  
 
 
1.3 Antimicrobial mechanisms of macrophages 
As key components of innate immune defence, macrophages are essential in controlling 
bacterial pathogens. Macrophages are one of the first cells recruited to the site of infection, 
which recognise and phagocytose invading bacteria to restrict their growth. Macrophages 
have evolved numerous mechanisms to restrict and kill intracellular bacteria. In this section I 
give an overview of some of the antimicrobial effector mechanisms used by macrophages in 
response to infection. 
 
1.3.1 Recognition and phagocytosis 
Phagocytosis is a form of endocytosis that recognises and internalises many different 
particles or solutes which can include pyroptotic cells, bacteria and viruses. The surfaces of 
macrophages are decorated with a multitude of receptors that recognise bacteria or opsonic 
ligands present on the bacteria.  Bacteria can be opsonised by antibody-dependant and 
antibody-independent mechanisms. Fcγ-Receptors (FcγRs) recognise the Fc region of IgG-
opsonised bacteria and initiate a signalling cascade leading to engulfment (Underhill and 
Ozinsky, 2002). Bacterial-bound opsonins C4b and C3b can engage the complement 
receptors CR1 and CR4 to promote opsonophagocytosis of bacteria (Virella, 2007). The 
surface of macrophages is also adorned with various pathogen recognition receptors (PRR) 
that directly bind to bacteria. For instance, scavenger receptors can bind to bacterial cell 
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wall components, like lipotechoic acid on Gram-positive pathogens or lipopolysaccharide 
(LPS) present on Gram-negatives (Haworth et al., 1997). Moreover, some bacteria 
containing exposed mannosylated glycoproteins can engage the mannose receptor (MR) on 
the cell surface (Zamze et al., 2002). Ligand-receptor engagement can also dictate the 
phagocytic uptake mechanism, such as phagocytosis, receptor-mediated endocytosis 
(clathrin-dependent or –independent) or macropinocytosis, the latter being a non-specific 
uptake mechanism (BoseDasgupta and Pieters, 2014; Liu and Roche, 2015).   
Pathogen engulfment and internalisation requires the activation of complex signalling 
pathways that are stimulated upon bacterial contact with the cells. Some of the signals 
which regulate phagocytosis include the phosphoinositide 3-kinase (PI3K), protein kinase C 
(PKC) and several members of the Rho GTPase family including CDC42, Rac and Rho 
(Underhill and Ozinsky, 2002). These proteins are crucial for actin rearrangement, 
membrane extension and engulfment of the bacteria into the cell.  
In many instances phagocytic uptake requires extensive plasmalemmal pseudopod 
formation, to engulf and deliver the cargo into the cell. Therefore, endomembranes are 
recruited to the site of entry to restore plasmamembrane content after phagocytosis (Bajno 
et al., 2000). Moreover, delivery of recycling endosomes is also important in the formation 
of the nascent phagosome.  
 
1.3.2 Phagolysosomal maturation 
Immediately following phagocytosis, the internalisation vacuole splits from the cell plasma 
membrane and traverses the endoyctic pathway, fusing with various sorting and recycling 
endosomes, to be delivered to lysosomes (Desjardins, 1995). The initial steps involved in 
early phagosome formation are mediated by the GTPase Rab5 and several Rab5-effector 
proteins including early endosome antigen 1 (EEA1) and PI3K (Somsel Rodman and 
Wandinger-Ness, 2000). This early phagosome exhibits weak bactericidal activity and has a 
slightly acidic luminal pH between 6.1-6.5. The phagosome matures into an acidic (pH 5.5-
6.0) and bactericidal compartment by the acquisition of vacuolar H+ ATPases (v-ATPases), 
and the accumulation of various hydrolytic enzymes, antimicrobial peptides and lysosomal-
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associated membrane proteins (LAMP) (Fairn and Grinstein, 2012). This transition is 
characterised by the switch from a Rab5 (early) to Rab7 (late) compartment (Mottola, 2014). 
Finally, the phagosome fuses with lysosomes, to become a phagolysosome with a luminal 
pH of 4.5-5.0 and numerous proteases and other acid hydrolase enzymes that can digest 
and degrade intracellular bacteria. 
 
1.3.3 Acidification of the phagosome 
v-ATPase is a large multiprotein complex consisting of a cytoplasmic (V1) and a membrane-
embedded (V0) component involved in the acidification of the phagosome (Beyenbach and 
Wieczorek, 2006). The v-ATPase hydrolyses ATP from the cytosol and pumps H+ ions across 
the membrane bilayer of the phagosome and into the lumen. The decrease in pH not only 
restricts bacterial growth but also activates various pH-sensitive proteases (Flannagan et al., 
2009). In addition, essential nutrients required for bacterial growth are extruded from the 
phagosome during translocation of H+ across the membrane. However the v-ATPase 
complex is not involved in phagolysosomal fusion (Kissing et al., 2015).  
 
1.3.4 Reactive oxygen and nitrogen species 
The ‘respiratory burst’ is the generation of reactive oxygen species (ROS) that contribute to 
pathogen killing. It is mediated by the NADPH oxidase, a multiprotein complex expressed 
within phagocytes, including neutrophils (PMN), monocytes and macrophages (Behe and 
Segal, 2007). Assembled on the phagosomal membrane, the NADPH oxidase complex 
consists of two transmembrane proteins, gp91-phox and p22-phox (flavocytochrome b558) 
and three cytosolic proteins, p47-phox, p67-phox and Rac (Fang, 2004).  ROS are produced 
by the transfer of electrons from NADH in the cytoplasm to molecular oxygen (O2), thereby 
generating superoxide (O2-), which is released into the phagosomal lumen. O2- dismutates to 
hydrogen peroxide (H2O2), which leads to further generation of hydroxyl radicals (OH) and 
other reactive oxygen intermediates (Dupré-Crochet et al., 2013). These compounds are 
highly reactive and can act as antimicrobial effectors. Myeloperoxidase (MPO) within the 
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phagosome catalyses the production of hypochlorous acid (HOCl) from H2O2 and chloride 
(Cl) (Fang, 2004).  HOCl has direct oxidising activity on lipids and amino acids and is highly 
toxic to bacteria (Rosen et al., 1990). Individuals with MPO deficiency often succumb to 
more severe infections (Kutter et al., 2000). A similar phenotype was also observed in MPO- 
and NADPH-knockout mice, indicating an important role of the NADPH oxidase system in 
host innate defense (Aratani et al., 2002, 2004). However, MPO is not expressed by 
differentiated macrophages in vitro (Nakagawara et al., 1981). 
Whereas macrophages are primed to generate ROS upon uptake of pathogens, reactive 
nitrogen species (RNS) require transcriptional activation. This is mediated by toll-like 
receptor (TLR) signalling and proinflammatory cytokines, such as tumor necrosis factor (TNF) 
and interferons (IFNs) (O’Neill and Hardie, 2013). Inducible nitric oxide synthetase (iNOS) is 
a dimeric complex which generates large quantities of nitric oxide by transferring electrons 
from NADPH to flavin mononucleotide (FMN) on one subunit, then to haem iron on the next 
subunit (Fang, 2004).  Like O2-, NO also accumulates in the phagosomal lumen where it can 
convert to many different RNS, like nitrogen dioxide (NO2), peroxynitrite (ONOO–) and 
dinitrogen trioxide (N2O3) (Nathan and Shiloh, 2000). In addition, RNS and ROS can work in 
tandem to enhance their toxic and microbicidal activity.  
 
1.3.5 NRAMP1 
The natural resistance-associated macrophage protein 1 (NRAMP1; also known as SlC11A1) 
is an integral membrane protein present on late endosomes and lysosomes, that restricts 
the growth of intracellular pathogens. NRMAP1 is a metal transporter which uses the 
electron transport chain to extrude various metals, like iron (Fe), manganese (Mn) and zinc 
(Zn) from the phagosome (Blackwell et al., 2000). These essential metals are required for 
microbial metabolism, protection against stress and/or virulence, and are severely limited 
during infection. NRAMP1 activity has also been shown to increase production of ROS and 
RNS and enhance the pro-inflammatory response (Fritsche et al., 2003; Nairz et al., 2009). 
Moreover, NRAMP1 also stimulates increased expression of Lipocalin 2 (Lcn2), a scavenger 
peptide that binds to iron-containing bacterial siderophores (Goetz et al., 2002; Holmes et 
al., 2005). It has also been revealed that mice harbouring defective NRAMP1 are more 
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susceptible to bacterial infections (Vidal et al., 1995). Overall, NRAMP1 functions as a metal 
withdrawal defence system in macrophages, generating an inhospitable environment for 
the intracellular pathogen.  
 
1.3.6 Antimicrobial peptides 
In addition to NRAMP1-dependant activation of Lcn2, many other proteins and peptides 
function to sequester iron upon stimulation of PRRs or TLR.  Hepcidin is an antimicrobial 
peptide expressed in macrophages which targets the iron export protein ferroportin 1 for 
degradation, to restrict the import and export of iron during infection (Ramey et al., 2010; 
Johnson and Wessling-Resnick, 2012). Hepcidin is upregulated in macrophages during IFN-γ 
stimulation or by TLR2/TLR4 and has been demonstrated to restrict the growth of 
Mycobacterium tuberculosis in vitro, by damaging the bacterial cell membrane (Sow et al., 
2007, 2011) 
Most antimicrobial peptides directly target the bacterial cell surface. Defensins are small (10 
kDa) cationic peptides belonging to two separate, structurally distinct α and β families 
(Ganz, 2003). Defensins are expressed in many cell types, some are constitutively expressed, 
whilst others are upregulated in response to infection and help to regulate both adaptive 
and innate immune response (Yang et al., 2004). Defensins are active against bacteria, 
binding to negatively charged surface components and forming multimeric ion-permeable 
pores (Kagan et al., 1990). Cathelicidins are also small antimicrobial peptides (10 kDa) which 
have similar roles in innate defence and work in synergy with defensins (Nagaoka et al., 
2000). One of the most widely studied cathelicidins is LL-37, produced in macrophages but 
found predominantly in neutrophil specific granules (Tecle et al., 2010). LL-37 accumulates 
and perturbs negatively charged lipids on the bacterial surface, causing membrane 
instability and leakage via a toroidal pore mechanism (Henzler Wildman et al., 2003). 
Interestingly, ubiquicidin is the only antimicrobial peptide discovered to date that is present 
exclusively within the cytosolic fraction of macrophages (Hiemstra et al., 1999). Ubiquicidin 
is induced upon IFN-γ stimulation and has potent antimicrobial activity against the cytosolic 
pathogen Listeria monocytogenes.   
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Most of the cell’s repertoire of antimicrobial peptides are usually enriched and sequestered 
within lysosomes (Kroemer and Jäättelä, 2005). Normally the lysosome is the ultimate 
destination for phagocytosed bacteria, either through endo-lysosomal maturation or via 
autophagosomal maturation through the autophagy pathway (explained further below). 
Lysosomes contain many different acid hydrolases, including proteases, lipases, 
endopeptidases, nucleases and glycosidases, capable of degrading all the major 
macromolecules of the pathogen (Flannagan et al., 2009).  
 
1.3.7 Autophagy 
Macrophages can use autophagy: a process of cellular phagocytosis involved in the 
degradation and recycling of damaged organelles and compartments, to capture and 
degrade bacteria in double membrane structures called autophagosomes. Many bacteria, 
including GAS, express virulence factors capable of destabilising or destroying its 
phagosome, thus activating autophagy in the process (Yuk et al., 2012). Autophagy can be 
activated by the cytosolic NOD-like receptors (NLR), AIM-2-like receptors (ALR) and RIG-I 
(retinoic-acid-inducible gene I)-like receptors  (RLR) which detect pathogen-associated 
molecular patterns (PAMPs) (Tang et al., 2012). 
These signals lead to the initiation and formation of the pre-autophagosomal structure 
called a phagophore (Vural et al., 2014). Autophagosome biogenesis is controlled and 
coordinated by the autophagy-related (Atg) proteins. The formation of the phagophore 
requires extensive liberation and mobilisation of intracellular membrane, thought to be 
derived from the Endoplasmic Reticulum (ER) and/or the Golgi (Chan and Tang, 2013). The 
phagophore is a double-membrane, crescent-shaped structure which enlarges to engulf the 
cytoplasmic cargo. The Atg1 complex with phosphatidylinositol-3-phosphate (PI3P) and 
beclin 1 (Atg6 homologue) activate downstream Atg- and autophagy-related proteins to 
trigger elongation and maturation of the autophagosome (Kang et al., 2011; Köfinger et al., 
2015). During autophagosome formation the microtubule-associated protein 1A/1B-light 
chain 3 (LC3) is recruited to the membrane. LC3 can act as a scaffold for interaction with 
autophagy cargo receptors and adaptor proteins like PLEKHM1, which mediate the 
36 
 
trafficking of the autophagsome to the lysosome (McEwan et al., 2015; McEwan and Dikic, 
2015). 
Upon entry into the cytosol, pathogens become coated in a dense layer of ubiquitin 
proteins, which act as “eat me” signals for several autophagy cargo receptors including 
NDP52, p62 and optineurin (Perrin et al., 2004; Zheng et al., 2009; Wild et al., 2011). These 
cargo receptors contain ubiquitin-binding domains and LC3-interacting regions (LIR) to 
mediate attachment of the ubiquitinated cargo to autophagosomal membranes for bacterial 
delivery into the autophagosome (Muhlinen et al., 2010). The autophagosome matures in a 
process analogous to the endolysosomal pathway, resulting in the formation of an 
autolysosome, in which the pathogen becomes degraded. 
 
1.3.8 Galectins  
Pathogens residing within phagosomes can also stimulate autophagy, particularly if the 
membrane becomes damaged or ruptured. In response, autophagy can retain bacteria 
within phagosomes and restrict their access to the cytosol via galectin recruitment to the 
exposed phagosome (Birmingham et al., 2006). The mammalian cell contains up to 15 
galectins, most of which are expressed in macrophages either constitutively or in an 
inducible manner. They are divided into three groups, prototype galectins (gal 1, gal 2, gal 
5, gal 7, gal 10, gal 11, gal 13, gal 14 and gal 15) containing one carbohydrate binding 
domain (CRD) that form homodimers; tandem repeat galectins (gal 4, gal 6, gal 8, gal 9, gal 
12) which contain two homologous CRDs connected via a 70 amino acid linker peptide and 
chimaera-type galectin 3 which contain one C-terminal CRD connected to a non-lectin N-
terminal region (Yang et al., 2008). 
Despite lacking a signal sequence required for secretion, galectins can be released from the 
cell, whereby they engage cell surface glycans to coordinate the innate and adaptive 
immune response. Galectins can regulate B-and T-cell activation, cell proliferation, cytokine 
production and apoptosis, among others (Rabinovich and Toscano, 2009). The 
disaccharide N-acetyllactosamine (LacNAc) is the preferred glycan for galectins, but a glycan 
microarray analysis revealed that many galectins exhibit subtle glycan binding preferences, 
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which could explain their functionally divergent roles (Stowell et al., 2008). Galectins are 
multivalent and can bind to numerous glycan ligands on the host cell and/or on the bacterial 
surface. Galectin 3 can bind lipopolysaccharide (LPS) from Neisseria meningitidis (containing 
terminal LacNAc) to increase bacterial attachment to macrophages (Quattroni et al., 2012). 
In addition, galectin 3 binding to Pseudomonas aeruginosa blocks bacterial attachment to its 
target cell (Gupta et al., 1997). 
Carbohydrates are typically expressed on the cell surface or in the lumen of endocytic 
vesicles but not within the cytosol. Therefore, cytosolic galectins (gal 1, gal 3, gal 8 and gal 9) 
act as danger receptors during infection, binding to β-galactosides localised within the inner 
leaflet of the phagosomal membrane that become exposed only upon membrane damage 
(Paz et al., 2010). Galectin 8 has been shown to activate antibacterial autophagy on 
damaged Salmonella-containing vacuoles (SCVs), via direct interaction with NDP52 to 
prevent bacterial proliferation in the cytosol (Thurston et al., 2012). However, the roles of 
galectin 1, 3 and 9 are less understood. 
 
 
1.4 Survival mechanisms of intracellular bacteria 
Intracellular pathogens have evolved various mechanisms to manipulate or arrest the 
phagolysosomal pathway in cells. This includes targeting different stages in the 
phagolysosomal maturation process or mediating escape from early/late phagosomes into 
the cytosol. In contrast, some organisms like Coxiella burnetti can withstand the harsh 
conditions within the phagolysosome.  
 
1.4.1 Interference with phagolysosomal maturation 
The success of M. tuberculosis as a human pathogen is largely attributed to its ability to 
prevent phagosomal maturation to promote its survival and growth within macrophages 
(Pethe et al., 2004). The M. tuberculosis-containing vacuole fails to undergo acidification 
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during infection and resembles that of an early phagosome, characterised by a mildly acidic 
pH (6.2) and retention of Rab5 (Clemens et al., 2000). Importantly, EEA1 is absent from the 
phagosome, an important mediator of phagosomal maturation. EEA1 mediates endosomal 
fusion through an interaction with PI3P and to hVPS34, a PI3 kinase which also recruits 
additional PI3P to the phagosome (Via et al., 1997; Fratti et al., 2001). Several mechanisms 
have been proposed to account for the maturation arrest in M. tuberculosis-infected cells, 
including the interaction between mannose-capped lipoarabinomannan (ManLAM) with MR 
on the surface of macrophages. ManLAM and MR interaction result in a unique bacterial 
uptake process that culminates in the arrest of phagosomal maturation (Kang et al., 2005). 
The same study showed that FcγR-mediated internalisation of M. tuberculosis or replacing 
ManLAM with phosphatidylinositol-capped LAM, resulted in normal phagolysosomal 
maturation. In addition, the M. tuberculosis lipid phosphatase SapM is reportedly involved 
in the depletion of PI3P from the phagosome, contributing to the arrest of phagosomal 
maturation (Vergne et al., 2005). Another proposed mechanism involves the delivery of 
bacterial effectors into the macrophage from the accessory SecA2 secretion system (Sullivan 
et al., 2012). A greater number of ΔsecA2 mutant bacteria are found within acidic 
compartments that associate with late endocytic markers, compared to WT bacteria.  
Salmonella Typhimurium is another intracellular pathogen which modifies its intracellular 
phagosome extensively, leading to the formation of the SCV that provides a suitable 
replicative niche (Brumell et al., 2002). The SCV transits through the endosomal pathway 
undergoing acidification by the v-ATPase and acquiring LAMP1/2, in a Rab7-dependant 
manner (Holden, 2002). However, the SCV remains devoid of many essential lysosomal 
hydrolases, including the mannose-phosphate receptors (MPR) that deliver lysosomal 
enzymes from the Golgi (Méresse et al., 1999; Thompson et al., 2011). It was discovered 
that Salmonella impair lysosomal activity through the interaction between the type III 
secretion system effector SifA and its host target SKIP (SifA and kinesin-interacting protein) 
(McGourty et al., 2012). SifA-SKIP can bind and sequester Rab9, preventing the Rab9-
dependent trafficking of MPRs, which in turn prevents the delivery of hydrolases to the 
lysosome.  
C. burnetii is a rare example of an intracellular bacterium that not only survives, but 
replicates in an acidified and fully functional lysosomal-like compartment (Flannagan et al., 
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2009). Upon uptake into alveolar macrophages, C. burnetii express a Dot/Icm type IV 
secretion system (T4SS) that transports effector proteins into the cytoplasm. Some of these 
effectors were found to recruit p62 and LC3 which delays the fusion with lysosomes, 
facilitating a transition to a replicative large-cell form (Winchell et al., 2014). Later during 
infection, C. burnetii resides within an acidified vacuole, containing v-ATPase and many 
lysosomal-associated hydrolases (Newton et al., 2013). It is speculated that the acidic pH is 
required for bacteria to express virulence factors that neutralise the effects of the 
antibacterial peptides (Howe et al., 2010). However, most of the bacterial effectors which 
mediate this process have not yet been characterised in detail (Larson et al., 2015).  
 
1.4.2 Cytosolic escape and evasion of autophagy 
L. monocytogenes is a facultative intracellular pathogen that arrests phagolysosomal 
maturation and mediates phagosomal escape through the actions of LLO. L. monocytogenes 
replicates rapidly in the cytosol and is therefore perceived as a professional cytosolic 
pathogen. LLO requires activation by IFN-γ-inducible lysosomal thiol reductase (GILT) and/or 
acidification to promote membrane damage (Singh et al., 2008). LLO is optimal at pH 5.5 
and is restricted to the L. monocytogenes-containing vacuole. The pore-forming activity of 
LLO is largely responsible for facilitating bacterial escape from the phagosome, albeit not in 
human cells (Cossart, 2011). L. monocytogenes also secretes two phospholipase enzymes, 
phosphoinositol-specific phospholipase C (PI-PLC) and the broad-range phosphatidylcholine-
specific phospholipase C (PC-PLC) (Smith et al., 1995). In macrophages, both PI-PLC and PC-
PLC mediate bacterial escape in the absence of LLO. It is speculated that LLO-mediated pore 
formation can delay the maturation of the phagosome by disrupting the pH gradient, 
thereby allowing more time for the bacteria to escape (Shaughnessy et al., 2006). In 
addition, LLO prevents the accumulation of ROS in the phagosome by suppressing PLC-
mediated activation of the NADPH oxidase (Lam et al., 2011).  
Upon entry into the cytosol, L. monocytogenes uses the virulence factor ActA to stimulate 
the polymerisation of actin filaments for actin-based motility. The hijacking of actin propels 
the bacteria throughout the cell and eventually to neighbouring cells, to promote cell-to-cell 
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spread (Portnoy et al., 2002). The N-terminal ActA domain binds to, and activates, the 
Arp2/3 complex, which nucleates actin filaments and a central ActA domain recruits 
proteins of the Ena/VASP family, which promote the actin-based motility. Importantly, this 
ActA-mediated accumulation of Arp2/3 and Ena/VASP on the bacterial surface prevents 
autophagic recognition and enables the cytosolic replication of L. monocytogenes 
(Yoshikawa et al., 2009). In contrast, ΔactA mutants are efficiently targeted by p62 and 
NDP52 cargo receptors and localised within LC3-positive autophagosomes (Mostowy et al., 
2011). L. monocytogenes can also use another camouflage strategy to avoid autophagy, by 
using the surface internalin InlK to recruit the major vault protein (MVP), a cytoplasmic 
ribonucleoprotein complex that prevents autophagic recognition (Dortet et al., 2011).  
 
1.4.3 Intracellular survival of GAS 
The global burden of severe GAS disease is remarkably high, with a prevalence of 18.1 
million cases and over 500,000 deaths per year (Carapetis et al., 2005a). The incidence of 
GAS disease likely outnumber tuberculosis rates and GAS disease kills more annually than 
hepatitis B, yet remains under-researched in comparison to other major pathogens. 
Although classically regarded as an extracellular pathogen, GAS can invade and survive 
within human epithelial and endothelial cells (LaPenta et al., 1994; Marouni and Sela, 2004; 
Amelung et al., 2011). Several GAS virulence factors have been shown to mediate bacterial 
uptake into cells, including the M protein, capsule, surface fibronectin-binding proteins 
(Fbps) and several proteases including SpeB and SpyCEP (Jadoun et al., 2002; 
Purushothaman et al., 2003; Kaur et al., 2010; Amelung et al., 2011). The consensus within 
the literature is that GAS fail to proliferate in epithelial and endothelial cells (Greco et al., 
1995; Marouni and Sela, 2004; Schrager et al., 1996).  Upon uptake of serotype M3 GAS in 
endothelial cells, the bacteria-containing vacuole does not deviate from the phagolysosomal 
pathway and is quickly trafficked to terminal lysosomal compartments (Amelung et al., 
2011; Nerlich et al., 2009). In epithelial cells, serotype M6 GAS can escape from the 
phagosomes into the host cytosol, mediated by the SLO toxin (Nakagawa et al., 2004). Once 
in the cytosol, M6 GAS is recognised by autophagy and sequestered in LC3 autophagosomes 
that are then degraded within autolysosomes (Sakurai et al., 2010; Yamaguchi et al., 2009a; 
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Nozawa et al., 2012). The crucial role of autophagy in restricting M6 GAS is highlighted by 
Nakagawa et al (2004), who showed GAS can survive and replicate in Atg5-deficient cells 
(Nakagawa et al., 2004). Because M6 GAS are efficiently recognised and sequestered by 
autophagy, this serotype is frequently used as an infection model for selective autophagy 
(Nakagawa, 2013).  Another study which examined the intracellular fate of serotype M49 
GAS, found that cells lacking the autophagy cargo receptor NDP52 can no longer restrict the 
growth of GAS (Thurston et al., 2009). In contrast, a recent study which examined the 
intracellular fate of the hyperinvasive M1T1 GAS clone in epithelial cells, found that this 
strain can replicate whereas an M6 serotype strain cannot (Barnett et al., 2013).  Because 
M6 GAS are defective for expression for SpeB, M1T1 evades autophagy by SpeB-mediated 
degradation of essential autophagy cargo recpetors, thereby facilitating bacterial growth.  
Macrophages are key components of the innate immune defence against pathogens, 
however very little is known regarding the intramacrophage fate of GAS. It has been well 
documented over the years that GAS can survive in human blood and this was attributed in 
part to the antiphagocytic capacity of the surface M-protein (Lancefield, 1962). GAS 
contains a wide variety of membrane-bound and secreted factors that function to prevent 
opsonophagocytosis in macrophages. Likewise, in vivo studies showed that chemical or 
genetic depletion of macrophages increase GAS disease severity (Goldmann et al., 2004; 
Phelps and Neely, 2007).  
However, the M1 protein has been demonstrated to prevent phagolysosomal fusion of 
M1T1 GAS in human macrophages (Hertzén et al., 2010). It was reported that GAS can resist 
killing and establish a replicative niche, although the mechanism is not yet understood. The 
same group also observed that bacteria can escape from infected macrophages to reinfect 
surrounding macrophages. In contrast, Bastiat-Sempe et al. found that M1T1 GAS do not 
inhibit phagolysosomal fusion in THP-1 macrophages, but rather prevent the acidification of 
the GAS-containing vacuole (GCV) in an SLO-dependant manner (Bastiat-Sempe et al., 2014). 
Failure of the GCV to undergo acidification led to enhanced intracellular survival of GAS.  
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Cell type         Cell line   Strain            Intracellular fate        Mechanism                                    Reference 
 
Macrophage  hMDM    M1 5448        Replication                - M1 protein inhibits lyso-              Hertzen et al. 2010                     
                                                                                                        somal fusion to the GCV 
                         THP-1      M1 5448        Enhanced survival      SLO inhibits acidification              Bastiat-S. et al. 2014          
                                                                                                        of the GCV 
                         J774         M1 5448        Survival                        SpyA-independant                         Lin et al. 2015                         
                         J774         5448ΔspyA - Replication                  Lack of SpyA-mediated casp-       Lin et al. 2015        
                                                                                                        ase-1-dependant cell death           
                         BMDM    M1 5448     -  Survival                        SpyA-independent                        Lin et al. 2015                
                         BMDM    5448ΔspyA    Replication                  Lack of SpyA-mediated casp-      Lin et al. 2015       
                                                                                                        ase-1-dependant cell death            
 
Neutrophil      hMDN     M1 AP1        Enhanced survival       M protein-dependant                  Staali et al. 2003 
                           
 
Epithelial        OKP7      M3 188         Enhanced survival        SLO inhibits lysosomal fusion    Häkansson et al. 2005 
                         OKP7      M3 188         Enhanced survival        SLO and SPN inhibit lyso-            O’Seagdha  et al. 2013 
                                                                                                         somal fusion to the GAS-  
                                                                                                         containing autophagosome        
                   WT MEFs      M6 JRS4        Survival                          Atg5 restricts growth                  Nakagawa et al. 2004 
             Atg5-/-  MEFs      M6 JRS4        Replication                    siRNA knockdown of Atg5          Nakagawa et al. 2004 
                                                                                                         facilitates growth of GAS 
                          Hep-2     M1 5448       Replication                    SpeB cleaves autophagy             Barnett et al. 2013 
                                                                                                         cargo receptors 
                   WT HeLa       M89 h293     Survival                         NDP52 restricts growth               Thurston et al. 2009 
          siNDP52 HeLa       M89 h293     Replication                   siRNA knockdown of NDP52      Thurston et al. 2009 
                                                                                                        facilitates growth of GAS 
  
 
Table 1. Different GAS isolates and cell types used in research articles that specifically reported 
enhanced intracellular survival and/or replication of GAS in vitro.  
 
1.4.4 Intracellular persistence 
The idea of GAS as an extracellular pathogen has undergone re-evaluation in the last 
number of years. GAS is a persistent coloniser of the oropharynx, which causes recurrent 
bouts of pharyngotonsillitis.  Some studies have reported that GAS can survive for several 
days in cultured epithelial cells (LaPenta et al., 1994; Osterlund and Engstrand, 1995; 
Marouni et al., 2004). Several ex vivo studies have also revealed an intracellular reservoir of 
GAS inside tonsillar epithelial cells in patients suffering from recurrent tonsillitis (Osterlund 
and Engstrand, 1997; Osterlund et al., 1997). The ability of GAS to invade and survive within 
eukaryotic cells may provide protection against host defence or antibacterial agents. 
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Treatment failure is frequently reported in cases of GAS infection and the mechanisms that 
underlie recurrent disease pathology are unknown (Ogawa et al., 2011a). It has been 
reported that some pathogens can enter a non-replicative persister state upon uptake in 
cells which may contribute significantly to recalcitrance of chronic infection in patients 
(Helaine and Kugelberg, 2014). 
 
 
1.5 Persisters in chronic infection 
1.5.1 Discovery of persisters 
Persisters are a sub-population of bacteria which are highly tolerant to bactericidal 
concentrations of multiple antibiotics. Research conducted in the last 10-15 years strongly 
suggests that persisters contribute significantly to the recalcitrance of chronic infections. 
The term ‘persisters’, was first coined by Joseph Bigger, who failed to sterilize a culture of 
Staphylococcus aureus with penicillin (Bigger, 1944). He reported that a small subpopulation 
of bacteria tolerated the effects of penicillin. Upon re-inoculation, the survivors were as 
tolerant to the antibiotic as the previous generation, leading him to the conclusion that this 
phenomenon was not attributed to bacterial resistance. He proposed that these persisters 
were slow or non-growing bacteria. Persisters are distinct from resistant bacteria since they 
fail to proliferate in the presence of antibiotics and re-establish growth only after the drug 
has been removed. Persister cells are phenotypic variants within an isogenic bacterial 
population. It was later shown that persisters were non-growing bacteria formed 
independently of exposure to antibiotics (Balaban et al., 2004). Since they do not undergo 
cellular activities which antibiotics can target, they can tolerate multidrug treatment. For 
example, β-lactams inhibit bacterial cell wall synthesis and exert their most bactericidal 
effect against actively dividing bacteria (Golan, 2008). Not surprisingly, persister formation is 
dependent on the growth stage of the bacteria. Whereas early log phase cultures of E. coli 
and P. aeruginosa produce few persisters, stationary phase cultures produce significantly 
more (Spoering and Lewis, 2001; Keren et al., 2004). However, no study to date has 
investigated persister formation of GAS. 
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1.5.2 Selection of high persister (hip) mutants during infection 
In the 1980’s, Moyed and Bertrand isolated the first high persister (hip) mutant of E. coli 
during in vitro selection with ampicillin following chemical mutagenesis (Moyed and 
Bertrand, 1983). Compared to wild-type (WT) cultures (10-5-10-6) the hipA7 mutant 
produced significantly more persisters (10-2). Based on this finding, other groups suggested 
that the repetitive application of antibiotics in patients, suffering with chronic disease, may 
represent a selective advantage for the high persister-producing pathogen and could lead to 
the emergence of hip mutants in a clinical setting. One study found a correlation between 
increased antibiotic tolerance and prolonged drug therapy in isolates of M. tuberculosis 
obtained from patients with pulmonary tuberculosis (Wallis et al., 1999). 
Over many years, P. aeruginosa is able to establish chronicity in the lung epithelium of 
patients suffering with cystic fibrosis (CF) (Davies, 2002). CF patients are given regular 
antibiotic treatment at high doses for long periods to control respiratory infections (Saiman 
et al., 2014). An important study conducted by Mulcahy and colleagues in the USA, reported 
that hip mutants were identified in a set of longitudinal P. aeruginosa isolates obtained from 
CF patients over a 96 month period (Mulcahy et al., 2010). The late hip isolates produced 
higher levels of persisters compared to early isolates and importantly, did not demonstrate 
resistance to antibiotics.  hip mutants can carry a number of mutations in quorum sensing 
genes (lasR) which can affect biofilm formation (D’Argenio et al., 2007), or multidrug efflux 
pumps (MexXY-OprM) (Mulcahy et al., 2010). These mutations produce elevated numbers 
of antibiotic tolerant persisters, but importantly do not significantly affect drug MIC levels.  
Candida albicans hip mutants are also selected for in vivo during prolonged antibiotic 
therapy. C. albicans isolates from patients with chronic candidiasis produced significantly 
more persisters compared to isolates from patients that were treated successfully (LaFleur 
et al., 2010). More recently, it was shown that hip mutants have been selected in clinical 
isolates from recurrent urinary tract infections (Schumacher et al., 2015). 
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1.5.3 Persisters in biofilms 
Biofilms are highly tolerant to antimicrobial agents and are a common cause of persistent 
infections (Costerton et al., 1999). Intensive and long term antibiotic therapy is required to 
treat biofilm infections but is often ineffective and fails to eradicate the bacteria. Biofilms 
are associated with obstructive pulmonary diseases, endocarditis, otitis media and wound 
infections (Wu et al., 2015). Biofilm infections are also a major problem with the use of 
medical prosthesis including heart valves and intravenous catheters. There are a number of 
potential mechanisms which allow biofilms to withstand killing by antibiotics. For instance, 
some antibiotics have a limited ability to penetrate biofilms due to their dense nature. 
Macrolides, tetracyclines and quinolones are better able to penetrate biofilms to achieve 
bactericidal concentrations, compared with most β-lactams (Singh et al., 2010a). 
Nonetheless, effective antibiotic penetration can still result in eradication failure (Walters et 
al., 2003). Alternatively, nutrient depletion and oxygen limitation within a biofilm can 
stimulate bacterial entry into an inactive, non-growing state and promote antibiotic 
tolerance and recalcitrance to treatment (Amato and Brynildsen, 2014).  
 
Bacteria within a biofilm have a much higher mutation rate and experience horizontal gene 
transfer more frequently than planktonic bacteria, which could explain how traditional drug 
resistance can be acquired (Molin and Tolker-Nielsen, 2003; Driffield et al., 2008). However, 
some biofilms remain highly resistant to antibiotics without having any classical antibiotic 
resistance profile (Lewis, 2005). For example it was shown that dose-dependent killing of a 
P. aeruginosa biofilm revealed the presence of a small non-growing fraction that was 
responsible for resistance to high concentrations of quinolones in the biofilm (Brooun et al., 
2000; Spoering and Lewis, 2001). It is proposed that a small proportion of bacteria in the 
biofilm persist in a non-growing state during antibiotic therapy but eventually resuscitate 
and repopulate the biofilm leading to relapse of infection. This process is depicted in Fig. 
1.1. 
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Figure 1.3. Persisters lead to relapse in biofilm infection 
Regular cells and persisters cells form a biofilm and are embedded into a three-dimensional polymer 
network called a biofilm matrix. However, some cells are released into the surrounding tissue which 
can be targeted and killed by the immune system. Regular cells are killed during antibiotic therapy 
but the drug-tolerant persisters remain. The matrix protects the persisters from killing by 
components of the immune system and when the antibiotic levels decline they can repopulate the 
biofilm to establish infection once more. 
  
 
 
1.6 Mechanism for persister formation 
1.6.1 Quorum sensing systems 
The growth stage-dependent formation of persisters is analogous to the dynamics of 
quorum sensing (QS) in bacteria.  QS is a cell-to-cell communication system based on the 
release of low molecular weight signal molecules, which increase in concentration as a 
function of bacterial density to coordinate gene expression in bacterial populations (Miller 
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and Bassler, 2001). The Lewis group found no evidence that spent medium from stationary 
phase cultures of E. coli could increase the rate of persisters in early log phase cultures 
(Lewis, 2007). Recently many studies have reported the existence of QS molecules and 
chemical inducers which can induce increased drug tolerance and affect the persister state 
(Prax and Bertram, 2014).  
 
It was recently discovered that secreted QS molecules of P. aeruginosa  called pyocyanin 
(PYO) and acyl-homoserine lactones (3-OC12-HSL) enhance the number of antibiotic-
tolerant persisters formed (Möker et al., 2010). This effect was further demonstrated by 
addition of spent stationary phase cultures to exponentially growing cultures of P. 
aeruginosa, but not S. aureus or E. coli. Another QS molecule called 2’ Amino-acetophenone 
(2-AA) from P. aeruginosa was recently shown to promote antibiotic tolerance by 
downregulating many factors involved in translation (Que et al., 2013). In addition, 
Streptococcus mutans secretes the QS-signalling CSP (competence stimulating peptide) 
pheromone that modulates the formation of stress-induced multidrug tolerant persisters 
(Leung and Lévesque, 2012). This same group later showed that CSP induction of LexA 
transcriptional regulator activates a non-classical SOS pathway that promotes tolerance 
towards DNA damaging agents (Leung et al., 2015). 
 
Alternatively, E. coli uses chemical signalling through indole to establish bacterial 
heterogeneity in the bulk population. Indole was previously shown to promote antibiotic 
resistance by inducing expression of multidrug efflux pumps (Hirakawa et al., 2005; Lee et 
al., 2010). However, indole signalling significantly increases the level of persisters as well 
through the activation of membrane and oxidative stress response (Vega et al., 2012). 
Remarkably, indole signalling was also found to positively influence persister formation in 
Salmonella, a bacterium which does not produce indole (Vega et al., 2013). It is thought that 
indole enhances antibiotic tolerance in Salmonella via the same stress pathways as for E. coli 
which reveals that persister-enhancing signalling is not limited to intra-species 
communication. This may have important implications in polymicrobial infections in vivo. 
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1.6.2 Toxin/antitoxin (TA) modules 
Toxin/antitoxin (TA) loci are common in many bacteria and archaea (Pandey and Gerdes, 
2005). TA systems were first described as plasmid addiction systems involved in the post-
segregational killing (PSK) of plasmid-free cells to maintain the stability of low copy plasmids 
in the bacterium (Ogura and Hiraga, 1983). This ensured that each cell received at least 1 
copy of each plasmid. The genetic architecture of most class II TA modules consists of an 
operon comprising two adjacent, co-orientated genes whose products encode for small 
antagonistic proteins; a toxin and an antitoxin (Kroll et al., 2010). TA systems are widely 
distributed throughout the chromosomes of many bacteria and have been implicated in 
virulence and persister formation. In the majority of chromosomal TA systems studied to 
date, the toxin is usually encoded downstream of the antitoxin gene and can disrupt 
important cellular functions, such as mRNA translation, to inhibit bacterial growth. The 
antitoxin can bind directly and form a complex with the toxin to counteract the toxic effect. 
The antitoxin can autoregulate transcription by binding to regulatory sequences upstream 
of the TA operon (Hayes and Kędzierska, 2014). Interaction with the promoter is further 
enhanced upon binding to the toxin, thus the toxin can function as a co-repressor of 
transcription (Christensen et al., 2001). Antitoxin proteins are much less stable than their 
toxin counterparts and must be expressed at higher levels. This system of regulation is 
required since antitoxins are proteolytically regulated by ATP-dependant proteases (Clp and 
Lon), activated upon environmental stress such as amino acid starvation. The degradation of 
the antitoxin liberates the toxin to disrupt essential cellular processes such as translation, 
replication and cell wall synthesis. This can induce a state of dormancy to protect the cell 
from stress and can promote antibiotic tolerance. Therefore, TA loci are attractive 
candidates for studying persisters (Unterholzner et al., 2013). 
There are 5 classes of TA systems (I-V) reported, which differ based on their structure and 
regulation (Unterholzner et al., 2013). In type I and III TA systems, the antitoxin are small 
non-coding RNAs, but will not be discussed further. In type II TA systems the genes encode 
two small proteins and are the most widely characterised system to date. Type II TA offers 
the best mechanisitic insights into persister formation and drug tolerance in many different 
bacteria.  
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Figure 1.4. A model for a type II TA module regulation 
The toxin and antitoxin genes encode two small proteins. The antitoxin contains a DNA binding motif 
and can repress activation of the TA promoter. Repression is strongest during exponential growth 
when toxin levels are minimal and the TA complex is bound to the promoter. When stress pathways 
are activated several ATP-dependant proteases can cleave the antitoxin and liberate the toxin. 
Liberated toxin can derepress TA transcription leading to an accumulation of toxin which then binds 
its target to induce rapid growth arrest. 
 
 
1.6.3 TA modules in the hip mutants 
The first genetic evidence for bacterial multidrug tolerance originated from the mutations 
acquired in the E. coli hip mutant (Moyed and Bertrand, 1983) that mapped to the hipA7 
locus, which is a toxin gene of the hipBA type II TA operon. The overexpression of HipA was 
shown to induce growth arrest and multidrug tolerance (Keren et al., 2004b; Correia et al., 
2006a). hipA encodes a kinase that phosphorylates glutamyl-transfer RNA synthase, thereby 
activating the stringent response leading to increased persistence (Germain et al., 2013; 
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Kaspy et al., 2013). Interestingly, structural studies revealed the mechanism behind the hip 
mutant phenotype. The mutant hipA7 gene contains two amino acid substitutions (G22S 
andD291A) which weakens the hipB/hipA complex and facilitates increased kinase activity 
(Schumacher et al., 2009). The same group also reported that HipA halts mRNA translation 
by phosphorylation of the essential translation factor EF-Tu (elongation factor-Tu). 
However, this finding has been disputed recently. Two independent studies have now 
shown that HipA phosphorylates glutamyl-transfer RNA synthase which causes an 
accumulation of uncharged glutamate (Glu), thereby leading to increased levels of the 
alarmone guanosine tetraphosphate (ppGpp), a central mediator of the stringent response 
(Germain et al., 2013; Kaspy et al., 2013). Crucially, a recent study has provided evidence 
that shows the hipA7 mutants are found within patients suffering from urinary tract 
infections (UTIs), a common chronic infection caused primarily by E. coli (Schumacher et al., 
2015).  
 
 
1.6.4 The relBE TA family  
RelE is one of the most widely studied toxins belonging to the relBE type II TA superfamily, 
with many homologues in both Gram-positive and Gram-negative species (Gerdes et al., 
2005). The relBE superfamily is subdivided into separate families:  HigBA (Hurley and 
Woychik, 2009), YfeM-YoeB (Zhang and Inouye, 2009), YgiTU(mqsAR) (Yamaguchi et al., 
2009b) and prlF-yhaV (Maisonneuve et al., 2011), based on sequence and/or structural 
similarity with the E. coli RelE toxin. Under normal growth conditions RelE is in complex with 
RelB and acts as a co-repressor of RelBE transcription. Therefore transcripts are low and 
toxicity is retarded. However, during amino acid starvation the stringent response is 
activated leading to Lon-mediated degradation of RelB, which allows RelE to induce growth 
arrest (Christensen et al., 2001). This has been shown to be an important mechanism of 
bacterial entry into dormancy. 
 
RelE acts as a strict ribosome-dependent RNA interferase that cleaves translating mRNA at 
the ribosome A-site codon, resulting in stalled ribosomes on damaged mRNA (Pedersen et 
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al., 2003). RelE displays a codon-independent cleavage specificity which preferentially 
cleaves upstream of purines between the second and third positions of codons (Neubauer 
et al., 2009). This has revealed the existence of RelE preferential cleavage sites, CAG CUG 
and GCG which are highly represented on the E. coli genome (Goeders et al., 2013). This 
cleavage specificity and broad substrate range suggests that RelE toxins have evolved to halt 
translation rapidly and efficiently to adapt to environmental changes.  
 
Transcriptomic analysis of M. tuberculosis persisters show that RelE toxins are induced 
during antibiotic treatment and are associated with entry into dormancy (Boshoff et al., 
2004; Keren et al., 2011). Several RelE-like toxins of M. tuberculosis are upregulated in vivo 
and are highly expressed in infected macrophages (Korch et al., 2009; Singh et al., 2010b). 
Similarly, S. Typhimurium contains 14 TA modules, including several relBE homologues, 
which are activated in response to acidification and nutrient starvation and contribute to 
the formation of intracellular persisters after uptake in cells (Helaine et al., 2014). 
Moreover, the overproduction of RelE-like toxins, from many bacterial species can induce 
bacterial growth arrest. Overexpression of E. coli RelE led to as much as a 10,000 fold 
increase in persisters formed (Keren et al., 2004b). This phenotype was reversible upon co-
expression of the RelB cognate antitoxin gene. Interestingly, the targeted deletion of all 10 
mRNase-encoding TA modules in E. coli K12 led to a 200 fold reduction in persister 
formation. 
 
 
1.6.5 Epsilon-zeta (ε/ζ) TA system in GAS 
Most of the current knowledge of TA systems is derived from organisms such as E. coli and 
P. aeruginosa. Currently, only one TA system has been characterised in GAS, the plasmid-
borne epsilon/zeta (ε/ζ) type II TA system encoded by the GAS plasmid pSM19035 
(Ceglowski et al., 1993). A low copy plasmid (two-five copies per cell), pSM19035 confers 
resistance to several antibiotics and is maintained in the absence of antibiotic selection 
(Hayes and Kędzierska, 2014). The ζ toxin contributes to the stable inheritance of pMS19035 
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by inducing PSK of plasmid-devoid offspring. Interestingly, a chromosomally encoded ε/ζ TA 
system has been identified in S. pneumoniae (PezAT) and is involved in promoting virulence 
(Brown et al., 2004). The PezT toxin was shown to disrupt peptidoglycan synthesis and 
trigger autolysis in E. coli (Mutschler et al., 2011). The current hypothesis is that the PezT 
toxin triggers lysis of S. pneumoniae during infection, resulting in cellular fragmentation and 
release of virulence factors like pneumolysin (Mutschler and Meinhart, 2011). Overall, no 
study has yet characterised the role of chromosomally-encoded TA modules in GAS.  
A toxin/antitoxin database (TADB) has been developed and is currently accessible as a web-
based compilation of predicted type II TA systems in over 1000 prokaryotic genomes (Shao 
et al., 2011).  According to TADB GAS encode multiple putative TA systems, some of which 
have been well characterised like the RelBE TA family, and others which represent new, as 
yet uncharacterised TA families. No study to date has investigated the functionality of the 
predicted type II TA systems in GAS.  
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1.7   Aims of the project 
GAS has been shown to survive for several days in epithelial cells grown in the presence of 
antibiotics. This and other work suggests that internalised GAS could establish a reservoir of 
bacteria with the potential to cause recurrent infections. Interestingly, an association 
between bacterial persister formation and recurrent infections have been reported in the 
literature as well as an essential role for toxin/antitoxin modules in persister formation 
during infection. Since no study to date has investigated persister formation of GAS, one 
objective of this study was to investigate the frequency of persister formation in clinical 
isolates of GAS and to investigate the role of putative GAS toxin/antitoxin modules in 
persister formation. It was hypothesised that clinical recurrent disease isolates of GAS form 
more persisters in vitro and in vivo compared to non-recurrent disease isolates.  
In contrast, some groups have reported that upon phagocytosis of M1 GAS in human 
neutrophils and macrophages, the M1 protein prevents fusion of the GCV with azurophilic 
granules and lysosomes, respectively. One study observed septum formation in intracellular 
GAS, suggesting an ability to replicate in macrophages. However, an in-depth analysis of 
survival and replication of GAS in human macrophages is currently lacking. Therefore 
another aim of this study was to establish an accurate and reproducible infection model of 
GAS in human macrophage-like cell lines and to measure intracellular growth of GAS at both 
population and single cell levels. The hypothesis was that by using a clinically relevant M1T1 
hyperinvasive strain, I would obtain evidence that GAS can resist killing in human 
macrophages and undergo vacuolar and/or cytosolic replication.  
During this study I aimed to understand more about the interactions between intracellular 
GAS and human macrophages and the nature of persisters in recurrent disease. This was to 
be achieved by: 
- Establishing a reliable and accurate infection system for GAS to detect intracellular 
replication using fluorescence microscopy 
- Investigating the involvement of M1 protein and other GAS virulence factors in 
promoting intracellular survival and replication 
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- Carrying out an analysis of GAS trafficking in macrophages to establish whether the 
GAS vacuole manipulates or deviates from the endosomal pathway  
- Investigating a potential role for persisters in chronic GAS infection by determining if 
GAS form persisters in vitro and in vivo and if clinical recurrent disease isolates form 
more persisters than non-recurrent isolates.  
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Chapter 2 
 
2.0   Materials and Methods 
 
2.1 Bacterial strains and growth conditions 
GAS strain 5448 is a clinical isolate obtained from a patient with NF and STSS and is 
representative of the globally disseminated M1T1 clone (Kansal et al., 2000). M1T1 5448 
was provided by A. Norrby-Teglund including the mutant lacking the M1 protein (5448 
Δemm1). The serotype M49 NZ131 strain  is a skin isolate from a patient with 
glomerulonephritis (Simon and Ferretti, 1991). NZ131 was provided by S. Sriskandan 
including the mutant lacking the SLO toxin (M49 Δslo). All clinical isolates of GAS were 
provided by Prof. S. Sriskandan (Imperial College).  
 
2.2 Bacterial growth conditions 
GAS strains were routinely grown at 37°C in a standing culture for 16 h until stationary 
phase in Todd-Hewitt Broth (THB, Oxoid) supplemented with 1% yeast extract. When 
appropriate, culture medium was supplemented with erythromycin (10 µg/ml). S. 
Typhimurium and E. coli strains were routinely grown in Luria-Bertani (LB) broth at 37°C in a 
shaking incubator at 200 rpm, or on agar plates incubated at 37°C (Sambrook and Russell, 
2001). When appropriate, culture medium or agar plates were supplemented with ampicillin 
(50 μg/ml) or kanamycin (50 μg/ml). Electroporated bacteria were recovered in SOC 
medium (20 g/L bacto-tryptone, 5 g/L yeast extract, 0.5 g/L NaCl, 2.5 mM KCl, 10 mM MgCl2 
and 20 mM glucose) (Sambrook and Russell, 2001). 
 
 
56 
 
2.3 Polymerase Chain Reaction (PCR) 
DNA fragments were PCR amplified using Expand High Fidelity (Roche) system, according to 
the manufacturer’s instructions.  Reactions were carried out in 1 X Expand High Fidelity 
Buffer, 0.2 µM dNTP Mix (Sigma), 0.1 µM forward and reverse primers, template DNA 
(typically 10 ng), 2.5 U Expand High and sterile water made up to a final reaction volume of 
50 µl. Parameters for PCR amplification were as follows: pre-denaturation at 95°C for 5 min, 
denaturation at 95°C for 30 sec and annealing at 55°C for 30 sec for 30 cycles, extension for 
1.5 min at 72°C followed by a final 5 min extension at 72°C and held at 4°C. Colony PCR was 
carried out using REDTaq ReadyMix PCR reaction mix (Sigma), according to manufacturer’s 
instructions. 
 
2.4 Extraction and purification of plasmid DNA 
Plasmid DNA was extracted from overnight (O/N) cultures of E. coli using the GenElute 
Plasmid Miniprep kit (Sigma), according to the manufacturer’s instructions, and eluted in 75 
μl sterile water.  
 
2.5 Electrophoresis of DNA 
Linear and circular DNA samples were prepared in 5 X loading buffer (Bioline) and DNA 
migration was through 1% agarose Tris-acetate EDTA buffer (TAE) gels containing SYBR safe 
DNA stain (1/1000 dilution) (Invitrogen). Samples were run alongside HyperLadder 1kb 
(Bioline) molecular weight marker and DNA was visualised by UV. DNA concentration was 
was measured at OD260 by Nanodrop 2000 Spectrophotometer (Thermo). 
 
2.6 Ligation into expression vectors 
PCR products were digested with restriction enzymes and the accompanying reaction buffer 
provided, according to manufacturer’s instructions. Digested PCR products and vectors were 
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recovered after electrophoresis in the appropriate percentage agarose gel containing 1 X 
TAE buffer. DNA of the correct size was excised from the gel and purified using QIAquick Gel 
Extraction kit (Qiagen), according to manufacturer’s instructions. Linear fragments were 
ligated into the corresponding vector using a 1:3 molar ratio (vector:insert) using Quick-Stick 
Ligase (Bioline), according to manufacturer’s instructions.  
 
2.7 Transformation of bacterial cells 
Bacteria were grown until stationary phase overnight at 37°C in LB with aeration. The 
culture was diluted 1:100 into 5 ml of fresh LB and sub-cultured in the same conditions for 
2.5 h or until an OD600 of 0.1 - 0.2 was reached. Bacteria were pelleted at 8,000 x g for 1 min 
(1ml of bacteria per transformation was used). Next, bacteria were resuspended in 1 ml ice 
cold dH20 and pelleted at 8,000 x g for 1 min at 4°C.  Bacteria were resuspended in 400 µl 
ice cold dH20 and pelleted again at 4°C. Once again, bacteria were resuspended in 100 µl ice 
cold dH20 and pelleted at 4°C. Bacteria were resuspended in 100 µl ice cold 10% glycerol. 75 
µl of bacterial cells were incubated with approximately 20 ng of DNA (plasmid or PCR 
product) in a 2 mm electroprotation cuvette (VWR) for 5 mins on ice. Bacteria were 
transformed by one of two methods: electroporation using GenePulser II (BioRad) with the 
following settings: 2.5 kV, 200 Ω, 25 μF for approximately 5 msec or heat shock at 42°C in a 
water bath for 1 min. Bacterial cells were transferred back on ice immediately for 2 mins. 
Bacteria were recovered in 750 µl of SOC medium at 37°C for 1 h. Bacteria were pelleted 
and resuspended in 1 ml of LB and plated onto LB agar plates containing appropriate 
antibiotics for the selection of transformants. 
 
 
2.8 DNA sequencing and analysis 
DNA sequencing was carried out by the MRC Clinical Sciences Centre Genomics Core 
Laboratory at Imperial College London. DNA sequences, restriction enzymes and alignments 
were analysed using GENtle software. The sequence data of the reference GAS strain 
MGAS5005 was available for download from the NCBI database 
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(http://www.ncbi.nlm.nih.gov/nuccore/861564765?report=graph). The sequence data for 
GAS strains emm1 and emm89 h293 (unpublished) was kindly provided by Prof. S. 
Sriskandan (Imperial College London). Sequence data was analysed using Artemis software 
(Sanger Institute). 
 
 
Name              5’ – 3’ Nucleotide Sequence                           Description 
 
Tox57pB For      GGGGTCGACGGGCAATTGAAGGAAAATGCTTAATG         Amplification of Spy_0457,  
Tox57pB Rev     GGGAAGCTTGGGTTACCAATTATTCATATGACGTG            Spy_1220, Spy_1465, Spy 
Tox20pB For      GGGGTCGACGGGCTTGAAGGGAAGATAGTCTATGAC       _1641 toxins containing  
Tox20pB Rev     GGGAAGCTTGGGTTAACCTATTAAAGTATAATATTC          Ribosomal Binding Site  
Tox65pB For      GGGGTCGACGGGAGAGAGAGGACTGCTCTATGATG        (RBS) and KpnI and XhoI 
Tox65pB Rev     GGGAAGCTTGGGTTAACTAATTAAAAACTCTAATTC          (underlined) restriction  
Tox41pB For      GGGGTCGACGGGTGAGGAAGTGAGGGCTGAACTTGG     sites for cloning in pBAD 
Tox41pB Rev     GGGAAGCTTGGGTTATTTGAATAACTTTATATAGTCG        33 for expression in E. coli 
 
Ant56pN For      TTGGTACCTTCAAAAAAGGAGGATAACCATGGC               Amplification of Spy_0456, 
Ant56pN Rev     GGACTCGAGTTAAGCATTTTCCTTCAATTGAAAT               Spy_1219, Spy_1464, Spy_ 
Ant19pN For      TTGGTACCTTTCCAGAAAGGTTGATAAATCAGTGG           1640 antitoxins containing 
Ant19pN Rev     GGACTCGAGCTATCTTCCCTTCAAGTAAATTTCA                Ribosomal Binding Site 
Ant64pN For      TTGGTACCTTGTAATCAGTCAAGTAGTTTACATGC             (RBS) and SalI and HindIII 
Ant64pN Rev     GGACTCGAGCTATTTTCTATTTTTGATGCGCGTT                (underlined) restriction 
Ani40pN For      TTGGTACCTTCATAAAGGGGTTACATAAAATGAC               sites for cloning in pNDM 
Ant40pN Rev     GGACTCGAGTTATAGTCCAAGTTCAGCCCTCACT               220 for expression in E.coli 
 
Tox57For RT        ATGAACTCTGTGCACCACAG                                                Forward and reverse  
Tox57Rev RT TGACGTGATCCATAGACGAC                                                primers for qRT-PCR to 
Tox20For RT AATGAACTATGGCCACGTCC                                                 measure expression of  
Tox20Rev RT CATCTTCAAGCAAACACCTG                                                 GAS toxin and antitoxins, 
Tox65For RT GGTACAAACACCCCTGGAAT                                                including 16sRNA in E. coli 
Tox65Rev RT CCCAATAGGATAGCTCTTCT 
Tox41For RT TGGAGCAAATCATTAGCGAC 
Tox41Rev RT GTCGCTTTGAGTAGGAAGCA 
 
Anti56For RT GTGCGGCAGATGATATTTTG 
Anti56Rev RT TGACATCCTGACGGTTGCCA 
Anti19For RT GGGGTATAGTCGAAATACCA 
Anti19Rev RT AAGCGGCTTACCATCGAACG 
Anti64For RT GAGGTATTTCCTTGGGATTGC 
Anti64Rev RT AGATCAATTGCGACCGAAGC 
Anti40For RT GGTAAGCGAAGCAATGACAG 
Anti40Rev RT ACTTCCCTTGACGAACATCC 
 
Table 2.1 - Primers used in this study. 
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2.9 RNA extraction and qRT-PCR  
E. coli was grown until stationary phase overnight (O/N) at 37°C in LB and then diluted 
1/100 into fresh LB with or without inducer for 1 h. Bacteria were pelleted and resuspended 
in RNA Protect Bacteria Reagent (Qiagen), according to manufacturer’s instructions. 
Bacterial cells were lysed in TE buffer containing 0.5 mg/ml lysozyme and 20 ul Proteinase K 
(Qiagen) and purification of released RNA was carried out by RNeasy Miniprep kit (Qiagen), 
according to manufacturer’s instructions. RNA was eluted in 60 µl of sterile RNase-free 
water (Ambion). Isolated RNA was incubated with DNase I (Qiagen) at room temperature 
(RT) for 15 min to remove any contaminating genomic DNA. RNA preps were concentrated 
using RNeasy MiniElute Cleanup kit (Qiagen). RNA concentration was measured by the 
OD260/280 ratio (Nanodrop 2000) and a test PCR was carried out to determine absence of 
contaminating DNA, using primers ´Tox57 For´ and ´Tox57 Rev´, with RNA as template. cDNA 
was synthesized from 400 ng of RNA by Quantiscript Reverse Transcriptase using QuantiTect 
Reverse Transcription Kit (Qiagen), according to manufacturer´s instructions. cDNA 
concentration was measured by OD260 (Nanodrop), aliquoted and stored at -20°C until 
needed. Quantitative Real-Time PCR was carried out on cDNA samples containing primers 
labelled ‘RT’ (Table. 2.1), including the 16sRNA housekeeping gene, using SensiMix SYBR No-
Rox Kit (Bioline) on a Rotor Gene 3000. 
 
 
2.10 Cell culture 
2.10.1     Epithelial and macrophage-like cell lines 
THP-1 is a human monocytic cell line kindly provided by Dr. Darius Armstrong (Imperial 
College London). THP-1 cells were maintained at 2 X 105 cells/ml in RPMI medium (Gibco) 
supplemented with 10% heat-inactivated fetal calf serum (FCS, Invitrogen), 2 mM L-
glutamine (Sigma), 10 mM HEPES (Sigma), 1 mM sodium pyruvate (Sigma), 2.5 g/L glucose 
(Sigma), and 0.05 mM β-mercaptoethanol (Sigma) at 37°C in 5% CO2. U937 is a human 
monocytic suspension cell line obtained from the ATCC (CRL-1593.2). U937 cells were 
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maintained at 1 X 106 cells/ml in RPMI medium (Gibco), supplemented with 10% FCS 
(Invitrogen) and 2 mM L-glutamine. To obtain a macrophage-like state, THP-1 and U937 cells 
were seeded onto 24 well plates at 2 X 105 cells/well or 6 well plates at 1 X 106 cells/well 
and differentiated in 100 ng/ml of phorbol 12-myristate 13-acetate (PMA, Sigma) for 3 days. 
HeLa is a cervix epithelial cell line obtained from the European Collection of Cell Cultures, 
Salisbury, UK. HeLa cells were grown in Dulbecco’s Modified Eagle Medium (DMEM, PAA 
laboratories) supplemented with 10% FCS (PAA laboratories) at 37°C in 5% CO2. RAW 264.7 
murine macrophage-like cells were obtained from the European Collection of Cell Cultures 
(ECACC; catalogue no. 91062702) and grown in DMEM (Sigma) supplemented with 10% FCS 
(PAA laboratories). 
 
 
2.10.2     Primary human monocyte-derived macrophages 
Peripheral blood mononuclear cells (PBMCs) were isolated from the blood healthy human 
volunteers.  80 ml of blood was extracted into a heparin blood collection tube (BD 
Biosciences) from each donor and centrifuged at 1800 x g at 20°C for 45 min. Cells were 
resuspended in sterile PBS (Sigma) and overlaid slowly onto Ficoll-Paque Plus (GE 
Healthcare). PBMCs were isolated by density gradient centrifugation at 1800 x g for 45 min 
at 20°C with no brake setting (as not to disturb PBMC layer). The layer of PBMCs were 
extracted using a Pasteur pipette and transferred to RPMI medium containing 10% FCS, 
supplemented with 100 U/ml Penicillin/Streptomycin (Sigma) and 2 mM L-glutamine. Cells 
were washed twice in RPMI medium and incubated in Red Blood Cell Lysing Buffer Hybri-
Max (Sigma) for 10 min at 37°C. Cells were centrifugated and resuspended in RPMI medium. 
Cells were counted and subjected to CD-14 positive selection (Miltenyi Biotec), according to 
manufacturer’s instructions. CD-14-positive monocytes were differentiated with 20 ng/ml of 
Macrophage Colony Stimulating Factor (MCSF) (Immunotools) and seeded onto 24 well 
plates at 2 x 105 cells per ml. MCSF was removed after 3 days and replaced with fresh RPMI 
medium for a further 4 days. Cells were cultured in antibiotic-free medium 24 h prior to 
infection. 
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2.11   in vitro infection assays 
2.11.1     Infection of macrophages 
Differentiated macrophages were cultured in 24 well plates at a density of 2 X 105 cells per 
well. GAS was grown until stationary phase O/N at 37°C in THB. Prior to infection, long 
chains of GAS were removed from the infection inoculum by a pre-centrifugation step as 
follows: the bacterial culture was pelleted and resuspended in warm RPMI containing 10% 
FCS. 1ml of culture was added to each Eppendorf tube and pelleted at 1000 x g for 1 min. 
The top half of each supernatant (containing an enriched mixture of single coccus, 
diplococcus and small chain forming GAS) was combined and pelleted at top speed. Each 
pellet was resuspended in RPMI and concentrated into a single tube. Bacteria were 
opsonised in 10% human serum (HS) at RT for 20 min. Bacteria were added to the cells at 
the appropriate MOI and centrifuged at 110 x g for 5 min, to increase and synchronise 
infection. After incubation for 30 min at 37°C, 5% CO2, cells were washed twice and 
incubated with 100 µg/ml of gentamicin for 1 h and then with 25 µg/ml gentamicin 
thereafter.  
S. Typhimurium 12023 strains and E. coli DH5α were grown until stationary phase at 37°C in 
LB.  Bacterial cultures were opsonised at RT for 20 min as follows: 15 μl of bacterial culture, 
20 μl of serum (Sigma) and 170 μl medium (varied depending on with cell type). 600 μl of 
medium was added to the opsonisation mix and 25 μl was added to the cells at a MOI 2 and 
centrifuged at 110 x g for 5 min. The infection was allowed to proceed for 30 min at 37°C, 
5% CO2, washed twice in PBS and then incubated with 100 µg/ml of gentamicin for 1 h. The 
concentration of gentamicin was reduced to 25 µg/ml for the remainder of the experiment. 
In chapter 5, the infections were stopped after 30 min incubation with S. Typhimurium.   
 
2.11.2    Infection of HeLa cells 
Cells were seeded at a density of 1 x 105 or 1 x 106 cells per well in 24-well plates or 6-well 
plates, 24 h prior to infection. The culture medium was replaced with DMEM containing 2% 
FCS before infection. GAS was grown until stationary phase O/N at 37°C in THB and bacterial 
chains were removed by pre-centrifugation. The bacteria were added to the confluent cell 
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culture monolayer (without opsonisation) at MOI 20.  Invasion was allowed to proceed for 1 
h or 2 h at 37°C in 5% CO2, followed by three PBS wash steps and incubation of the cells with 
100 μg/ml gentamicin for 1 h in DMEM containing 10% FCS. The concentration of 
gentamicin was reduced to 25 μg/ml for the remainder of the experiment. 
S. Typhimurium 12023 was grown until stationary phase at 37°C with shaking and diluted 
1:33 into fresh LB broth and then incubated in the same conditions for 3.0 h. The cultures 
were diluted in Earle’s Buffered Salt Solution (EBSS) (Sigma) and added to the confluent 
HeLa cells at a MOI 10. Bacterial invasion was allowed to proceed for 15 min at 37°C in 5% 
CO2.  
 
2.12    Transfection and transduction 
Vectors coding for eGFP-tagged galectin 3 and 8 and MCherry galectin 3 and 8 were 
generated and kindly provided by Dr. Thurston (Thurston et al., 2012). The plasmid M5P was 
used to produce recombinant lentivirus for the expression of fluorescently tagged galectin 
proteins in THP-1 and U937 monocytes. For virus production, 293T packaging cells were 
seeded into 24 well plates 24 h prior to transfection. For each well, 250 ng of proviral 
plasmid, 100 ng of the envelope glycoprotein VSV-G (vesicular stomatitis virus GP), 150 ng 
pMD-GAGPOL (packaging plasmid containing gag, pol, rev genes) were mixed in OptiMEM 
serum-free medium and left for 20 min. DNA mix was combined with Lipofectamine 2000 
and added to the cells.  24 h after transfection the culture medium was discarded and 
replaced with fresh DMEM to remove DNA/liposomes. 48 h and 72 h after transfection the 
supernatant containing the virus was harvested and centrifuged at 200 x g for 5 min to 
remove cell debris. The supernatant fraction was kept and stored at -20°C until needed.  
For transduction, U937 and THP-1 monocytes were seeded into 24 well plates at 1 x 105 cell 
per well. Virus was added to the monocytes with 8 µg/ml polybrene to enhance 
transduction efficiency (Davis et al., 2002). The monocytes were centrifuged at 1800 x g for 
2 h at 37°C and incubated at 37°C, 5% CO2. The culture medium was replaced every 24 h and 
maximal expression of the fluorescently tagged galectins was observed by microscopy at 48 
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h. GFP-positive or MCherry-positive monocytes were then sorted by FACS to obtain a pure 
population of highly fluorescent monocytes.  
 
2.13    Bacterial survival by colony forming unit counts 
Differentiated macrophages and HeLa cells, seeded in 24-well plates were infected with GAS 
strains, S. Typhimurium 12023 and/or E. coli DH5α as described above (section 2.5). 
Bacterial intracellular survival was determined by colony forming unit (CFU) counts on agar 
plates. At selected times post-uptake, cells were washed 3 x with PBS and lysed in 250 µl 
0.05% Triton X100 in PBS for 5 min at RT. Cell lysates containing released bacteria were 
adjusted to 1 ml with 750 µl PBS. The lysate was serially diluted in 1 x PBS and the number 
of colony-forming units ml-1 was determined after plating onto agar plates. Bacterial survival 
was measured as the total CFU/ml or as the percentage survival, calculated as the number 
of CFU recovered at various times post-uptake divided by the CFU recovered at 1 h post-
uptake multiplied by 100%.  
 
2.14   Lactate dehydrogenase (LDH) assay  
Macrophages differentiated in 24-well plates were infected with GAS strains and E. coli 
DH5α as described previously. Prior to infection, the normal cell culture medium was 
replaced with RPMI phenol-free medium (Gibco), containing the appropriate supplements 
as previously described (section 2.10.2). At selected times post-uptake, cell culture 
supernatants were removed from each well and centrifuged at 300 x g for 5 mins to pellet 
any suspended cells. The supernatant was removed and kept at -20°C until all samples were 
collected. Cytotoxicity was determined by measuring the amount of LDH released into the 
cell culture medium using the CytoTox 96 Non-radioactive cytotoxicity assay (Promega), 
according to manufacturer’s instructions. 50 µl of supernatant was mixed with 50 µl of 
substrate reagent and incubated at RT in the dark. Absorbance was measured at 490 nm 
and cytotoxicity was calculated as follows: (sample LDH release – spontaneous LDH release) 
divided by (maximum LDH release – spontaneous LDH release) X 100. The maximum LDH 
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release was determined by freezing replicate uninfected wells at -80°C for 30 min and 
harvesting the supernatants after thawing. The spontaneous LDH release was determined 
by harvesting supernatants from uninfected wells throughout the experiment. 
 
2.15   Antibodies and Reagents 
Macrophage colony stimulating factor (MCSF, Immunotools), Phorbol 12-myristate 13-
acetate (PMA, Sigma), Lysotracker Red DND-99 (Molecular Probes), Propidium-iodide (PI, 
Life Technologies). Heat-inactivated human serum (H3667, Sigma), Accutase (A6964, Sigma) 
Primary antibodies used were goat anti-group A polysaccharide (9191, Abcam), mouse anti-
LAMP1 (555798, BD Bioscience), mouse anti-ubiquitin (FK2, Enzo), mouse anti-SQSTM1 
(p62) (56416, Abcam). Secondary antibodies used for immunofluorescence were Alexa 
Fluor-conjugated donkey anti-mouse or donkey anti-goat (Invitrogen).  
 
2.16   Immunoflourescence 
For visualisation and quantification of intracellular bacteria, differentiated macrophages and 
HeLa cells were seeded onto glass coverslips in 24-well plates and infected with different 
bacteria as described previously. At the selected time post-uptake coverslips were washed 
and fixed in 3% paraformaldehyde (PFA) in PBS for 15 min at RT. Coverslips were washed 3 X 
with PBS and PFA was quenched by incubating cells in 500 µl NH4Cl in PBS for 20 min. 
Primary antibodies were diluted to the appropriate working concentration in 10% horse 
serum in PBS containing the permeabilising agent saponin (0.1%) or triton X-100 (0.1%) and 
was left incubating with the cells from 20 min to 1 h (depending on the antibody) at RT. Cells 
were washed twice in PBS between primary and secondary labelling. After secondary 
antibody labelling, cells were washed twice in PBS/saponin or PBS/triton, then twice in PBS, 
then once in MilliQ water, then excess liquid was removed by tissue and coverslips were 
mounted using Aqua polymount (Polysciences Inc.) on a microscope slide (VWR). Fixed cells 
were imaged using an epi-fluorescence microscope (BX50; Olympus) or a laser-scanning 
microscope (LSM710; Zeiss). Acquired images were processed and false-coloured using the 
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Zeiss image software or Adobe Illustrator software. For bacterial in/out labelling, 
extracellular bacteria were labelled by primary (anti-GAS) and secondary antibodies without 
permeabilisation, then intracellular bacteria were differentially labelled with anti-GAS 
primary and a different Alexa Fluor secondary antibody, in the presence of a permeabilising 
agent. In some experiments in chapter 3, cells infected with WT-pGFP1 GAS were labelled 
without permeabilisation with anti-GAS primary to label the extracellular bacteria only.  
 
2.17   Flow cytometry 
Differentiated macrophages were seeded in 6-well plates and infected with GAS strains or E. 
coli DH5α as described previously. At the selected time, cells were washed and detached 
with accutase (Sigma) for 15 min and centrifuged at 250 x g for 5 min. Cells were 
resuspended in 4% PFA in PBS for 15 min, and then centrifuged. The fixed cells were 
resuspended in 10% horse serum in PBS/saponin containing anti-GAS primary antibody and 
secondary antibody for 30 min periods. Between labelling, cells were washed once by 
centrifugation and resuspension in PBS. After labelling, cells were resuspended in 500 µl PBS 
for analysis by flow cytometry. For the cytotoxicity experiments described in Chapter 3, 
propidium iodide (PI) was added at a concentration of 10 nM to non-fixed, infected cells 
(containing GFP-expressing bacteria) suspended in 500 µl PBS prior to sample analysis on 
the FACS Calibur. Analysis was carried out on a two-laser, four colour FACS CaliburTM flow 
cytometer (BD Biosciences). Uninfected cells were used to calibrate the instrument settings. 
FACS data were analysed using FlowJo software version 7.6.5 (TreeStar).  
 
2.18   Live imaging 
U937 cells were differentiated on a 35mm glass-bottomed dish 3 days prior to infection with 
WT-pGFP1 GAS or S. Typhimurium ΔsifA mutant, as described previously. At 1h 30 min prior 
to imaging, the medium was replaced with OPTI-MEM (Gibco) imaging medium, 
supplemented with 5% FCS, 10 nM HEPES and 25 µg/ml gentamicin. The dish was 
transferred to the confocal microscope and mounted onto an automated stage, fully 
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enclosed within a 37°C live cell chamber. The dish was left undisturbed for 20 min to 
maintain temperature stability within the chamber. Live imaging was initiated at 2 h p.u. 
until 10 h p.u. with a 63 x objective. Multipositional acquisition was used to select and 
record approximately 20-30 different fields of view that contained at least 1 galectin-
positive GCV. Images were acquired every 25 min for each selected position by means of the 
automated motorised stage. Imaging movies were processed using ImageJ and Fiji software. 
 
2.19    Digitonin permeabilisation 
For visualisation and quantification of intracellular cytosolic bacteria, differentiated 
macrophages were seeded onto glass coverslips in 24-well plates and infected with M49 
NZ131 GAS strains as described previously. At the selected time post-uptake cells were 
washed twice in warm PBS and incubated on ice for 2-3 min. Cells were gently washed twice 
in ice cold sterile KHM buffer (110 mM KOAc, 20 mM HEPES, 2mM MgCl2 in 1 x PBS) and 
incubated in 500 µl ice cold digitonin in KHM buffer at three different concentrations of 20 
µg/ml, 40 µg/ml and 50 µg/ml for approximately 5 min on ice. Cells were gently washed 
once in ice cold KHM buffer and once more with ice cold PBS. To label the cytosolic bacteria, 
the primary anti-GAS antibody was prepared in 10% horse serum in PBS and 200 µl was 
transferred onto the cells for 30 min at RT. Cells were gently washed twice in PBS and fixed 
with 3% PFA for 10 min at RT. Cells were washed twice in PBS and 38 µl of secondary 
antibody in 10% horse serum/PBS containing 0.1% saponin, was added to the cells for 1 h. 
To label total bacteria (vacuolated and cytosolic), the cells were washed and the antibody 
labelling was repeated again in the presence of saponin, but with an different secondary 
Alexa Fluor secondary antibody. Each experiment was carried out using three different 
concentrations to assess the efficacy of selective permeabilisation and heat-killed bacteria 
were used as the internal negative control. Each experiment was carried out in duplicate 
with 3 independent repeats.  
 
2.20    Antibiotic killing assays in GAS clinical isolates 
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GAS strains were grown until stationary phase overnight at 37°C in THB. Bacterial cultures 
were diluted to 0.8 OD600 (as not all strains grew to similar density) and then diluted 1/100 
(5 x 105 – 1 x 106 CFU per ml) into 10 ml of fresh THB broth.  The cultures were inoculated 
with 100 µg/ml of gentamicin, 100 µg/ml of amoxicillin, 100 µg/ml of cefotaxime or 25 
µg/ml of erythromycin, mixed well and 1 ml was aliquoted into eppendorf tubes and then 
incubated at 37°C for 2 h, 5 h and 24 h. At the selected time, the cultures were centrifuged 
at 8,000 x g for 2 min, the supernatant containing the antibiotic was discarded and the 
pellet washed with sterile PBS. The culture was centrifuged again and resuspended in 1 ml 
of PBS. The culture was serially diluted and plated onto THB agar for CFU enumeration. Data 
presented was the culmination of 3 independent experiments performed in triplicate with 
duplicate colony counts.  
 
2.21    Functional assays in E. coli 
E. coli DH5α strains harbouring the recombinant pBAD33 and/or pNDM220 plasmids were 
grown until stationary phase with or without appropriate antibiotics. The bacterial culture 
was diluted to 0.1 OD600 in fresh LB broth containing 0.2% arabinose and/or 2 mM IPTG with 
the appropriate antibiotics. Control strains carrying empty vectors were also induced with 
either arabinose or IPTG in the presence of antibiotics. The bacterial culture was then 
incubated in the same conditions for 6 h and every hour 500 µl was removed from the 
bacterial cultures for growth analysis by optical density (OD600) and CFU plating onto LB agar 
with or without antibiotics. CFU data was expressed as Log/CFU per ml. To analyse the 
recovery from dormancy, E. coli harbouring both pBADRelE2 and pNDMDRelB2 was grown 
until stationary phase and diluted to 0.1 OD600 in fresh LB broth containing or not 0.2% 
arabinose with the appropriate antibiotics. The bacterial culture was then incubated in the 
same conditions for 6 h and every hour 500 µl was removed from the cultures and plated 
onto agar supplemented or not with 2 mM IPTG and containing 0.2% glucose (to repress 
PBAD promoter) with the appropriate antibiotics. CFU data was expressed as log/CFU per ml. 
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2.22    Statistical Analysis 
The results presented in this thesis are reported as mean ± standard error of the mean 
(SEM) unless otherwise stated. Statistical testing was carried out using two-tailed Student’s 
t-test on data arising from experimental assays repeated at least two times. P values < 0.05 
were considered as statistically significant. 
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Chapter 3 
 
3. Fate of M1T1 GAS in human macrophages 
 
3.1  Introduction 
Although classically regarded as an extracellular pathogen, GAS can invade and persist 
within human endothelial (Rohde et al., 2003; Amelung et al., 2011) and epithelial cells 
(LaPenta et al., 1994; Marouni and Sela, 2004), including neutrophils (Medina et al., 2003) 
and macrophages (Thulin et al., 2006). Upon invasion into epithelial cells, GAS has been 
shown to survive for several days (Osterlund et al., 1997; Kaplan et al., 2006). However, 
many strains fail to proliferate and reports indicate that antibacterial autophagy can 
contribute to the intracellular clearance of GAS (Håkansson et al., 2005; Kaur et al., 2010; 
Sakurai et al., 2010; Amelung et al., 2011). It is hypothesised that the internalisation of GAS 
prevents its antibiotic eradication and helps establish a persistent disease state. 
Phagocytic cells comprise an essential part of the innate immune response. Macrophages 
have a wide range of mechanisms to destroy bacteria following uptake, including the 
lysosomal degradation pathway, antimicrobial peptides and attack by reactive oxygen (ROS) 
and nitrogen (NOS) species (Flannagan et al., 2009). Several in vivo experiments have shown 
that innate immune cells determine the susceptibility to GAS disease. Whereas B cell- and T 
cell-deficient mice exhibit a similar resistance to GAS in comparison to immunocompetent 
control mice (Medina et al., 2001), chemical or genetic depletion of macrophages causes a 
substantial increase in bacterial dissemination and mortality (Goldmann et al., 2004; 
Mishalian et al., 2011).  
However, the role of macrophages in determining disease outcome in humans is not well 
studied. Thulin and colleagues (2006) observed that in biopsy tissue of patients with invasive 
disease, macrophages served as the primary reservoir of viable GAS (Thulin et al., 2006). The 
presence of a high bacterial load despite intravenous antibiotic therapy, suggests that GAS 
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can resist and/or exploit host-killing mechanisms to promote dissemination and sepsis. This 
finding was later supported by in vitro observations, which implicated the surface-localised 
M1 protein in the ability of GAS to avoid fusion with azurophilic granules and lysosomes in 
human neutrophils and monocyte-derived macrophages, respectively (Staali et al., 2006; 
Hertzen et al., 2010).  Both studies provided tentative evidence for intracellular replication 
of GAS in both cell types but lacked convincing quantitative evidence.  
Currently, very little is known regarding the fate of GAS in human macrophages and an 
accurate quantitative-based approach on the intracellular dynamics of survival and growth 
is required. The aim of this study was to determine if GAS can survive and/or replicate in 
human THP-1 and U937 macrophage like cell lines, and primary human macrophages. This 
chapter outlines the initial set up and optimisation of a reproducible infection system in 
THP-1 cells using immunofluorescence and CFU assays, and infections in U937 and primary 
macrophages. Finally, the contribution of the M1 surface protein in promoting intracellular 
survival and replication is investigated.  
 
 
3.2  Results 
3.2.1     Growth of the WT-pGFP1 strain 
The GAS M1T1 5448 strain was used in this study because it is a clinical isolate removed 
from a patient with NF and the same strain was subsequently reported to replicate inside 
human macrophages (Thulin et al., 2006; Hertzén et al., 2010). We received the WT GAS 
strain and a GFP-expressing WT strain containing the plasmid pGFP1 (WT-pGFP1) from Dr. A. 
Norbby-Teglund (Karolinksa Institutet, Sweden) (Fig. 3.1 A).  
pGFP1 has a pVA838 backbone and a rep origin of replication (Macrina et al., 1982). It is a 
high copy number plasmid (50-100 copies/cell) due to a mutation in the repressor of the 
primer (rop) gene. pGFP1 also confers erythromycin resistance and the expression of gfp is 
controlled by an uncharacterised constitutive pneumococcal promoter (Kadioglu et al., 
2001).  
71 
 
To determine whether pGFP1 has a negative effect on the growth of GAS, the growth 
kinetics of the strains were compared. WT and WT-pGFP1 were grown to stationary phase 
and subcultured into THB with or without erythromycin, for WT-pGFP1 selection. The OD600 
was adjusted to 0.01 and the subculture was incubated at 37°C for 12 h. The optical density 
was measured every 2 h. The graph in Fig. 3.1 B shows that both strains grew at a similar 
rate. 
To assess the stability of the plasmid, bacteria were grown in THB in the absence of 
antibiotic selection for 12 h and plated onto blood agar plates supplemented or not with 
erythromycin (Fig. 3.1 C). After 12 h of culture and more than 12 generations of growth, 
100% of the bacterial colonies were still resistant to erythromycin. This indicates that the 
plasmid is stable. 
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Figure 3.1 Growth behaviour of the GAS WT-pGFP1 strain 
A. Plasmid map of pGFP1. gfp expression is under the control of an unknown constitutively active 
promoter. eryR denotes the gene for erythromycin resistance. The vector backbone is pVA838. B. 
Growth of WT GAS (blue) and the same strain carrying pGFP1 plasmid (black) grown in THB and 
determined by OD600 at time points indicated. Error bars (SEM) are based on 3 independent 
experiments. C. Plasmid stability assay for WT-pGFP1. Bacteria were subcultured in THB without 
antibiotic and plated on blood agar with erythromycin (blue) or without erythromycin (black). A 
representative curve of 3 independent experiments of is shown.  
 
 
3.2.2     Optimization of GFP fluorescence in WT-pGFP1  
To determine if the WT-pGFP1 strain could be used to easily detect bacteria during host cell 
infection, the level of GFP fluorescence in the WT-pGFP1 strain was examined. Overnight 
cultures of WT-pGFP1 and WT control were grown in standing cultures under limited O2 
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conditions and analysed by flow cytometry. The WT-pGFP1 bacterial population identified 
by forward and side scatters displayed low green fluorescence intensities in approximately 
15% of the population (Fig. 3.2 A). This finding is consistent with a previous report (Hertzen 
et al., (2010) that GFP fluorescence is depleted in a proportion of intracellular WT-pGFP1 
5448 bacteria during in vitro infection.  
To determine if low oxygen availability contributed to this, bacteria were grown in the 
presence of oxygen to try and enable better maturation of the fluorophore (Remington, 
2006). Stationary phase WT-pGFP1 was transferred into a 6-well dish and after every hour 
bacteria were fixed and analysed by flow cytometry for GFP fluorescence. A clear sequential 
shift in the curves could be seen indicating increasing GFP fluorescence over time (Fig. 3.2 
B). As early as 4 h in the presence of O2, GFP fluorescence was significantly higher, occurring 
in 98% of the entire bacterial population. Given that gfp expression is stable and the GFP 
fluorescence was increased in GAS, this strain was used to quantify intracellular growth 
inside cells. 
For investigations using the WT strain, I assessed the efficacy of a commercially available 
anti-GAS polyclonal antibody (ab20901) recognising the group A streptococcal cell wall 
carbohydrate antigen. Bacteria were labelled with the primary antibody and a secondary 
antibody coupled with Alexa Fluor 488. The efficacy of the labelling was assessed by 
comparison to Draq5-positive DNA staining of all bacteria. Within the Draq5-positive 
population (Fig. 3.2 C), 92.6% of the bacteria were successfully labelled by the anti-GAS 
antibody (Fig. 3.2 D). This was similar to what was observed by microscopy after labelling 
with the antibody (not shown). Therefore, assuming the epitope(s) recognized by the 
antibody are present during infection, the antibody can be used with WT-pGFP1 in 
combination with different Alexa Fluor antibodies to differentially label intracellular and 
extracellular bacteria (in/out labelling).  
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Figure 3.2 Detection of WT and WT-pGFP1 GAS by flow cytometry 
A. Detection of GFP fluorescence using flow cytometry from the WT-pGFP1 overnight culture (blue). 
WT non-fluorescent bacteria were used as negative control (red). B. Increase in GFP fluorescence 
over time for WT-pGFP1 in the presence of O2. C. Identification of WT GAS population identified by 
side scatter and by Draq5 DNA staining. D. Fluorescence intensities for Draq 5-positive WT bacterial 
population labelled with anti-GAS antibody and Alexa Fluor 488. All samples were fixed and analysed 
by flow cytometry.  
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3.2.3     Optimisation of infection conditions in the THP-1 cell line 
THP-1 cells are human-derived monocytes and one of the most widely used cell lines for 
investigations into macrophage function and signalling. Treatment with PMA induces 
differentiation into a macrophage-like phenotype, consistent with that of macrophages 
derived from human monocytes (Auwerx, 1991). In addition, these cells have been utilised 
for the study of many intracellular pathogens including: M. tuberculosis (Theus et al., 2004), 
Neisseria gonorrhoea (Duncan et al., 2009) and Salmonella Typhi (Forest et al., 2010). 
The THP-1 monocytic cell line was chosen as an alternative to primary human macrophages, 
based on their 3 day differentiation period using PMA (whereas primary human cells require 
isolation and purification from blood with 7 days of differentiation time), ability to culture 
large numbers of cells and the relative homogeneity. Thus, the THP-1 macrophage model 
could represent a useful tool to study the intracellular biology of GAS. 
THP-1 cells were differentiated into macrophage-like cells using 100 ng/ml of PMA for 72 h. 
Representative examples of the morphological changes undergone by THP-1 cells through 
the differentiation period are shown in Fig. 3.3 A. Noticeable differences include increased 
adherence, as early as 1 h following treatment and an increase in size and granularity of 
these macrophages as previously described (Daigneault et al., 2010).  
It has long been established that GAS is resistant to phagocytosis (Lancefield, 1962), a 
feature attributed to expression of the capsule and outer surface M-protein. THP-1 
macrophages were infected with WT-pGFP1 5448 at different MOI to measure relative 
uptake rates under two separate conditions: allowing bacteria to settle onto the 
macrophages (Fig. 3.3 B) or using mild centrifugation (Fig. 3.3 C). When the bacteria were 
allowed to settle, infection rates were low for all 3 MOI tested, peaking at 6% after 30 min 
incubation (Fig. 3.3 B). When the bacteria were subjected to mild centrifugation (110 x g for 
5 min), infection rates increased for the higher MOI (50:1 and 100:1) but remained 
unchanged for the lower MOI (10:1) (Fig. 3.3 C). As a result, subsequent infections were 
carried out using centrifugation to increase and synchronise uptake. The latter is important 
for work focusing on spatial and temporal trafficking of intracellular GAS.  
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GAS form long coccal chains during growth in culture, which can consist of up to 12 
individual cocci.  Therefore, a low MOI was used (1 bacteria for every 2 host cells) to 
accurately quantify any intracellular growth by microscopy. Opsonisation in 10% heat-
inactivated human serum for 20 min considerably improved bacterial uptake by THP-1 cells, 
even at very low MOI (1:1 and 2:1) (Fig. 3.3 D). However, clumping of bacterial chains was 
observed in the presence of serum, which would complicate later analysis of intracellular 
growth by microscopy. Fortunately, clumping was eliminated by removal of serum after 
opsonisation, replacement with fresh medium and vigorous vortexing of the bacterial 
culture for 10 seconds. This is evident from representative images in Fig. 3.3 E. This also had 
the combined effect of improving infection rates further whilst reducing the percentage of 
infected cells containing high numbers of bacteria (11+) attributed to the clumping effect 
(Fig. 3.3 F). Overall, the effect of centrifuging and opsonising bacteria vastly improved 
uptake in THP-1 cells. In addition, removing serum after opsonisation and infecting cells at a 
MOI of 0.5 gave the desired result of obtaining few bacteria per infected cell. These 
optimised infection conditions will be useful to determine if GAS can replicate within 
macrophages using fluorescence microscopy.  
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Figure 3.3 Optimisation of infection conditions in the THP-1 cell line 
A. Representative differential interference contrast (DIC) images of the morphological changes of 
THP-1 cells before and during 3 days of differentiation with 100 ng/ml of PMA. B. Percentage of THP-
1 macrophages infected with WT using 3 different MOIs without centrifugation. 100 infected cells 
were counted at each time point indicated. Result from 1 experiment done in triplicate. C. 
Percentage of infected THP-1 macrophages from centrifugation at 110 x g for 5 min with WT GAS 
using 3 different MOIs. (mean ± SEM, n=2). D. Percentage uptake of WT-pGFP1 in THP-1 cells at MOI 
1:1 with or without opsonisation in 10% human serum. 100 infected cells were counted after 30 min 
post-uptake. (mean ± SEM, n=2). E. Representative images for infected cells under 3 different pre-
infection conditions for GAS. Intracellular WT-pGFP1 (in) and extracellular WT-pGFP1 (out) were 
differentially labelled with anti-GAS primary antibody and AlexaFluor 555 secondary (red) without 
permeabilisation. Scale bar corresponds to a distance of 10 µm. F. WT-pGFP1 was treated to 3 
different pre-infection conditions, and added to THP-1 cells at MOI 1. The percentage of infected 
cells containing 1-2, 3-5, 6-10 or 11+ bacteria were counted at 30 min post-uptake by fluorescence 
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microscopy. The number of bacteria in at least 100 infected cells were counted per experiment 
(mean ± SEM, n=3) 
 
 
3.2.4     M1T1 5448 GAS is killed by THP-1 macrophages 
The number of intracellular bacteria can be assayed over time by fluorescence microscopy 
or recovery of viable CFU using a classical gentamicin protection assay. Whereas 
fluorescence microscopy can distinguish the number of bacteria within individual cells, CFU 
is a readout of the total number of viable intracellular bacteria. CFU assays were carried out 
using WT-pGFP1 strain under opsonising or non-opsonising conditions. It is reported that 
opsonised S. pneumoniae are quickly phagocytosed by alveolar macrophages and killed by 
phagolysosomal fusion (Gordon et al., 2000). Therefore, I determined whether opsonising 
GAS to increase uptake, would affect the dynamics of killing and/or survival over time.  
WT bacteria were opsonised or not in HS and THP-1 cells were infected for 30 min. 100 
µg/ml of gentamicin was added to the cells for 1 h to kill cell-associated and extracellular 
bacteria, the medium was then supplemented with 20 µg/ml for the duration of the 
experiment to prevent regrowth (see Fig. 5.1 for the gentamicin susceptibility test). At the 
indicated time points post-uptake (p.u.); THP-1 cells were lysed and intracellular bacteria 
plated onto THB agar for enumeration by CFU. At 0.5 h p.u., the CFU counts were similar for 
both conditions (Fig. 3.4 A). However, greater numbers of CFU were detected for opsonised 
GAS compared to non-opsonised at 1.5 h p.u., the earliest time point after gentamicin killing 
of extracellular and adherent bacteria. An overall decrease in the number of CFUs was 
observed for both conditions during infection, with an equivalent number of GAS recovered 
at 6 h and 9 h p.u. Likewise, for opsonising and non-opsonising conditions, infection was 
eradicated at 24 h with no viable colonies detected.   
 
It has been previously reported that the expression of fluorescent proteins can confer an 
intracellular growth defect in Salmonella (Knodler et al., 2005). To determine if expression 
from the pGFP1 plasmid affects the outcome of infection, CFU assays were carried out on 
WT- and WT-pGFP1-infected THP-1 cells at different time points after bacterial uptake. The 
results obtained for the WT and WT-pGFP1 strains revealed no discernible differences in the 
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number of bacteria recovered during infection (Fig. 3.4 B). The rate of killing endured by 
both strains were gradual resulting in a 2 log decrease at 9 h p.u. and the infection was 
completely cleared by 24 h p.u. This result supports the previous observation that GAS 
undergoes efficient killing by THP-1 cells. 
 
S. Typhimurium is a Gram-negative pathogen that survives and replicates in murine 
macrophages but is killed by macrophages of human origin (Schwan et al., 2000). THP-1 cells 
were infected with S. Typhimurium and the rate of killing was determined in relation to WT 
GAS. THP-1 cells were infected with WT-pGFP1 GAS or WT S. Typhimurium 12023, opsonised 
in HS at similar MOI. Once again, GAS was reproducibly and efficiently killed, with 
significantly lower numbers of bacteria recovered 6 and 9 h p.u. By 24 h, no viable bacteria 
were recovered from THP-1 cells (Fig. 3.4 C). In contrast, the total number of intracellular S. 
Typhimurium recovered from THP-1 cells remained stable up until 9 h p.u. However, THP-1 
cells had successfully eradicated S. Typhimurium by 24 h p.u. Although human THP-1 
macrophages can restrict the growth of S. Typhimurium, it is more resistant to killing at the 
early stage of infection in comparison to GAS. This observation also implies that the killing of 
GAS is not solely attributed to internalisation of extracellular antibiotic into infected cells 
since S. Typhimurium is much more sensitive to the actions of gentamicin compared to GAS, 
as determined by MIC (data not shown). 
 
Lastly, I also determined if the concentration of PMA used to differentiate THP-1 cells could 
have an impact on the killing kinetics of GAS in vitro. The concentrations of PMA cited in the 
literature can vary widely from 10 ng/ml (Juliet et al., 2003) to over 400 ng/ml (LaMendola 
et al., 1997). However, concentrations as low as 2.5 ng/ml have been shown to promote 
adherence and differentiation into a macrophage-like phenotype (Park et al., 2007). 
Therefore, it was tested if using a 10 fold lower concentration of PMA (10 ng/ml) to induce 
differentiation could alter the ability of GAS to survive in THP-1 macrophages, as 
determined previously. THP-1 cells were differentiated with 10 ng/ml or 100 ng/ml of PMA 
and infected with WT GAS (Fig. 3.4 D). However, no difference in CFU counts was recorded 
at any time during the course of infection, indicating that PMA concentration does not 
influence the ability of THP-1 cells to clear GAS infection.   
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These results indicate that a significant proportion of intracellular GAS undergoes killing by 
host cells. However, because CFU is a measurement of net bacterial load, we cannot rule 
out the possibility that small subpopulation of GAS might replicate during the early stages of 
infection. Therefore, a more thorough examination of infected macrophages using 
fluorescence microscopy over time was required.  
 
 
 
 
 
Figure 3.4 Intracellular survival of GAS in THP-1 macrophages 
A. Stationary phase WT GAS was either opsonised or not in 10% human serum for 20 min and THP-1 
cells infected at MOI 5. Intracellular bacteria were quantified by CFU counts for both conditions 
(mean ± SEM, n=3) B. WT and WT-pGFP1 were grown until stationary phase; the WT-pGFP1 strain 
was oxygenated for 3 h and both strains were opsonised. THP-1 cells were infected at MOI 5 and 
intracellular bacteria were quantified by CFU counts. (mean ± SEM, n=3) C. WT-pGFP1 and S. 
Typhimurium 12023 were grown until stationary phase and both strains opsonised with 10% human 
serum. THP-1 cells were infected at MOI 5 and intracellular bacteria were quantified by CFU counts. 
(mean ± SEM, n=3). D. THP-1 cells were differentiated with 10 ng/ml or 100 ng/ml PMA for 3 days 
and infected with opsonised WT-pGFP1 GAS at MOI 5. Intracellular bacteria were counted by CFU at 
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indicated time points (mean ± SEM, n=2). P-values were determined by a two-tailed student’s t test. 
*, p < 0.05 ** p<0.01; *** p<0.001. 
 
 
 
3.2.5   Quantification of intracellular GAS by fluorescence microscopy 
GAS has been reported previously to replicate inside human macrophages between 6 and 
10 h post infection (Hertzen et al, 2010). This finding was deduced from septum formation 
observed in electron microscopy (EM) images of infected cells, indicating bacterial division. 
Further evidence to support intracellular replication was provided by CFU counts from cell 
culture media of infected cells 4 h after antibiotic removal which was 10-fold higher 
compared with culture media inoculated with the same bacterial load. 
To determine if GAS replicates inside THP-1 macrophages, CFU analysis is not sensitive 
enough as it provides a measurement of net bacterial load: a product of both replication 
and killing. Another limitation of CFU analysis is that GAS can grow in long chains of up to 12 
cocci and one CFU may not derive from one bacterial cell. As a result, CFU data might not 
reflect accurately the true intracellular number of bacterial cells. Therefore, fluorescence 
microscopy analysis was carried out in conjunction with CFU assays to quantify accurately 
the number of intracellular bacteria inside THP-1 macrophages over time.  
 
First, to improve quantification of intracellular bacteria by microscopy, the number of chain-
forming GAS in the infection inoculum was reduced by using short low-speed centrifugation 
(Fig. 3.5 A). In stationary phase cultures, up to 50% of GAS form chains (Fig. 3.5 B (i)). 
Bacteria were centrifuged at 1000 x g for 1 min to pellet the larger bacterial clumps and 
coccal chains resulting in a supernatant enriched for single coccus, diplococcus and a few 
short chains (Fig. 3.5 B (ii)). Supernatant from multiple tubes were combined to collect 
enough bacteria for the infections. To assess whether removal of long chain-forming GAS 
influences the net bacteria load, a CFU assay was carried out in THP-1 cells infected at MOI 
0.5 with WT-pGFP1. A similar rate of decrease in CFU was recorded over time (Fig. 3.5 C), as 
recorded in section 3.5, previously. 
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THP-1 cells were differentiated on glass coverslips and infected with WT-pGFP1 at MOI 0.5, 
to accurately count the number of intracellular bacteria in infected cells during infection. To 
observe and quantify the true intracellular population only, extracellular and adherent GFP-
expressing bacteria were differentially labelled with anti-GAS antibody and AlexaFluor 
conjugated secondary antibody, without permeabilisation. The numbers of intracellular 
bacteria were categorised into 4 different groups (1-2, 3-5, 6-10 and 11+ bacteria). The 
percentage of cells containing 11+ bacteria decreased from 5% at 30 min p.u. to 2% at 6 h 
p.u. (Fig. 3.5. D). At 9 h p.u., only 1% of the total infected population contained 11+ bacteria. 
Likewise, a steady decline in the percentage of infected cells containing 3-5 and 6-10 
bacteria was also observed during infection. As the proportion of heavily infected cells 
declined over time, the percentage of cells containing few bacteria (1-2) steadily increased 
from 38% at 30 min p.u. to 55% at 6 h and 66% at 9 h p.u. Figure 5. E shows representative 
confocal microscopy images of THP-1 macrophages containing few or several bacterial cells. 
No increase in the number of bacteria was observed even at later time points during 
infection. Overall, data obtained by microscopic quantification indicates that GAS fail to 
replicate within THP-1 macrophages. 
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Figure 3.5 Quantification of intracellular GAS by fluorescence microscopy 
A. Schematic diagram of the low speed centrifugation step to remove long chains of GAS from the 
infection inoculum. B Representative confocal microscopy images of stationary phase WT-pGFP1 
bacteria seeded onto glass coverslips before low speed centrifugation (i) or after (ii). C. THP-1 cells 
were infected with opsonised WT-pGFP1 GAS at MOI 0.5 and intracellular bacteria were recovered 
and plated onto THB agar for CFU enumeration. The net bacterial load (CFU/ml) was calculated at 
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the indicated time points. D. Quantification of intracellular GAS by fluorescence microscopy. THP-1 
cells were differentiated on glass coverslips and infected with WT-pGFP1 at MOI 0.5. At the indicated 
time point, the number of bacteria per infected cell was recorded into 4 separate groups: 
representing 1-2, 3-5, 6-10 or 11+ bacteria. At least 100 infected cells were counted per time point. 
E. Representative confocal microscopic images of infected THP-1 cells at time points indicated. 
Intracellular WT-pGFP1 (in) and extracellular WT-pGFP1 (out) were differentially labelled with anti-
GAS primary antibody and AlexaFluor 555 secondary (red) without permeabilisation. Cell outline is 
delineated by broken white lines. Scale bar corresponds to a distance of 5 µm. Error bars (SEM) are 
based on 3 independent experiments. P-values were determined by a two-tailed student’s t test. *, p 
< 0.05, ** p < 0.01. 
 
 
 
 
3.2.6     Intracellular growth of GAS in HeLa cells 
The infection assays carried out in the THP-1 cell line using the M1T1 5448 strain failed to 
reveal a replicating population. Recently it was reported that M1T1 GAS is capable of 
replicating in epithelial cells (Barnett et al., 2013). CFU counts of the M1T1 5448 strain 
increased 3 fold between 5 h and 8 h post-invasion (p.i.), whereas an M6 strain failed to 
replicate within this time. To test whether the M1T1 strain is capable of replicating 
intracellularly, HeLa cells were infected and the number of intracellular GAS was quantified 
over time by CFU and microscopy. 
First, the invasion potential of M1T1 5448 in HeLa cells was determined (Fig. 3.6 A). 
Stationary phase bacteria were added to the cells at MOI 20 for 1 h or 2 h in the presence of 
2% FCS. Decreasing the concentration of FCS in the cell culture medium reduces 
extracellular bacterial proliferation, thereby maintaining the appropriate MOI throughout 
invasion (Nerlich et al., 2009). At the appropriate time p.i., infected cells were washed to 
remove unbound extracellular bacteria. Infected cells were lysed in Triton and the adherent 
and internalised bacteria were released and plated onto agar for CFU analysis. In replicate 
wells, cells containing gentamicin were lysed and the intracellular population was 
determined by CFU. Therefore, the percentage of bacteria that successfully invaded was 
determined from the infection inoculum. As expected, the invasion potential of M1T1 was 
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very low during 1 h invasion with only 0.3% of inoculum internalised. However, by 
increasing the incubation time to 2 h, the rate of bacterial invasion increased to a modest 
2% of inoculum. The low invasion rates recorded for M1T1 GAS was expected and has been 
reported previously (Anderson et al., 2014). 
CFU counts from infected cells showed no overall increase in the number of intracellular 
GAS over time (Fig. 3.6 B). Between 2 h and 4 h p.i., a 1.5 log decrease in CFU was recorded. 
However, this could be due to effects of gentamicin treatment after the 2 h invasion period 
and not intracellular killing.  Although an increase in CFU was not detected, colony counts 
remained stable from 4 h to 9 h p.i. and a significant number of viable colonies could be 
detected at 24 h p.i. However, evidence of replication was observed by fluorescence 
microscopy. Quantification by microscopy revealed that a percentage of cells containing 6-
10 bacteria increased significantly from 7% at 2 h p.i., to 20% at 6 h p.i. This increased 
further to 32% of infected cells at 9 h p.i. (Fig. 3.6 C). Likewise, a significant increase in cells 
containing 11+ bacteria were detected at the later time points of 6 h and 9 h p.i. 
Representative images of infected HeLa cells show greater numbers of intracellular GAS at 
later time points (Fig. 3.6 D). Overall, these results indicate that the M1T1 GAS can replicate 
in human cells, although detection it is not efficient or easily observable due to the low 
invasion rates. Confident that the M1T1 strain is capable of replicating in human cells, I 
decided to continue investigating the intracellular survival and growth of GAS in another 
human monocytic cell line called U937. 
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Figure 3.6 Quantification of intracellular GAS in HeLa cells 
A. HeLa cells were seeded at 1 X 105 per well and infected with WT-pGFP1 GAS at MOI 20. At 1 h or 2 
h post-invasion, cells were lysed and plated on THB agar for CFU quantification. In replicate wells 
gentamicin was added for 30 mins and cells were lysed and plated for CFU quantification. The 
percentage of adherent bacteria (blue) or internalised bacteria (red) from the infection inoculum 
was determined. B. HeLa cells were infected with WT-pGFP1 GAS at MOI 20 for 2 h and intracellular 
bacteria were recovered and plated onto THB agar for CFU quantification. The net bacterial load (Log 
CFU/ml) was calculated at the indicated time points. C. Quantification of intracellular GAS by 
fluorescence microscopy. HeLa cells were seeded onto glass coverslips and infected with WT-pGFP1 
at MOI 20. At the indicated time point, the number of bacteria per infected cell was recorded into 4 
separate groups: 1-2, 3-5, 6-10 or 11+ bacteria. At least 100 infected cells were counted per time 
point. D. Representative confocal microscopic images of infected HeLa cells at time points indicated. 
Cells are shown by DIC containing intracellular WT-pGFP1 GAS (in) and extracellular WT-pGFP1 (out) 
was differentially labelled with anti-GAS primary antibody and AlexaFluor 555 secondary (red) 
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without permeabilisation. Scale bar corresponds to a distance of 5 µm. Error bars (SEM) are based 
on 3 independent experiments. P-values were determined by a two-tailed student’s t test. *, p < 
0.05, ** p < 0.01. 
 
 
 
3.2.7     Replication of GAS in a U937 macrophage-like cell line 
The U937 human monocytic cell line was chosen as an alternative macrophage model for 
GAS infection. U937 macrophages have been widely used to study mechanisms of bacterial 
survival and replication for a wide range of pathogens including and Shigella flexneri 
(Lucchini et al., 2005), Francisella tularensis (Su et al., 2011) and Chlamydia trachomatis 
(Nettelnbreker et al., 1998).  U937 cells were differentiated using PMA and exhibited similar 
morphological changes to THP-1 cells under the same conditions (not shown).  
U937 cells were seeded onto glass coverslips and infected with WT-pGFP1 to investigate 
intracellular growth of GAS by fluorescence microscopy. The numbers of bacteria were 
counted in at least 100 infected cells per time point. The percentage of cells containing 
many intracellular GAS (11+) increased significantly from 4% at 0.5 h p.u., to 36% at 6 h and 
36.5% at 9 h p.u. (Fig. 3.7 A). The percentage of cells containing 3-5 bacteria decreased 
significantly from 44% at 0.5 h p.u., to 21% at 6 h p.u., and eventually to 18% at 9 h p.u. 
Strikingly, many infected cells were observed with a high intracellular burden of long chain 
forming GAS, as highlighted by representative microscopy images in Fig. 3.7 B. Next, I 
investigated the survival of WT-pGFP1 and a non-pathogenic E. coli DH5α strain expressing 
GFP in U937 cells (Fig. 3.7 C). CFU analysis failed to reveal an increase in the total number of 
intracellular bacteria during infection. However, CFU counts were stable between 3 h p.u., 
and 9 p.u., which could be explained by intracellular growth coupled with bacterial killing.  
Overall, CFU counts decreased by 4 logs for E. coli-infected cells during 24 h infection (Fig. 
3.7 C). Notably, CFUs did not decrease considerably between 3 h and 9 h p.u. Nonetheless, 
microscopic quantification clearly showed no evidence of E. coli replication during infection 
(Fig. 3.7 D). This indicates that U937 macrophages restrict the growth of a non-pathogenic 
strain of E. coli but not of M1T1 GAS.  
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Figure 3.7 Quantification of intracellular bacteria in U937 macrophages. 
A. U937 cells were differentiated on glass coverslips and infected with WT-pGFP1 at MOI 0.5. At the 
indicated time point, the number of bacteria per infected cell was recorded into 4 separate groups: 
1-2, 3-5, 6-10 or 11+ bacteria. At least 100 infected cells were counted per time point (mean ± SEM, 
n=3). B. Representative confocal microscopic images of infected U937 cells at time points indicated. 
Intracellular WT-pGFP1 (in) and extracellular WT-pGFP1 (out) were differentially labelled with anti-
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GAS primary antibody and AlexaFluor 555 secondary (red) without permeabilisation. Cell outline is 
delineated by broken white lines. Scale bar corresponds to a distance of 5 µm. C. CFU count for U937 
cells infected with WT-pGFP1 GAS or GFP-E. coli DH5α at MOI 0.5 and MOI 2, respectively (mean ± 
SEM, n=3). D. Microscopic quantification of GFP-E. coli-infected U937 cells. At least 100 infected cells 
were counted and the number of E. coli was recorded as 1-2, 3-5 and 6+ per infected cell (mean ± 
SEM, n=2). P-values were determined by a two-tailed student’s t test. *, p < 0.05, ** p < 0.01, *** p 
<0.001. 
 
 
3.2.8     Replication of GAS in primary human macrophages 
In vitro infections with M1T1 GAS were also carried out using primary human monocyte-
derived macrophages (hMDMs). In a previous study conducted by Norrby-Teglund and 
colleagues, it was reported that M1T1 can survive and replicate in hMDMs (Hertzen et al., 
2010). It can be argued that primary macrophages represent the most physiologically 
relevant cell type since they are obtained from an in vivo source. We isolated monocytes 
from the blood of healthy donors using CD14-positive selection. The specificity of selection 
and the viability of the isolated monocytes were assessed prior to conducting infections 
with GAS. The isolated cells were labelled with anti-CD14 antibody or treated with 
propidium-iodide (PI), a cell viability marker, and analysed by flow cytometry. PI enters cells 
and fluoresces only after damage or loss of plasma membrane integrity. 
 
The positive selection of monocytes from peripheral blood mononuclear cells (PBMCs) was 
98% efficient (Fig. 3.8 A (i)) and 97% of monocytes recovered were negative for PI staining 
(Fig. 3.8 A (ii)). Cells were seeded onto 24 well plates and differentiated with macrophage 
colony stimulating factor (MCSF) for 7 days prior to infection. Macrophages were infected 
with WT-pGFP1 at MOI 0.5 and the number of bacteria was quantified over time. 
Quantification by microscopy revealed strong evidence of replication with 39% of infected 
cells containing 11+ bacteria at 9 h p.u., compared to 2% at 30 min p.u. (Fig. 3.8 B). At the 
same time point post-uptake, the percentage of cells containing fewer bacteria (3-5) was 
significantly reduced from 42% to 21%. Although an increase in the percentage of heavily 
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infected cells was recorded at 6 h p.u., there was considerable variation between 
experiments. Nonetheless, a proportion of primary cells containing many intracellular 
bacteria were consistently observed by microscopy (Fig. 3.8 C).  
 
CFU counts revealed that GAS can survive for up to 24 h in primary macrophages (Fig. 3.8 D).  
Despite no evidence of growth by CFU counts, a relatively stable number of bacteria was 
recovered between 3 h and 9 h p.u., similar to that of U937 cells. GFP-E. coli was also shown 
to survive for up to 24 h and was not killed efficiently in the first 9 h of infection in primary 
macrophages. Nonetheless, the number of intracellular E. coli never increased during the 
course of infection (Fig. 3.8 E), indicating that primary macrophages restrict the growth of E. 
coli, but not of M1T1 GAS. These data indicate that GAS can replicate in primary human 
macrophages and are in agreement with results obtained from U937 macrophage-like cell 
line. Therefore, the U937 cell line was chosen as a reliable and suitable model for further 
study into GAS-macrophage interactions. 
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Figure 3.8 Intracellular growth of GAS in primary human macrophages  
A (i). Monocytes were isolated from blood of healthy donors and extracted from PBMCs using CD14-
positive selection. PBMCs or CD14-selected cells were labelled with anti-CD14 primary antibody and 
AlexaFluor 488 secondary and analysed by flow cytometry. The percentage of CD14-positive cells 
was determined by flow cytometry. A (ii) CD14-selected monocytes were fixed or not in 3% PFA and 
stained with PI to determine the percentage of viable cells after positive selection. B. Monocytes 
92 
 
were differentiated with 20 ng/ml MCSF and seeded onto glass coverslips for 7 days prior to 
infection with WT-pGFP1 at MOI 0.5. At the indicated time point, the number of bacteria per 
infected cell was recorded into 4 separate groups: representing 1-2, 3-5, 6-10 or 11+ bacteria. At 
least 100 infected cells were counted per time point. C. Representative confocal microscopic images 
of infected macrophages. Intracellular WT-pGFP1 (in) and extracellular WT-pGFP1 (out) were 
differentially labelled with anti-GAS primary antibody and AlexaFluor 555 secondary (red) without 
permeabilisation. Cell outline is delineated by broken white lines. Scale bar corresponds to a 
distance of 5 µm. D. CFU count for macrophages infected with WT-pGFP1 GAS or GFP-E. coli DH5α at 
MOI 0.5 and MOI 2, respectively. E. Microscopic quantification of GFP-E. coli-infected macrophages. 
At least 100 infected cells were counted and the number of E. coli was recorded as 1-2, 3-5 and 6+ 
per infected cell. Error bars (SEM) are based on 3 independent experiments. P-values were 
determined by a two-tailed student’s t test. *, p < 0.05, ** p < 0.01, *** p <0.001. 
 
 
 
3.2.9     GAS-mediated cytotoxicity in macrophages  
During infection and intracellular microscopic quantification of M1T1 GAS in macrophages, 
some evidence of cytotoxicity was observed. GAS has been shown to induce a strong 
cytotoxic response in many cell types, including epithelial cells (Tsai et al., 1999), neutrophils 
(Sierig et al., 2003) and macrophages (Goldmann et al., 2009). To investigate the cytotoxicity 
induced upon infection with M1T1 GAS, PI uptake or the release of lactate dehydrogenase 
(LDH) was measured in THP-1, U937 and primary macrophages.  LDH is a stable cytoplasmic 
enzyme that is released into the culture supernatant after damage to the plasma 
membrane.  U937 cells were infected with WT-pGFP1 GAS or GFP-E. coli DH5α, which 
served as a negative control, and LDH release was assayed (Fig. 3.9 A). GAS induced a 
significant release of LDH into the supernatant, as early as 1 h p.u., and LDH was increasingly 
detected until 24 h post-uptake. As expected, negligible amounts of LDH were detected for 
E. coli-infected cells, indicating that this bacterium is not cytotoxic.  
 
Despite the obvious differences in intracellular proliferation and host cytotoxicity between 
M1T1 GAS and E. coli DH5α, CFU counts were found to be comparable during previous 
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infections (Section 3.2.7, Fig. 3.7 A). Therefore, U937 cells were infected with WT-pGFP1 and 
GFP-E. coli DH5α and the rate of infection over time was determined by flow cytometry (Fig. 
3.9 B). The percentage of GAS-infected cells decreased over time, from 31% at 30 min p.u., 
to 9.5% at 9 h p.u. The reduction in the infection rate correlates with the increase in LDH 
release over time. In contrast, E. coli did not exert a cytotoxic response in U937 cells and the 
percentage of infected cells over time remained relatively stable until 9 h p.u. However, at 
24 h p.u., only 4% of cells contained E. coli, whereas at 9 h p.u., 45% were infected.  
 
The LDH release assay is readout of total cellular toxicity. Therefore, flow cytometry was 
used to analyse cell viability at the single cell level using PI. U937 cells were infected with 
WT-pGFP1 at MOI 0.5 and at the indicated time point cells were gently detached with 
accutase and exposed to PI prior to flow cytometry analysis. In agreement with the LDH 
data, a significant proportion of GAS-infected cells were PI-positive from 3 h to 24 h p.u. 
(Fig. 3.9 C). Importantly, single cell analysis revealed that GAS-induced cytotoxicity was 
specific only for the infected population, whereas non-infected bystander cells remained PI-
negative throughout infection. In contrast, results from E. coli-infected U937 cells revealed 
no induction of cytotoxicity throughout infection (Fig. 3.9 D).  
 
Uptake of PI was also measured in THP-1 and primary macrophages to determine the level 
of cytotoxicity induced by M1T1 GAS in these cell types. PI uptake was also observed in a 
proportion of infected cells in both THP-1 and primary macrophages throughout infection 
(Fig. 3.9 E-F). Although a slightly higher percentage of THP-1 cells were PI-positive compared 
to U937 and primary macrophages, there was no significant difference at each time point 
tested. This suggests that inability of GAS to proliferate in THP-1 cells is unlikely a 
consequence of greater host cell death. 
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Figure 3.9 Cytotoxicity of M1T1 GAS in human macrophages 
A. Cytotoxicity was assessed by measuring LDH release into the supernatant using a 
colorimetric assay after infection with WT-pGFP1 GAS or GFP-E. coli DH5α in U937 cells. LDH is 
presented as percentage of maximum LDH release (mean ± SEM, n=3). B. U937 cells were infected 
with WT-pGFP1 or GFP-E. coli at MOI 0.5 or MOI 2, respectively. The percentage of infected cells was 
determined by analysing GFP-positive cells during infection by flow cytometry (mean ± SEM, n=2). C. 
WT-pGFP1-infected cells were detached using accutase and uptake of PI was assessed at indicated 
time points using by flow cytometry. Percentage of PI uptake is presented for infected (GFP-positive) 
and non-infected (GFP-negative) cells (mean ± SEM, n=3). D. Percentage of PI uptake in U937 cells 
infected with GFP-E. coli, as determined by flow cytometry (mean ± SEM, n=2) E. Percentage of PI 
uptake in THP-1 cells infected with WT-pGFP1, as determined by flow cytometry (mean ± SEM, n=3). 
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F. Percentage of PI uptake in human monocyte-derived macrophages infected with WT-pGFP1, as 
determined by flow cytometry (mean ± SEM, n=3). P-values were determined by a two-tailed 
student’s t test. *, p < 0.05, ** p < 0.01. 
 
 
3.2.10   M1T1 GAS replicates in PI-negative U937 macrophages 
I have shown that GAS can replicate in U937 and primary macrophages despite inducing a 
significant cytotoxic response upon infection. Although other studies have reported that 
GAS-induced macrophage apoptosis promotes intracellular survival (Timmer et al., 2009), 
many professional intracellular pathogens have mechanisms to counteract host cell death, 
to facilitate their intracellular growth (Ashida et al., 2011). 
Therefore, I tested if intracellular replication of M1T1 GAS occurs before the onset of host 
cell death. U937 cells were infected with WT-pGFP1 in the presence of PI and the number of 
bacteria in PI-negative cells was quantified (Fig. 3.10 A). PI is a non-fixable viability dye, and 
the number of bacteria was counted in live cells using a confocal microscope with an 
integrated live cell chamber at 37°C. At 6 h p.u. (the earliest time point of replication), a 
significant increase in the percentage of PI-negative cells containing high numbers of 
bacteria (11+) was detected, compared to 2 h p.u. Likewise, a decrease in the percentage of 
PI-negative cells containing few bacteria (1-2) was observed at 6 h p.u. Representative 
confocal images of infected PI-positive and PI-negative cells at 2 h and 6 h p.u. are shown in 
Fig. 3.10 B. Although GAS is generally regarded as being cytotoxic to macrophages, these 
results show that intracellular bacterial replication can occur inside macrophages with intact 
plasma membranes. 
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Figure 3.10 Growth of M1T1 GAS in PI-negative U937 cells 
A. Quantification of intracellular WT-pGFP1 in PI-negative cells at 2h and 6 h p.u. The number of 
bacteria in at least 50 infected cells was counted per experiment (mean ± SEM, n=3). B. 
Representative confocal images of PI-positive or PI-negative cells infected with WT-pGFP1 at 
indicated time points (scale bars, 5 µm). P-values were determined by a two-tailed student’s t test .* 
p<0.05; ** p<0.01.  
 
 
 
3.2.11   Investigating intracellular replication of different emm-type 
strains in U937 cells 
To date, only two studies report that GAS can survive and replicate in human cells (Hertzen 
et al, 2010; Barnett et al., 2013). However, the growth phenotype reported by both groups 
was specific for the M1T1 5448 strain. M1T1 5448 is a hyper-invasive strain, originally 
isolated from a patient with invasive disease and has acquired unique virulence proteins 
(Aziz and Kotb, 2008; Uchiyama et al., 2012). Although many different emm-type strains 
have been demonstrated to invade and survive in epithelial cells since the mid 1990’s, the 
majority fail to proliferate (Osterlund et al., 1997; Kaplan et al., 2006; Amelung et al., 2011).  
U937 cells were infected with clinically relevant GAS strains of the M12, M28 and M49 
background to determine if intracellular replication was specific for the M1T1 5448 strain. 
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Although M1 serotype is the most prevalent in cases of invasive GAS disease, M49 isolates 
are commonly associated with acute post-streptococcal glomerulonephritis (ASPGN) 
(McShan et al., 2008; Meehan et al., 2013; Williamson et al., 2015). M28 is a major serotype 
responsible for puerperal sepsis and M12 is prevalent in severe throat infections (Lynskey et 
al., 2011; Talkington et al., 1993).  
 
The M28 and M12 clinical strains were isolated from patients admitted to Hammersmith 
hospital (UK) with acute throat infection. Two additional M49 strains were also obtained: 
the M49 CS101 impetigo strain first characterised by Patrick Cleary and colleagues at the 
University of Minnesota and the M49 NZ131 and a clinical nephritogenic strain isolated from 
a patient with APSGN in New Zealand (Haanes and Cleary, 1989; Simon and Ferretti, 1991).  
 
U937 cells were infected with all 4 strains and bacterial cytotoxicity, survival and growth 
was determined. Amongst all 4 strains, the M28 strain induced the highest levels of 
cytotoxicity in U937 cells at 6 h, 9 h and 24 h p.u. (Fig. 3.11 A). In contrast, U937 cells 
infected with the M49 CS101 exhibited the lowest amount of cytotoxicity compared to M12, 
M28 and M49 NZ131. The M12 and M49 NZ131 strains had the highest percentage survival 
rates during infection with 6% and 4.5% survival at 9 h, respectively (Fig. 3.11 B). The 
survival rate for M28 GAS was the lowest recorded, with no viable colonies detected at 24 h.  
Next, the intracellular growth was examined by microscopy for each strain, by counting only 
the cells that contained 11+ bacteria. M12 GAS exhibited the greatest level of replication 
with 30% of cells containing 11+ bacteria at 6 h p.u. (Fig. 3.11 C). This increased slightly to 
32% at 9 h p.u. and many cells contained long chains of intracellular bacteria, as indicated by 
representative microscopy images in Fig. 3.11 D. The number of M49 NZ131 GAS was also 
significantly increased during infection, albeit replication was slightly less efficient than M12 
GAS (Fig. 3.11 C). Nonetheless, at 6 h and 9 h p.u. 19% and 26% of cells contained 11+ 
bacteria respectively, compared to 2% at 0.5 h p.u. Cells containing 50-100 intracellular GAS 
were frequently observed at late time points (Fig. 3.11 D). Intracellular replication was 
infrequently detected for the M28 strain and a slight but significant increase was recorded 
at 6 h and 9 h p.u. (Fig. 3.11 C-D). Moreover, the M49 CS101 strain was unable to replicate 
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in U937 cells. Overall, these results show for the first time that non-M1 type strains can 
replicate in human macrophages. 
 
 
 
 
Figure 3.11 Intracellular growth of different emm-type strains in U937 cells 
A. Measurement of LDH release in U937 cells infected with M12, M28, M49 CS101 and M49 NZ131 
strains at MOI 5. LDH is presented as percentage of maximum LDH release. B. U937 cells were 
infected with indicated GAS strains at MOI 5 and intracellular bacteria were recovered and plated 
onto THB agar for CFU quantification. Values are the mean numbers of CFU recovered and expressed 
as a percentage of the value at 0.5 h post-uptake. C. U937 cells were seeded onto glass coverslips 
and infected with indicated GAS strains at MOI 0.5. At various time points post-uptake, the number 
of infected cells containing 11+ bacteria was counted. At least 100 infected cells were counted per 
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time point. D. Representative confocal microscopy images of infected U937 cells. Extracellular 
bacteria (out) were labelled by antibodies without permeabilisation and intracellular bacteria (in) 
were labelled after permeabilisation. Cell outline is shown by DIC. Scale bar corresponds to a 
distance of 5 µm. Error bars (SEM) are based on 3 independent experiments. P-values were 
determined by a two-tailed student’s t test.* p<0.05; ** p<0.01.   
 
 
 
3.2.12   Replication is not dependent on the M1 protein 
The M1 protein is encoded by the emm gene and is a major virulence factor with a variety of 
functions, from endothelial cell invasion (Ochel et al., 2014), to protection against 
complement deposition (Lauth et al., 2009) and antimicrobial peptides (Ermert et al., 2013). 
It was previously reported that M1 protein promotes intracellular survival and replication of 
GAS in human neutrophils and macrophages (Staali et al., 2006; Hertzen et al., 2010). An M1 
deletion mutant (Δemm1) in the 5448 strain was kindly provided by the Norrby-Teglund 
group.  
To determine if the M1 protein is required for intracellular replication under our 
experimental conditions, we infected U937 cells with isogenic WT M1T1 or Δemm1 mutant 
strains. The amount of LDH released during infection was assessed for both strains and a 
small but significant decrease in cytotoxicity was detected at 9 h and 24 h p.u. for the 
Δemm1 mutant compared to the WT strain (Fig. 3.12 A). The total number of intracellular 
bacteria was also examined during infection by CFU assay. However, no difference in CFU 
counts was detected at any time during infection (Fig. 3.12 B). In addition, quantification by 
fluorescence microscopy indicated no significant difference in the percentage of infected 
cells containing 11+ bacteria when comparing these strains (Fig. 3.12 C). The intracellular 
growth of Δemm1 was as efficient as the isogenic WT strain and infected cells at late time 
points contained a high intracellular burden of long chain forming GAS, as shown in Fig. 3.12 
D. Overall, these results indicate that replication of M1T1 GAS in U937 macrophages is 
independent of the surface M1 protein. 
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Figure 3. 12 M1 protein is not required for intracellular replication in U937 cells 
A. Measurement of LDH release in U937 cells infected with isogenic WT M1T1 5448 and Δemm1 
mutant strains at MOI 5. LDH is presented as percentage of maximum LDH release. B. U937 cells 
were infected with WT 5448 and Δemm1 strains at MOI 5 and intracellular bacteria were recovered 
and plated onto THB agar for CFU enumeration. The net bacterial load (Log CFU/ml) was calculated 
at the indicated time points. C. U937 cells were seeded onto glass coverslips and infected with WT 
5448 and Δemm1 strains at MOI 0.5. At various time points post-uptake, the number of cells 
containing 11 or greater intracellular bacteria was counted. At least 100 infected cells were counted 
per time point. D. Representative confocal microscopy images of infected U937 cells containing 
intracellular bacteria (WT (in)) and extracellular bacteria (WT (out)) are shown. Cell outline is shown 
by DIC. Scale bar corresponds to a distance of 5 µm. Error bars (SEM) are based on 3 independent 
experiments. P-values were determined by a two-tailed student’s t test.* p<0.05. 
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3.2.13   Summary 
• Long chains of GAS formed during growth in culture can be removed prior to 
infection by short speed centrifugation, allowing accurate microscopic quantification 
of bacteria in cells over time. 
• M1T1 GAS fail to replicate in THP-1 cells. 
• M1T1 GAS is cytotoxic to cells but can replicate in PI-negative U937 cells as well as 
primary human macrophages. 
• In addition to the M1T1 strain, an M12 strain and M49 NZ131 replicated efficiently in 
U937 cells. 
• The outer surface M1 protein was not required for intracellular survival or 
replication of M1T1 GAS in U937 cells. 
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Chapter 4 
 
Streptolysin O (SLO) is required for intracellular replication in 
U937 macrophages 
 
4.1  Introduction 
In the previous chapter I carried out an in depth analysis of the intracellular survival and 
growth of GAS in a variety of human cell types. For the first time, quantitative evidence of 
intracellular replication of GAS was demonstrated in human macrophages. Moreover, 
replication of GAS in U937 macrophages was found to be both M1- and serotype-
independent. However, the intracellular localisation and trafficking of GAS in macrophages 
during infection remains poorly understood. In this chapter, I attempt to understand how 
GAS resist and/or exploit macrophage-killing mechanisms to promote intracellular its 
growth. 
It is believed that GAS could contain over 200 virulence factors (McMillan et al., 2006; Kizy 
and Neely, 2009). Since GAS is classically regarded as an extracellular pathogen, the most 
widely studied virulence factors are predominantly involved in its extracellular lifecycle 
(Cunningham, 2000). Earlier work carried out in neutrophils and macrophages proposed 
that the outer surface M protein promotes survival (Staali et al., 2003; Hertzen at al., 2010), 
however recent studies have identified Streptolysin O (SLO) in contributing to GAS immune 
evasion and intracellular survival (O’Seaghdha and Wessels, 2013). In macrophages, SLO 
contributes significantly to host cell death. SLO activates the Nlrp3 inflammasome leading to 
caspase1-dependant cell death (Harder et al., 2009). In another study, SLO was also 
demonstrated to result in loss of mitochondrial membrane potential, leading to a rapid form 
of apoptotic cell death (Timmer et al., 2009). In vitro and in vivo data support the hypothesis 
that SLO-induced toxicity contributes to GAS immune evasion and increased virulence.  In 
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epithelial cells, CFU data show that WT GAS survives better in cells compared to a Δslo 
deletion mutant strain and SLO activity promotes bacterial escape from phagosomes into 
the cytoplasm (Nakagawa et al., 2004).  
In contrast, two independent studies carried out in human macrophages failed to observe a 
cytosolic population and concluded that GAS survives within a modified vacuolated 
compartment throughout infection (Hertzén et al., 2010; Bastiat-Sempe et al., 2014). 
Moreover, the mechanism of how GAS promotes intracellular survival in macrophages is 
disputed. According to Hertzen and colleagues, survival of M1T1 GAS requires the M1 
protein to prevent fusion of lysosomes to the GCV. In contrast, Bastiat-Sempe et al. (2014) 
found that SLO activity promotes survival in macrophages. The authors suggested that SLO 
forms pores in the membrane of the GCV, thereby preventing acidification of the vacuole, 
rendering the compartment more hospitable for survival. 
Clearly further work is required to better understand the intracellular fate of GAS in 
macrophages and to help resolve some of the contradictory results reported in the 
literature. In this chapter, I investigate the role of SLO in promoting survival and intracellular 
replication in U937 macrophages.  
 
 
4.2  Results 
4.2.1    Streptolysin O promotes intracellular replication. 
The pore-forming toxin SLO is an important virulence factor in GAS-host interactions. SLO is 
produced and secreted as a monomer that binds cholesterol in cell membranes and 
oligomerises to form transmembrane pores 30 nm wide (Feil et al., 2014). It was found that 
a GAS mutant deficient in SLO was impaired for intracellular survival and less cytotoxic to 
macrophages (Timmer et al., 2009; Bastiat-Sempe et al., 2014). An M49 NZ131 SLO deletion 
mutant (Δslo) strain was obtained from S. Sriskandan and I investigated the role of SLO in 
promoting intracellular growth. 
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U937 cells were infected with WT M49 and the isogenic Δslo mutant. As expected, 
cytotoxicity was considerably reduced for the Δslo compared to WT M49 (Fig. 4.1 A). 
Despite this, CFU counts revealed that the percentage survival was comparable for both 
strains throughout infection (Fig. 4.1 B). It was suspected that the impact of cytotoxicity on 
intracellular survival could be offset by differences observed for intracellular growth. 
Indeed, microscopy analysis revealed that the Δslo mutant strain was significantly impaired 
for intracellular growth compared to isogenic WT (Fig. 4.1 C). At 9 h p.u., 7% of infected cells 
contained 11+ Δslo bacteria compared to 20% for WT. Microscopic examination also showed 
that the Δslo mutant bacteria did not produce the long replicating chains observed for the 
WT strain (Fig. 4.1 D). As an alternative measure of intracellular replication, the geometric 
mean fluorescence intensity of antibody-labeled WT and Δslo mutant bacteria (per infected) 
was determined cell by flow cytometry. In agreement with the results obtained by 
microscopy, replication of the Δslo mutant was significantly impaired compared to the WT 
strain at 6 h and 9 h p.u. (Fig. 4.1 E-F). These results show that the pore forming SLO toxin is 
required for replication of GAS in U937 macrophages. 
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Figure 4.1 SLO is required for intracellular replication of GAS  
A. Cytotoxicity was assessed by measuring LDH release into the supernatant using a 
colorimetric assay after infection with isogenic WT M49 and Δslo mutant at MOI 5 in U937 cells. LDH 
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is presented as percentage of maximum LDH. B. Cells were infected with WT M49 and Δslo mutant 
at MOI 5 and intracellular bacteria counted by CFU. Values are the mean numbers of CFU recovered 
and expressed as a percentage of the value at 0.5 h post-uptake. C. Cells were infected with WT M49 
and Δslo mutant, and the number of infected cells containing 11+ bacteria were quantified. At least 
100 infected cells were counted per experiment. D. Representative confocal images of WT M49 and 
Δslo infected cells at indicated time points (scale bars, 5 µm). E (i-iii). Representative contour plots 
showing the fluorescence profile of WT M49 and Δslo mutant in U937 cells, including non-infected 
cells, at 9 h p.u. Black box indicates the gating for the infected population and blue box indicates 
gating for infected cells containing replicating bacteria. F. Values for the geometric mean 
fluorescence of WT M49 and Δslo mutant in U937 cells across all time points.  Error bars (SEM) are 
based on 3 independent experiments. P-values were determined by a two-tailed student’s t test.* 
p<0.05; ** p<0.01; *** p<0.001. 
 
 
4.2.2    GAS induces damage to the GCV  
Upon bacterial invasion into host cells, many different bacteria can escape the vacuolar 
compartment and enter the nutrient rich cytosol. Galectins are cytosolic lectins that bind to 
β-galactose glycans on the inner leaflet of endocytic compartments (Barondes et al., 1994). 
Hence they can be used as danger receptors. Galectin 8 has been shown to detect invasion 
of Salmonella by binding to exposed glycans on the damaged Salmonella-containing vacuole 
(SCV) (Thurston et al., 2012). Similarly, galectin 3 was shown to reveal vacuolar rupture by 
both Shigella and Listeria (Paz et al., 2010; Weng et al., 2010). Upon internalisation into 
epithelial cells, GAS was demonstrated to escape the vacuolar compartment, resulting in 
recruitment of galectins (Nakagawa et al., 2004; Sakurai et al., 2010). Galectin 8 is recruited 
to the damaged GCV but is predominantly associated with Streptolysin S (SLS) activity 
(O’Seaghdha and Wessels, 2013). However, it was reported that in macrophages, GAS-
induced damage to the GCV is dependent on SLO expression but does not lead to vacuolar 
rupture and cytosolic entry (Bastiat-Sempe et al., 2014) 
To determine if GAS damages the phagosomal membrane in U937 cells, I engineered cells 
that stably express GFP-tagged galectin 8 or MCherry-tagged galectin 3. As a positive 
control, U937 cells were infected with S. Typhimurium ΔsifA deletion mutant. The sifA gene 
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encodes a type III secretion system (STSS) effector required to maintain the integrity of 
the Salmonella-containing vacuole (SCV) (Beuzón et al., 2000). Loss of sifA leads to SCV 
instability and release of bacteria into the cytosol between 4-10 h post-uptake in 
macrophages. After 8 h p.u. of the ΔsifA mutant, galectin 3 and galectin 8 were observed in 
association with the SCV (Fig. 4.2 A, B). The damaged SCV was enveloped in a galectin-
positive ring-like structure. In contrast, in E. coli-infected cells galectin 3 and galectin 8 were 
never observed in association to the bacteria-containing vacuole (Fig. 4.2 A, C). 
U937 cells were infected with WT M1T1 GAS and the percentage of galectin 3- and 8-
positive cells were quantified at early and late time points after uptake. Recruitment of 
galectin 3 and galectin 8 to the GCV was clearly evident during infection (Fig. 4.2 A, C). 33% 
of GCVs were associated with galectin 3 as early as 0.5 h p.u. (Fig. 4.2 B). Likewise, 20% of 
cells contained galectin 8-postive GCVs at 0.5 h p.u. (Fig. 4.2 D). Interestingly, at 2 h p.u. the 
number of GCVs associated with galectins peaked, with galectin 3 and 8 recruited to roughly 
half of all GCVs (Fig. 4.2 B, D). However, a significant decrease in the percentage of galectin-
positive GCVs was observed at 6 h p.u. 
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Figure 4.2 GAS damages the GCV in U937 cells 
A. U937 cells stably expressing MCherry-tagged galectin 3 were infected with GFP-expressing S. 
Typhimurium ΔsifA mutant, which served as positive control, GFP-expressing E. coli DH5α, which 
served as a negative control or WT-pGFP1 GAS. GFP bacteria are shown in green, galectin 3 in red 
and DNA was stained with DAPI (blue). Representative confocal images are shown with higher 
magnification in boxed areas. Scale bars, 5 µm. B. Quantification of galectin 3 association with WT-
pGFP1 GAS at time points indicated. Data shown represents the results of at least 100 infected cells. 
C. U937 cells stably expressing GFP-tagged galectin 8 were infected with MCherry-expressing S. 
Typhimurium ΔsifA mutant, MCherry-expressing E. coli DH5α, or WT GAS. Galectin 8 is shown green, 
MCherry bacteria are shown in red with WT GAS labelled with anti-GAS antibody and Alexa Fluor 555 
(red) and DNA was stained with DAPI (blue). Representative confocal images are shown with higher 
magnification in boxed areas. Scale bars, 5 µm. D. Quantification of galectin 8 association with WT 
GAS at time points indicated. Data shown represents the results of at least 100 infected cells.  Error 
bars (SEM) are based on 3 independent experiments. P-values were determined by a two-tailed 
student’s t test.* p<0.05. 
 
 
 
4.2.3    Damage to the GCV in THP-1 cells  
In the previous chapter it was demonstrated that M1T1 GAS failed to replicate in THP-1 
macrophages (section 3.2.5, Fig. 3.5). In addition, the levels of GAS-induced cytotoxicity in 
THP-1 cells were comparable to U937 and primary macrophages (section 3.2.9, Fig. 3.9), 
suggesting that restriction of bacterial growth was independent of cytotoxicity in this cell 
type. To determine if vacuolar damage was less frequent in THP-1 cells the recruitment of 
galectins to the GCV was quantified. 
THP-1 cells stably expressing MCherry-tagged galectin 3 and GFP-tagged galectin 8 were 
infected with WT M1T1 and E. coli DH5α and the percentage of galectin-positive GCVs were 
quantified by microscopy. As expected, galectin 3 and galectin 8 did not accumulate in 
proximity to E. coli but were recruited to the GCV at all-time points during infection (Fig. 4.3 
A, C). Galectin 3 and galectin 8 recruitment was observed as early as 0.5 h p.u., and peaked 
at 2 h p.u. (Fig. 4.3 B, D). Likewise, the percentage of galectin-positive GCVs was significantly 
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lower at 6 h p.u., compared to 2 h p.u. Although the percentage of galectin 3 and 8-positive 
GCVs were slightly lower in THP-1 cells compared to U937, there was no significant 
difference recorded. Therefore, the ability of GAS to damage its vacuole is unlikely to 
explain the lack of intracellular growth in THP-1 cells. 
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Figure 4.3 GAS damages the GCV in THP-1 cells 
A. THP-1 cells stably expressing MCherry-tagged galectin 3 were infected with GFP-expressing S. 
Typhimurium ΔsifA mutant, GFP-expressing E. coli DH5α or WT-pGFP1 GAS. GFP bacteria are shown 
in green, galectin 3 in red and DNA was stained with DAPI (blue). Representative confocal images are 
shown with higher magnification in boxed areas. Scale bars, 5 µm. B. Quantification of galectin 3 
association with WT-pGFP1 GAS at time points indicated. Data shown represents the results of at 
least 50 infected cells. C. THP-1 cells stably expressing GFP-tagged galectin 8 were infected with 
MCherry-expressing S. Typhimurium ΔsifA mutant, MCherry-expressing E. coli DH5α or WT GAS. 
Galectin 8 is shown in green, MCherry bacteria are shown in red and WT GAS labelled with anti-GAS 
antibody and Alexa Fluor 555 (red) and DNA was stained with DAPI (blue). Representative confocal 
images are shown with higher magnification in boxed areas. Scale bars, 5 µm. D. Quantification of 
galectin 8 association with WT GAS at time points indicated. Data shown represents the results of at 
least 50 infected cells. Error bars (SEM) are based on 3 independent experiments. P-values were 
determined by a two-tailed student’s t test. * p<0.05. 
 
 
4.2.4    GAS damage to the GCV is SLO-dependant  
To further investigate the interaction of galectin 3 with GAS, I quantified the association of 
galectin 3 with different emm-type strains, including the isogenic Δemm1 and Δslo deletion 
mutants. Microscopic quantification of galectin association in WT M1T1 and Δemm1-
infected cells at 2 h p.u., revealed no difference in the percentage of galectin 3-positive 
GCVs (Fig. 4.4 A, B). However, some variation was observed for galectin 3 association with 
different GAS strains. In cells infected with M28 GAS, 29% of GCVs were galectin-positive at 
2 h p.u., whereas 9% of GCVs were galectin-positive in cells infected with the M49 CS101 
strain. It was previously shown that both strains replicated poorly in U937 cells, but the M28 
was much more cytotoxic compared to M49 CS101. The frequency with which each strain 
damaged the GCV did not seem to correlate with their ability to replicate intracellularly. 
Whereas 20% of M1T1 GCVs were galectin-positive, the M12 strain, which replicates 
efficiently in U937 cells, had only 10% of GCVs associated with galectin 3. 
Although only a minority of WT M49 NZ131 accumulated galectin 3 to their vacuolar 
membranes, this was significantly higher compared to the Δslo mutant strain. 8% of M49 
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NZ131 GCVs associated with galectin 3 at 2 h p.u., whereas only 2% of Δslo bacterial GCVs 
were found in association with galectin 3. These results show that damage to the GCV in 
U937 cells is dependent on SLO. 
 
 
 
Figure 4.4 Damage of the GCV is SLO-dependent  
114 
 
A. U937 cells stably expressing MCherry-tagged galectin 3 were infected with the indicated GAS 
strains at MOI 0.5 and cells were fixed and labelled at 2 h p.u. Intracellular bacteria are shown as 
green only, extracellular bacteria are shown as blue and galectin 3 as red. Representative confocal 
images are shown with higher magnification in boxed areas. Scale bars, 5 µm. B. Quantification of 
galectin 3 association with various GAS strains and isogenic mutants at time points indicated. Data 
shown represents the results of at least 100 infected cells from 3 independent experiments (mean ± 
SEM). P-values were determined by a two-tailed student’s t test.* p<0.05. 
 
 
4.2.5    SLO mediates escape from LAMP1-containing vacuoles 
Fusion of lysosomes to the bacterial vacuole is an essential bactericidal mechanism of 
macrophages (Amer and Swanson, 2002). Reports on the intracellular localisation and 
trafficking of GAS vary widely between studies.  These differences may reflect variations in 
emm-type, cell-type or different infection techniques adopted. In epithelial cells, M6 GAS 
fails to localise with the early endocytic marker EEA1 and the late endocytic/lysosomal 
marker LAMP1 (Nakagawa et al., 2004; Håkansson et al., 2005). However, reports in 
endothelial cells suggest that an M3 GAS is efficiently trafficked to lysosomal compartments 
(Kaur et al., 2010). Currently, an in depth analysis of GAS trafficking in macrophages is 
lacking. A study carried out by Norrby-Teglund and colleagues reported that GAS did not 
colocalise with LAMP1-positive compartments but found no evidence of cytosolic GAS by 
EM micrographs (Hertzen at al., 2010). They concluded that GAS can modify its vacuole to 
avoid lysosomal maturation. However, in a separate study using the same M1T1 5448 strain, 
GAS was found to reside exclusively within LAMP1-positive phagolysosomes (Bastiat-Sempe 
et al., 2014). 
U937 cells were infected with M49 NZ131 WT and Δslo mutant strains and infected cells 
were labelled for LAMP1 at 1 h, 2 h and 6 h p.u. (Fig. 4.5 A). There was a strong co-
localisation of LAMP1 with WT heat-killed (HK) GAS, which served as a positive control. At 2 
h p.u., over 95% of HK bacteria were at least partially surrounded by LAMP1 (Fig. 4.5 B). In 
Δslo mutant-infected cells, there was an 82% association at 2 h, increasing slightly to 85% at 
6 h p.u. However, in cells infected with the isogenic WT strain the association was 
significantly reduced to 50% at 2 h and 45% at 6 h p.u. Therefore this result suggests that a 
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significant proportion of GAS is trafficked away from late endosomal compartments in an 
SLO-dependant manner.  
 
 
 
Figure 4.5 SLO-mediated escape from LAMP1-containing phagosomes 
A. U937 cells were infected with WT M49 and Δslo mutant at MOI 0.5. Bacteria were labelled with 
anti-GAS antibody (green), anti-LAMP1 (red) and DNA stained with DAPI (blue). Representative 
confocal images are shown with higher magnification in boxed areas. Scale bars, 5 µm. B. 
Quantification of GAS colocalisation with LAMP1 at time points indicated. Data shown represents 
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the results of at least 100 infected cells from 3 independent experiments (mean ± SEM). P-values 
were determined by a two-tailed student’s t test .* p<0.05; ** p<0.01. 
 
 
4.2.6    SLO-deficient GAS undergo acidification in phagolysosomes 
Next, I tested whether WT GAS avoids fusion with phagolysosomes using an acidotropic 
LysoTracker dye, a marker of acidified phagosomes. U937 cells were infected with M49 
NZ131 WT and Δslo mutant strains and LysoTracker was added to infected cells 15 mins 
before the indicated time points. The majority of WT GAS did not colocalise with lysotracker 
during infection (Fig. 4.6 A, B). However, a significantly higher proportion of Δslo-containing 
vacuoles underwent acidification at all tested time points. At 2 h p.u., 61% of Δslo bacteria 
co-localised with LysoTracker compared to 21% of WT (Fig. 4.6 B). These data suggest that 
SLO interferes with the maturation or stability of the GCV in infected U937 macrophages. 
Moreover, although up to 60% of WT bacteria were localised within LAMP1-positive late 
phagosomes at 3 h p.u., only 21% of GCVs underwent acidification at the same time point 
post-uptake. These data suggest that SLO might promote escape from the vacuole or 
prevent acidification of the GCV.  
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Figure 4.6 GAS require SLO to prevent acidification of the GCV 
A. U937 cells were infected with WT M49 and Δslo mutant at MOI 0.5. 15 mins prior to each time 
point, LysoTracker dye was added to infected cells. Bacteria were labelled with anti-GAS antibody 
(green), LysoTracker-stained compartments are shown in red and DNA was stained with DAPI (blue). 
Representative confocal images are shown with higher magnification in boxed areas. Scale bars, 5 
µm. B. Quantification of GAS colocalisation with LysoTracker at indicated time points. Data shown 
represents the results of at least 100 infected cells from 3 independent experiments (mean ± SEM). 
P-values were determined by a two-tailed student’s t test . * p<0.05; ** p<0.01; *** p<0.001. 
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4.2.7    GAS replicate after rupture of the GCV 
Reports have shown that GAS uses a variety of mechanisms to avoid the host endo-
lysosomal pathway to promote its intracellular survival. The results described above indicate 
that the GCV is damaged soon after uptake in U937 macrophages and that SLO is required 
for bacterial escape from LAMP1-positive vacuoles. It was hypothesised that intracellular 
replication could occur within damaged GCVs and/or within the host cytosol. To better 
visualise the dynamics of replication, I used time-lapse confocal microscopy of infected 
U937 cells, expressing MCherry-tagged galectin 3, to investigate the intracellular fate of GAS 
directly, after damage to the vacuole. 
U937 cells were differentiated on glass-bottomed dishes and infected with WT-pGFP1 at 
MOI 0.5. Extracellular bacteria were killed by gentamicin and a bacteriostatic concentration 
was maintained throughout infection. Infected cells containing 1-2 galectin-positive GCVs 
were chosen for time lapse acquisition and imaging was initiated at 2 h p.u. using an 
automated stage in a 37°C live cell chamber. Images were acquired at 25 min intervals until 
10 h p.u. I obtained strong evidence of intracellular replication of GAS after damage to the 
GCV. Among 4 independent live imaging experiments, replication occurred in 31% of 
selected cells. I consistently observed the formation of a rapidly expanding coccal chain 
after the recruitment of galectin 3 to the damaged phagosome. Still images from the movie 
at 2 h and 4 h p.u., show the formation of a long coccal chain of 20+ bacteria created from a 
single cocci (Fig. 4.7). Highlighted selected regions indicate that bacterial replication resulted 
in complete rupture of the galectin-positive vacuole, resulting in a residual galectin signal 
observed at the poles of the expanding coccal chain (indicated by arrows in Fig. 4.7). In 
addition, bacterial replication was frequently followed by loss of macrophage morphology 
and loss of the MCherry galectin signal. These data strongly suggest that GAS escapes its 
vacuole and undergoes replication upon access to the host cytosol.  
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Figure 4.7 Rupture of the GCV precedes replication 
A. Live confocal imaging of MCherry-tagged galectin 3 U937 cells infected with WT-pGFP1 at MOI 
0.5. Elapsed time is highlighted at bottom left of each picture. Yellow arrows highlight a single cocci 
that replicates to form a long chain as well as the association of MCherry-galectin3 throughout the 
infection. This region is magnified and shown in white boxes. This data is representative of 27 other 
infected cells in 4 independent live imaging experiments (scale bars, 5 µm).  
 
 
 
4.2.8    The cytosol of U937 macrophages is restrictive for Salmonella 
growth 
Reports show that GAS is normally restricted in the cytosol of cells and knockdown of 
essential autophagy components like ATG5 or NDP52 leads to bacterial proliferation 
(Nakagawa et al., 2004; Thurston et al., 2009). The cytosol of macrophages is generally more 
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restrictive against bacterial growth compared to the cytosol of epithelial cells (Beuzón et al., 
2000). However, little is currently known regarding the bactericidal activity of the U937 
cytosol. 
Although U937 cells restrict the growth of non-pathogenic E. coli, this is probably by endo-
lysosomal fusion since E. coli failed to associate with galectins. Therefore, Salmonella ΔsifA 
was used to assess whether the cytosol of U937 macrophages is restrictive or permissive for 
growth of a bacterium that normally resides within a vacuole. MCherry-tagged U937 cells 
were infected with GFP-expressing Salmonella ΔsifA at MOI 2, in the presence of 
gentamicin.  Infected cells containing at least 1 galectin-positive SCV was chosen for time 
lapse acquisition and imaging was initiated at 6 h p.u. Images were acquired at 25 min 
intervals until 18 h p.u. In 3 independent experiments, it was observed that the Salmonella 
ΔsifA mutant failed to replicate in U937 cells after galectin-association to the ruptured SCV. 
The majority of cells containing galectin-associated ΔsifA bacteria underwent a form of cell 
death resembling pyroptosis (Fig. 4.6 A). Likewise, a proportion of ΔsifA bacteria remained 
in proximity with galectin-positive structures during infection (Fig. 4.6 B). In the latter case, 
the bacterial rod morphology became more rounded during infection, eventually leading to 
loss of GFP signal. Therefore, ΔsifA Salmonella fail to proliferate in U937 cells and no 
detectable increase in bacterial number was observed after association of galectin to the 
SCV. 
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Figure 4.8 U937 macrophages restrict the growth of cytosolic Salmonella  
A-B. Live confocal imaging of MCherry-tagged galectin3 U937 cells infected with GFP-expressing S. 
Typhimurium ΔsifA mutant at MOI 2. Elapsed time is highlighted at bottom left of each picture. 
White boxes highlight SCV rupture (A) or damaged SCV (B). This region is magnified in the top right 
corner. This data is representative of 3 independent live imaging experiments (scale bars, 5 µm).  
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4.2.9    Digitonin-based assay to detect cytosolic replication 
To confirm that SLO-mediated damage to the GCV results in entry of GAS into the host 
cytosol, a vacuole integrity assay was adopted using digitonin.  At certain concentrations, 
digitonin selectively permeabilizes the plasma membrane without compromising the 
integrity of intracellular vacuoles. Under such conditions, only the cytosolic population of 
GAS will be immunolabeled with an anti-GAS antibody whereas intact GCVs remain 
inaccessible to anti-GAS antibodies. The method is represented by schematic diagram in Fig. 
4.9 A.  
To determine the optimal concentration of digitonin, an antibody against the trans-Golgi 
network integral membrane protein 2 (TGN46) was used. The anti-TGN46 antibody 
recognises only the luminal epitope and its binding should be blocked after selective 
permeabilisation in digitonin. U937 cells were infected with WT M49 NZ131 GAS and 
labelled with anti-GAS and anti-TGN46 antibodies without permeabilisation, or with 
digitonin or saponin (Fig. 4.9 B).  In the absence of any permeabilising agent, antibodies 
failed to bind their targets (left image in Fig. 4.9 B). After saponin treatment, the anti-TGN46 
antibody showed the characteristic perinuclear staining of the Golgi membranes, and 
intracellular GAS was detected with anti-GAS antibody (right image in Fig. 4.9 B). Using high 
concentrations of digitonin (100 µg/ml or higher), both the TGN and GAS could also be 
visualised in many cells, similar to that observed in saponin-treated cells (middle right in Fig. 
4.9 B). However, using lower concentrations of digitonin (between 30-50 µg/ml), anti-
TGN46 antibodies did not bind their target whereas anti-GAS antibodies labelled 
intracellular GAS (middle left in Fig. 4.9 B).  
Once the assay was optimised, U937 cells were infected with WT and Δslo bacteria and the 
percentage of cells containing cytosolic bacteria was determined at 1 h, 3 h and 6 h p.u. (Fig. 
4.9 C, D). HK bacteria served as a negative control and were detected in less than 5% of 
infected cells by digitonin-delivered antibodies (Fig. 4.9 D). Cytosolic WT bacteria were 
present in 45% of infected cells at 1 h p.u. and 48% at 3 h p.u. This increased further at 6 h 
p.u., with 64% of cells containing cytosolic GAS. In contrast, the percentage of cells 
containing cytosolic Δslo bacteria was significantly reduced compared to WT at all tested 
time points. From 1 h and 6 h p.u., the percentage of cells containing cytosolic Δslo ranged 
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between 20-25%. In heavily infected cells containing more than 20 bacteria, 84% of WT 
bacteria were found to reside within the cytosol at 6 h p.u. (Fig. 4.9 E). Due to the 
replication defect, heavily infected cells containing Δslo bacteria were less frequently 
observed compared to the WT strain. Nonetheless, the percentage of cytosolic Δslo bacteria 
was significantly lower in heavily infected cells compared to the WT strain. These results 
show that GAS replication occurs predominantly within the cytosol of U937 macrophages. 
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Figure 4.9 Digitonin-based quantification of cytosolic GAS  
A. Schematic diagram of the selective labelling of intracellular GAS using digitonin. B. For the control 
experiments, U937 cells were infected with WT M49 GAS and labelled with anti-GAS and anti-TGN46 
antibodies permeabilised with different concentrations of digitonin, 0.1% saponin or without any 
permeabilisation. C. Representative microscopy images of U937 cells infected with WT M49 or Δslo 
mutant at 6 h p.u. Cytosolic bacteria were labelled with digitonin-delivered antibodies (green and 
red) and vacuolar bacteria were labelled with saponin-delivered antibodies (red only) and DNA was 
stained with DAPI (blue). Scale bars, 5 µm. D. The percentage of HK, WT and Δslo-infected cells 
containing at least one cytosolic bacterium at time points indicated. E. Cytosolic bacteria were 
scored at 6 h p.u., in cells containing 20+ bacteria. Data shown represents the results of at least 100 
infected cells from 3 independent experiments (mean ± SEM). P-values were determined by a two-
tailed student’s t test . * p<0.05; ** p<0.01. 
 
 
 4.2.10    Cytosolic GAS are recognised by autophagy pathway 
Anti-bacterial autophagy is considered a major immune defence mechanism against 
cytosolic bacteria and has been reported to operate against GAS in epithelial cells 
(Nakagawa et al., 2004; Thurston et al., 2009). Bacteria that escape their vacuoles and enter 
the host cytosol are frequently decorated with ubiquitin and recognised by autophagy 
receptors, which target them for degradation. Upon invasion into epithelial cells, various 
strains of GAS are efficiently targeted by autophagy and restricted within LC3-positive 
autophagosomes (Nakagawa et al., 2004; Nozawa et al., 2012) Since cytosolic GAS replicates 
proficiently in the cytosol of U937 macrophages, I investigated whether GAS avoids 
recognition by the autophagy pathway. U937 cells were infected with the WT M49 NZ131 
and at different time periods exposed to digitonin and then immunolabelled for ubiquitin 
(Fig. 4.10 A). Approximately 45% of cytosolic bacteria were ubiquitinated at 1 h p.u. and a 
similar percentage (40%) of ubiquitin colocalisation was recorded at 3 h p.u. (Fig. 4.10 B). At 
6 h p.u., more than half of cytosolic bacteria (59%) were associated with ubiquitin.  
Ubiquitin-coated cytosolic bacteria are sensed by autophagy cargo receptors such as p62 
and NDP52. These proteins function to sequester the invading pathogen into 
126 
 
autophagosomes which are then delivered to bactericidal autolysosomes, the terminal 
destination for bacterial degradation (Randow, 2011). To quantify autophagy receptor 
association with cytosolic M49 WT GAS, U937-infected cells were digitonin-treated and 
immunolabelled for p62 (Fig. 4.10 C). Approximately 40% of cytosolic GAS co-localised with 
p62 at 1 h p.u. (Fig. 4.10 D). A slight increase to 44% was recorded at 3 h p.u., and a further 
increase to 55% at 6 h p.u. This result suggests that a significant proportion of cytosolic GAS 
is targeted by autophagy receptors but recognition alone is not sufficient to restrict the 
overall replication of GAS. It remains to be determined if the inadequate host response is 
due to inefficient recognition by other autophagy adaptors/modifiers or to a bacterial 
mechanism to interfere with autophagosome formation and/or downstream events.   
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Figure 4.10 Cytosolic GAS is recognized by autophagy 
A. Representative confocal microscopy images of digitonin treated WT M49-infected U937 cells at 1 
h, 3 h and 6 h p.u. Cells were immunolabelled with anti-ubiquitin antibodies after saponin treatment 
to determine the percentage of ubiquitinated cytosolic GAS. B. Microscopic quantification of 
ubiquitin colocalisation with cytosolic bacteria from (A) (mean ± SEM). C. Representative confocal 
microscopy images of digitonin treated WT M49-infected U937 cells at 1 h, 3 h and 6 h p.u. Cells 
were immunolabelled with anti-p62 antibodies after saponin treatment to determine the 
percentage of p62-positive cytosolic GAS. D. Microscopic quantification of p62 colocalisation with 
cytosolic bacteria from (C) (mean ± SEM). At least 100 infected cells were counted per experiment. 
Region of colocalisation is magnified and shown in boxed areas. Scale bars, 5 µm.  
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4.2.11   Summary 
• The pore forming toxin SLO is required for replication in U937 cells. 
• SLO pores damage the membrane of the GCV, reducing the colocalisation of GAS to 
late endosomes and acidic phagolysosomes. 
• Fluorescently-tagged galectin 3 and galectin 8 act as markers of damaged or 
ruptured GCVs. 
• M1T1 GAS replicate after rupture of the GCV and SLO is required for bacterial escape 
to the macrophage cytosol.  
• Despite the recruitment of autophagy cargo receptors to cytosolic GAS, the majority 
of replicating GAS are localised predominantly within the cytosol. 
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Chapter 5 
 
Persister cell formation of clinically relevant GAS strains 
 
5.1  Introduction 
The phenomenon of bacterial persisters was first described in 1944 by Joseph Bigger, after 
he discovered that a small sub-population of S. aureus survives after penicillin treatment 
(Bigger, 1944). Bigger re-inoculated the surviving colonies and found that they were as 
susceptible as the original culture and termed the surviving fraction as “persisters”. 
However, the clinical significance of this antibiotic-tolerant persister population has become 
apparent only within the last 10-15 years. It is now understood that persisters are dormant 
cells and their tolerance to antibiotics is attributed to the inactivity of target sites.  
Despite the introduction of penicillin in the 1940’s, remarkably GAS remain susceptible to β-
lactams, including first generation cephalosporins (Horn et al., 1998; Walker et al., 2014). 
Nonetheless, treatment failure is frequently reported in cases of GAS pharyngitis and the 
mechanisms that underlie recurrent disease are unknown (Ogawa et al., 2011a). Some 
studies suggest biofilm formation is responsible for relapse, whereas other studies point to 
an intracellular source of streptococci that may enter a quiescent state, protected against 
antibiotic and host cell killing (Podbielski and Kreikemeyer, 2001; Kaplan et al., 2006; 
Baldassarri et al., 2006). Interestingly, some studies have isolated viable GAS from 
macrophage-like cells and epithelial cells from nasopharyngeal lymphoid tissue of 
chronically-infected patients undergone tonsillectomy (Osterlund et al., 1997; Stępińska et 
al., 2014). However, no study to date has investigated whether GAS produces a persister 
subpopulation and if so, whether it could represent a reservoir for recurrent and disease. 
The clinical evidence supporting a link between persister cell formation and recurrent 
disease is growing. An important study has shown that high persister (hip) strains of P. 
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aeruginosa are selected for in the lung of cystic fibrosis (CF) patients due to periodic 
exposure of antibiotics over many years (Mulcahy et al., 2010). Candida albicans hip 
mutants are also selected for in vivo. C. albicans isolates from patients with chronic 
candidiasis produced significantly more persisters compared to isolates from patients that 
were successfully treated (LaFleur et al., 2010). 
There is no single underlying mechanism that governs a switch to a persistent state. Many 
different transposon mutagenesis screens have been carried out in different bacterial 
species and all have failed to obtain a single mutant strain that was unable to form 
persisters (Spoering et al., 2006; De Groote et al., 2009). This indicates a high degree of 
redundancy with different regulatory pathways contributing to this phenomenon. However, 
in many organisms toxin/antitoxin (TA) modules have been shown to contribute to persister 
formation and may have an important role in chronic infection. 
The majority of the hip mutations discovered were localised to the hipA locus, a type II toxin 
that when ectopically expressed causes growth arrest and multidrug tolerance (Moyed and 
Bertrand, 1983; (Correia et al., 2006). The TA RelBE family is by far the most widely studied 
to date. The RelE toxin is a riboendonuclease that cleaves mRNA, inhibiting translation and 
inducing a reversible growth arrest, which can be alleviated by its cognate RelB antitoxin 
(Pedersen et al., 2002; Andreev et al., 2008; Neubauer et al., 2009). Up to six RelBE loci have 
been identified in E. coli K12 suggesting a certain degree of redundancy (Tsilibaris et al., 
2007; Christensen-Dalsgaard et al., 2010). Recent work in Salmonella has shown an 
important role of toxin/antitoxins in persister formation during infection (Helaine et al., 
2014). S. Typhimurium contains 14 putative type II TA modules, which are up-regulated 
upon bacterial uptake in mouse bone marrow derived macrophages (BMDMs). TA modules 
were activated in response to the acidic vacuolar environment and mutation of individual TA 
genes reduced the number of intracellular persisters. 
In this chapter, I set out to investigate if GAS form a persister subpopulation, tolerant to 
different classes of antibiotics. Clinical GAS isolates obtained from patients with chronic or 
acute infection were obtained from Prof. S. Sriskandan at Hammersmith Hospital, UK. It was 
investigated whether recurrent disease strains could form more persister cells in vitro 
compared to non-recurrent disease strains. In addition, mechanisms underlying persister 
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formation in GAS was examined. The functionality of several putative TA modules in emm1 
GAS was investigated (including a new uncharacterised family), by expressing toxin and 
antitoxin components in E. coli, using an inducible overexpression system. Finally, it was 
determined whether GAS form more persisters after internalisation into macrophages and 
epithelial cells. 
 
 
5.2 Results 
5.2.1   Susceptibility of clinical GAS strains to different classes of 
antibiotics  
In designing the initial experiments to be carried out, only two GAS strains were currently 
available for study in the Holden lab; the hyperinvasive M1T1 5448 strain provided by 
Norrby-Teglund at colleagues at Karolinska, Sweden and an M89 H293 strain originating 
from Felix Randow group in Cambridge, UK. However, both strains were reported to be 
isolated from patients suffering from necrotising fasciitis (NF) and sepsis and likely have 
been pre-exposed to antibiotics (Sriskandan et al., 2000; Thulin et al., 2006). Therefore, it 
was suspected that these strains might not be representative of many common pharyngeal 
isolates. Nonetheless, the M1T1 5448 strain was chosen as a control strain.  
Additional clinically relevant strains of GAS were obtained to conduct studies on persisters. 
It was noted that some of the most widely used GAS strains are not clinically relevant or 
have become lab-adapted (Barnett et al., 2013). Likewise, some bacterial culture stocks may 
have undergone multiple passages over time, which could result in undesirable genotypic 
and/or phenotypic traits. Therefore, five different clinical serotype strains of GAS, isolated 
from the throats of patients with acute infection, were kindly provided by Prof. S. 
Sriskandan at Hammersmith hospital, UK. (emm1, emm3, emm12, emm28, emm87). To 
determine whether any of the GAS strains were resistant to antibiotics, a minimum 
inhibitory concentration (MIC) assay was carried out for each isolate using four different 
antibiotics commonly used to treat GAS infection. Each antibiotic represented the 
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macrolide, aminoglycoside, β-lactam and cephalosporin classes. A two fold serial dilution of 
each antibiotic was carried out and the lowest concentration of antibiotic that inhibited 
visible growth by 24 h was selected as the MIC. Results from Table. 1 show that all strains 
tested were antibiotic susceptible. The most potent antibiotics were amoxicillin and 
erythromycin, with MIC values ranging from 0.01-0.001 µg/ml. Based on the MIC values 
concentrations of 10-100 times the MIC were chosen to carry out antibiotic killing assays. 
Antibiotic treatment of GAS was found to exhibit a killing pattern similar to E. coli 
(Hofsteenge et al., 2013) and M. tuberculosis (Ahmad et al., 2009) resulting in a typical 
biphasic decrease of the bulk population. Fig. 5.1A shows a representative biphasic kill curve 
of emm1 5448 strain treated with four antibiotics over a 24 h period. The population 
underwent an initial rapid killing within the initial 2 h exposure. The rate of killing was 
decreased by 5 h and plateaued at 24 h. These results indicate that the selected GAS strains 
are antibiotic susceptible and emm1 5448 strain is killed in a biphasic pattern and a 
subpopulation is detected after 24 h of drug treatment. 
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Figure 5.1 Antibiotic susceptibility in clinical isolates of GAS  
Table 1 shows the result of the MIC susceptibility test for selected GAS strains. B. Biphasic kill curve 
of WT emm1 5448 strain at 0 h and 2 h, 5 h and 24 h post-exposure to 100 µg/ml gentamicin, 25 
µg/ml erythromycin, 100 µg/ml cefotaxime or 5 µg/ml amoxicillin. A representative kill curve of 3 
independent experiments is shown. 
 
 
5.2.2   Identification of a drug tolerant persister cell subpopulation 
The frequency of GAS in vitro persister formation was examined for all clinical strains. GAS 
was grown until stationary phase and diluted to 1 X 106 – 1 X 107 per ml in liquid culture 
containing antibiotic. The surviving fraction was plated onto agar at 2 h, 5 h and 24 h for 
CFU enumeration and represented as the log survival. 
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CFU counts revealed a large sub-population of GAS at 24 h that survived killing to all 
antibiotics tested (Fig. 5.2 A-D). On average, 2 h of drug treatment reduced bacterial culture 
by 1-2 orders of magnitude, which decreased further at 5 h incubation. At 24 h, roughly 1% 
of bacteria survived killing to all four antibiotics. Gentamicin was the most potent antibiotic 
tested with rapid killing sustained by GAS at 2 h and 5 h treatment (Fig 5.2 D). Erythromycin 
activity had a slower effect than gentamicin but resulted in the greatest killing at 24 h in 5 
strains out of 6 (Fig. 5.2 C).  Strangely, up to 10% of emm3 GAS was recovered by CFU after 
24 h erythromycin. Ineffective killing of emm3 GAS was also observed with clarithromycin, a 
macrolide with similar pharmokinetics to erythromycin (not shown) (Amsden, 1996). In 
contrast, this strain sustained greater than 3-log killing after 24 h treatment to gentamicin, 
cefotaxime and amoxicillin, indicating that greater tolerability is specific for macrolides. 
Overall, the log survival of GAS clinical isolates followed a similar trend for each antibiotic, 
with emm87 and emm1 exhibiting the highest surviving sub-population after 24 h.  
Interestingly, the log survival of the hyperinvasive emm1 5448 strain was comparable 
amongst the other clinical GAS strains that originated from patients with acute infection 
(Fig. 5.2 A-D). Drug-tolerance can be distinguished from drug-resistance if the surviving 
bacteria remain sensitive to antibiotics upon regrowth (Levin and Rozen, 2006). The 
surviving fraction at 24 h were allowed to resuscitate on agar (without antibiotic) for a short 
period of time and re-inoculated in fresh media containing antibiotic for a second round of 
killing (Fig 5.2 E (i)). Results from Fig. 5.2 E (ii) show that a second round of cefotaxime 
treatment reveals the presence of a true persister subpopulation that tolerate and survive 
antibiotic exposure. 
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Figure 5.2 GAS form an antibiotic persister cell population 
A-D. Antibiotic killing of five clinical GAS isolates isolated from patients with sore throat and the 
M1T1 5448 strain isolated from a patient with invasive disease. GAS was grown in THB until 
stationary phase and diluted 1/100 into fresh THB containing: 100 µg/ml cefotaxime (A), 5 µg/ml 
amoxicillin (B), 25 µg/ml erythromycin (C), 100 µg/ml gentamicin (D) and CFU measurements were 
taken at 2 h, 5 h and 24 h and expressed as log survival.  E (i). CFU quantification of selected GAS 
strains treated with cefotaxime at times indicated. E (ii). Second round of cefotaxime killing. Five 
surviving colonies from the 24 h time point of the first round of cefotaxime killing (E) were selected 
and inoculated into fresh THB containing 100 µg/ml cefotaxime. CFU measurements were made at 
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times indicated and the log survival was determined. Killing assays were performed in triplicate and 
error bars (SEM) are based on 3 independent experiments. 
 
  
5.2.3   Persister formation in recurrent disease strains 
Many studies now show that persister cells are clinically relevant, and antibiotic therapy can 
select for high-persister strains in vivo. In this section I investigated the persister frequency 
of GAS strains isolated from patients with recurrent tonsillitis and compared them with GAS 
strains isolated from patients with acute infection. Four recurrent disease strains were 
isolated from patients attending at Hammersmith Hospital and were kindly provided by 
Prof. Shiranee Sriskandan. One strain was confirmed as emm75 serotype, but the remaining 
three strains were of unknown emm-type. 
All four recurrent disease strains were subjected to antibiotic killing assays using 
erythromycin, amoxicillin, cefotaxime and gentamicin (Fig. 5.3 A-D). The log percentage 
survival of the recurrent disease strains was compared to the acute infection strains, 
including the invasive emm1 5448 strain, at 24 h to determine if recurrent disease strains 
form more persisters in vitro. 
Among the 4 recurrent disease strains tested, there was no evidence to indicate that the 
recurrent disease strains formed more persisters compared to non-recurrent disease 
strains. In some cases, recurrent disease strains formed significantly less persisters. After 24 
h cefotaxime treatment, emm75 and h355 strains formed less persisters compared to the 
emm1 throat isolate (Fig. 5.3 A). The h339 strain also formed less persisters than the 
hyperinvasive emm1 5448 strain after amoxicillin treatment (Fig. 5.3 B). Interestingly, the 
non-recurrent emm3 strain was demonstrated to form more persisters in vitro compared to 
all 4 recurrent disease strains after erythromycin treatment (Fig. 5.3 C). Lastly, after 24 h 
gentamicin treatment no significant increase in persister formation was recorded for 
recurrent strains emm75, h353 and h355 compared to the non-recurrent strains (Fig. 5.3 D). 
Furthermore, just one recurrent disease strain (h339) was found to form significantly more 
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persisters compared to emm1, emm28 and emm3 non-recurrent disease strains of GAS (Fig. 
5.3 D). 
Overall, these data suggest that GAS strains isolated from patients with recurrent disease 
and presumably pre-exposed to antibiotics, did not form more persisters in vitro compared 
to strains that caused acute throat infection. 
 
 
Figure 5.3 in vitro persister formation of recurrent and non-recurrent disease strains 
A-D. Log survival of recurrent disease strains (white) compared to non-recurrent disease strains, 
including an invasive disease strain (grey) at 24 h post-treatment with cefotaxime (A), amoxicillin (B), 
erythromycin (C) and gentamicin (D). Killing assays were performed in triplicate and error bars (SEM) 
are based on 3 independent experiments. P-values were determined by a two-tailed student’s t test. 
*, p < 0.05; ** p<0.01. 
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5.2.4 Test for a secreted signalling molecule on GAS persister 
formation  
It has previously been demonstrated that P. aeruginosa secretes quorum sensing (QS) 
signalling molecules called pyocyanin (PYO) and acyl-homoserine lactone (3-OC12-HSL) in 
stationary phase cultures (Möker et al., 2010). It was found that recombinant PYO and 3-
OCL-HSL added exogenously to cultures of P.aeurginosa increased persister formation 
during antibiotic treatment. In addition, it was also shown that spent media (containing QS 
molecules) from stationary phase cultures could increase the fraction of persisters 
recovered. Likewise, in S. mutans a QS peptide called CSP pheromone was involved in the 
formation of stress-induced antibiotic-tolerant persisters (Leung and Lévesque, 2012). 
Therefore, I tested whether GAS can secrete a molecule in stationary phase cultures that 
could contribute to increased or decreased persister formation. An emm1 strain was used to 
assess bacterial survival in antibiotics at 2 h, 5 h and 24 h post-exposure (Fig. 5.4 A-C). To 
determine if a secreted compound affects persister frequency, stationary phase bacteria 
were resuspended in either fresh THB or the stationary phase supernatant supplemented 
with fresh THB powder (to replenish lost nutrients during bacterial growth) and the log 
survival was determined during antibiotic treatment. In addition, bacteria were also pre-
incubated in either fresh THB or stationary phase supernatant for 2 h prior to antibiotic 
treatment. However, the results from the in vitro killing assays using stationary phase 
supernatant did not reveal any difference in persister formation compared to fresh THB 
alone. Likewise, pre-incubating the bacteria in stationary phase supernatant did not alter 
the frequency of persister formation in response to antibiotic killing compared to fresh THB. 
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Figure 5.4 Effect of cell-free stationary phase supernatant on persister formation 
Stationary phase emm1 GAS was diluted into fresh THB or in cell-free stationary phase supernatant 
supplemented with THB powder and treated with cefotaxime (A), erythromycin (B) or amoxicillin (C) 
immediately or after 2 h pre-incubation at 37°C.  Killing assays were performed in triplicate and error 
bars (SEM) are based on 3 independent experiments. 
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5.2.5   Identification of toxin/antitoxin (TA) modules in GAS strains of 
interest  
Table 2 provides a list of putative TA modules in a reference emm1 GAS strain MGAS5005 
obtained from the toxin/antitoxin Database (TADB). TADB is an online resource that 
catalogues Type II toxin/antitoxin loci in bacteria in which the genome sequence is 
published. Several different emm-type strains of GAS are listed containing various predicted 
TA modules. The emm1 MGAS5005 strain was interesting for several reasons. This strain 
contained the fewest number of TA modules and two of these TA systems (Spy_1220/19 
and Spy_1465/64) were documented as an uncharacterised family of TA, perhaps with novel 
function. Interestingly, this unknown family were not found in other Gram-negative 
organisms such as E. coli and Salmonella, but were identified in Gram-positives such as S. 
pneumoniae. The other two toxins were predicted as a RelBE family and have been widely 
characterised in different bacterial species.  
The amino acid sequences of all four putative toxins were queried with I-TASSER (Iterative 
Threading ASSEmbly Refinement) and PHYRE (Protein Homology/analogY Recognition 
Engine), which provides a structure/function prediction analysis. The top significant hits 
recovered from queried sequences of the GAS RelBE-predicted TA systems (Spy_0457/56 
and Spy_1641/40) were other RelBE complexes from various other organisms. This 
suggested that toxins Spy_0457 and Spy_1641 are likely to be riboendonucleases that 
cleave mRNA - similar to what has been described in E. coli. When sequences of the 
predicted toxins Spy_1220 and Spy_1465 were queried, significant similarity to various zinc 
metalloproteases was recorded including the IRRE protein, involved in DNA damage repair 
and radiation resistance in Deinococcus radiodurans (Vujicić-Zagar et al., 2009).  
Lastly, both toxins Spy_1220 and Spy_1465 were queried with MEROPS peptidase database. 
Each queried peptidase is assigned to a family on the basis of statistically significant 
similarities in amino acid sequence. Both toxins were assigned to the M78 family of 
metallopeptidases. Both toxins were predicted to be zinc-dependant due to the presence of 
a conserved HEXXH motif including a conserved glutamic acid at amino acid position 72, 
which is predicted to be a third zinc ligand (Fig. 5.5 A). 
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The sequence data were available for two GAS strains, emm89 (h293) and emm1 throat 
isolate, used previously. The sequences of each strain were compared to the reference 
MGAS5005 strain using Artemis software. It was found that emm89 contained genes for 
both predicted RelBE families but lacked the Cog2856 family. However, the emm1 strain 
harboured all four putative TA families with 100% amino acid identity to those reported in 
MGAS5005. Therefore, the functionality of all four toxin/antitoxin modules from emm1 GAS 
was examined. 
 
 
 
 
Figure 5.5 List of putative TA modules and predicted function 
Table 2 shows four putative TA modules in GAS MGAS5005 strain as listed in the Type II 
toxin/antitoxin database, including the putative function as predicted by amino acid sequence entry 
of all four toxins into ITASSER and PHYRE programs. A. Amino acid sequence of CogT1 and CogT2 
toxins showing the predicted zinc binding domains highlighted in yellow, as predicted by the 
MEROPS database. 
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5.2.6   Functional analysis of GAS toxin and antitoxin genes in E. coli 
To investigate whether GAS loci Spy_0456/0457, Spy_1219/1220, Spy_1464/1465 and 
Spy_1640/1641 encode functional TA systems, the toxin genes (Spy_0457, 1220, 1465 and 
1641) and antitoxin genes (Spy_0456, 1219, 1464 and 1640) were ligated into different 
plasmids and expressed in E. coli. E. coli is commonly used as a model for verification of 
putative TA loci from other organisms (Khoo et al., 2007; Florek et al., 2008) Schematic 
figure 1 in Fig. 5.6 shows the plasmids that were used for ectopic overexpression of GAS TA 
components in E. coli. pBAD33 and pNDM220 were provided by Ken Gerdes, University of 
Newcastle, UK. The pBAD33 expression system contains a tightly regulated, arabinose-
inducible PBAD promoter (Guzman et al., 1995). Therefore, the GAS putative toxin genes 
were PCR amplified and inserted downstream of the PBAD promoter in pBAD33. The 
antitoxin genes were expressed in pNDM220, a low copy plasmid, under the control of a 
strong, LacI-regulated promoter (pA1/O3/O4) (Christensen-Dalsgaard et al., 2010). 
Bacterial growth was measured by optical density (OD600) and CFU counts of exponentially 
growing E. coli cultures. OD600 readings revealed that WT E. coli, including bacteria 
transformed with pBAD and pNDM empty vectors, grew exponentially in liquid medium 
after an initial lag phase (Fig. 5.6 A(i)). E. coli (pNRelB1) grew without inhibition with similar 
density to WT cells at 6 h post-induction with IPTG (2 mM). However, the growth of E. coli 
(pBRelE1) supplemented with 0.2% arabinose showed significant growth differences after 4 
h post-induction. This was also demonstrated by reduced CFU counts detectable after 3 h 
post-induction (Fig. 5.6 A (ii)). Overexpression of RelE1 lead to a 104 log growth inhibition 
from 4 h to 6 h, compared to positive control E. coli (pNempty). This suggests that that RelE1 
is a bona fide GAS toxin. Of note, increasing the concentration of arabinose to 1% did not 
result in a greater growth defect, indicating that growth inhibition was maximal (not 
shown).  
To determine if the RelB1 antitoxin can offset the effect of RelE1-induced growth inhibition, 
E. coli (pRelBE1) was co-transformed with plasmids expressing both RelE1 and RelB1 
proteins. Cells were diluted to O.D600 0.1 and co-induced with IPTG and arabinose for 6 h 
(Fig. 5.6 A (i)). Upon induction of RelB1, growth of E. coli was partially restored, indicating 
that the antitoxin could counteract the toxic effect of the cognate RelE toxin. An increase of 
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102 – 103 log CFU was recovered between 3 h – 6 h with concomitant induction of RelB1 (Fig. 
5.6 A (ii)). 
Similar results were obtained for the second putative RelBE class TA module expressed in E. 
coli. O.D readings revealed that induction of RelE2 led to the inhibition of growth at 4 h 
post-induction (Fig. 5.6 B (i)). Overexpression of RelE1 led to a dramatic decrease in CFU 
counts after 3h post-induction and co-induction of the antitoxin RelB2 reversed the toxicity 
of RelE2 (Fig. 5.6 B (ii)). CFU results showed that co-induction of RelB2 lead to the complete 
recovery of growth with an increase of 104 log CFU recovered at 4h, 5h and 6 h post-
induction. The time and kinetics of RelE1 and RelE2 growth arrest were closely comparable, 
suggesting that both toxins have a similar mode of action and likely belong to the same class 
of TA system, as predicted. 
The two remaining putative TA modules of unknown function were tested for toxicity in E. 
coli. Induction of CogT1 and CogT2 with 0.2% arabinose failed to induce growth arrest and 
CFU counts were similar to E. coli strains containing the induced antitoxin CogA1 (pN) and 
CogA2 (pN) only (Fig. 5.6 C,D). Moreover, increasing the concentration of arabinose to 1% 
had no effect on growth (not shown). Quantitative real-time PCR (qRT-PCR) was used to 
measure the level of RelE1, CogT1, CogT2 and RelE2 transcripts with or without inducer. 
Expression of each toxin (under inducing conditions) was measured relative to 16sRNA and 
normalised to non-induced conditions. The data show increased expression of CogT1 and 
CogT2 in the presence of inducer (Fig. 5.6 E). In addition, ectopic overexpression of CogT1 
and CogT2 toxins in pathogenic S. Typhimurium 12023 strain did not produce a toxic effect 
either (not shown). This result suggests that both GAS putative toxins may not be bona fide 
toxins.  
Finally, it was investigated whether RelE2-induced growth arrest was reversible and could 
be counteracted by subsequent induction of the antitoxin as opposed to concomitant as in 
(Fig. 5.6 B). A proportion of cells from RelE2-induced cultures were resuscitated when plated 
on agar plates containing glucose (to repress RelE2) and IPTG to stimulate production of the 
cognate antitoxin (Fig. 5.6 F). This result is in agreement with published literature, indicating 
that RelE toxin does not kill the cells but rather induces a reversible bacteriostatic state 
(Pedersen et al., 2002). 
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Figure 5.6 Ectopic overexpression of GAS TA modules in E. coli 
Schematic 1 shows the plasmids used for the functional assays carried out in E. coli.  Toxin and 
antitoxins from emm1 GAS were cloned and inserted upstream of the respective promoters. PBAD 
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promoter was induced by 0.2% arabinose and pA1 promoter by 2mM IPTG. (A) Growth of E .coli 
after 6h induction of RelE1 toxin (RelE1 pB) and co-induction of both RelE1 toxin and RelB1 antitoxin 
(RelBE1 co-induced) as determined by O.D (i) and CFU (ii). Control strains included non-induced E. 
coli (WT), E. coli containing induced empty pBAD vector (pBAD empty) or empty pBAD and pNDM 
vectors (pB + pN), and RelB1 induced antitoxin (RelB1 pN). B. O.D readings (i) and CFU quantification 
(ii) of induced RelE2, RelB2 and co-induced RelEB2 in E. coli. C. O.D readings (i) and CFU 
quantification (ii) of induced CogT1, CogA1 and co-induced CogTA1 in E. coli. D. O.D readings (i) and 
CFU quantification (ii) of induced CogT2, CogA2 and co-induced CogTA2 in E. coli. E. Quantitative RT-
PCR of induced RelE1, CogT1, CogT2 and RelE2 transcripts relative to 16sRNA and normailsed to non-
induced F.  Resuscitation of cell viability by antitoxin RelB2. The E. coli RelE2 (pB) strain was grown in 
THB with or without 0.2% arabinose and plated onto THB agar plates containing 0.2% glucose, with 
2mM IPTG or without IPTG (mean ± SEM, n=3). Functional assays were performed in duplicate and 
error bars (SEM) are based on 4 independent experiments. P-values were determined by a two-
tailed student’s t test. *, p < 0.05; ** p<0.01. 
 
 
5.2.7   Investigating persister formation of GAS during infection  
In this chapter I have shown that persister cells of GAS comprise up to 1% in the stationary 
growth state, revealed by exposure to antibiotics in vitro. It is widely believed that chronic 
infections are caused by persister cells of drug-sensitive bacteria. Antibiotic treatment 
failure is common in many streptococcal pharyngitis patients. Studies have detected viable 
intracellular GAS in tonsillar tissue of patients with chronic disease (Osterlund et al., 1997). 
It is hypothesised that internalisation of GAS into epithelial cells could explain the 
occurrence of chronic infection and treatment failure. 
Recent work carried out by Dr. Sophie Helaine of our Section showed that a proportion of S. 
Typhimurium enter a non-replicating state upon internalisation into macrophages (Helaine 
et al., 2010). In addition, Helaine and colleagues reported that 30 min phagocytosis of 
Salmonella in primary mouse macrophages was sufficient to produce a 100 fold increase in 
the number of persisters compared to growth in liquid culture (Helaine et al., 2014).   
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Therefore, I investigated if GAS can form more persisters upon uptake into macrophages 
and epithelial cells. I infected two macrophage cell lines, human THP-1 and mouse RAW 
264.7 and the human epithelial HeLa cell line with the non-recurrent emm1 isolate and 
recurrent-disease emm75 isolate, to investigate if more persisters are formed during 
infection (Fig. 5.7 A). THP-1 and RAW macrophages were infected for 30 min with opsonised 
bacteria and HeLa cells were infected for 2 h with GAS strains, or 15 min with Salmonella. 
After internalization, the bacteria were released by lysis of the host cells and exposed to 100 
µg/ml gentamicin for 24 h. Infections were optimised so that roughly 1 x 107 intracellular 
bacteria were recovered after cell lysis. The intracellularly released bacteria and the bacteria 
from the original inoculum were subjected to gentamicin treatment for 24 h and then plated 
onto agar for CFU quantification. The number of surviving persisters from the intracellular 
population was compared to the number of surviving persisters from the inoculum and the 
data was expressed as the fold increase in persisters formed. S. Typhimurium was used as a 
positive control for intracellular persister formation. Results from Fig 3.6 A clearly show that 
whereas Salmonella produced significantly more persister cells upon uptake into all 3 cell 
types, there was no significant increase in the number of persisters formed by emm1 or the 
recurrent disease emm75 strain.  
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Figure 5.7 Persister formation of GAS during infection 
A. GAS strains and S. Typhimurium were grown until stationary phase and opsonised in human (THP-
1, HeLa) or mouse serum (RAW 264.7). Macrophages were infected with GAS at MOI 5 for 30 min 
and HeLa were infected at MOI 20 for 2 h. Macrophages were infected with S. Typhimurium at MOI 
2 for 30 min and HeLa cells infected at MOI 10 for 15 mins after 3 h subculture (to induce SPI-1). The 
fold increase in persisters caused by 15-30 min internalisation in cells was relative to the number of 
persisters present in THB (GAS) or LB (Salmonella), as revealed by 24 h in 100 µg/ml gentamicin. 
Infection assays were performed in duplicate and error bars (SEM) are based on 3-5 independent 
experiments. P-values were determined by a two-tailed student’s t test. *, p < 0.05; ** p<0.01; *** p 
<0.001. 
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5.2.8   Summary 
• GAS form a drug tolerant persister cell subpopulation comprised of roughly 1% in 
stationary phase after 24 h treatment with different classes of antibiotics.  
• Recurrent disease isolates of GAS did not form more persisters in vitro compared to 
non-recurrent disease isolates. 
• M1 GAS contain fewer toxin/antitoxin modules compared to other pathogens 
associated with chronic infection, but contain a previously unidentified family of TA 
modules predicted to contain a metalloprotease toxin. 
• The two RelE toxins of M1 GAS are bona fide toxins and are toxic when 
overexpressed in E.coli. The two RelB antitoxins are bona fide antitoxins and can 
alleviate toxicity when co-induced with the cognate toxins. 
• Whereas Salmonella formed more persisters after uptake in THP-1, RAW and HeLa 
cells, neither a clinical isolate nor recurrent disease isolate of GAS formed 
significantly more persisters. 
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Chapter 6     
 
Discussion 
 
6.1 Introduction 
The selection of a suitable cell type for the investigation of the intracellular fate of GAS was 
a critical point for the present study. All the relevant literature from the last 30 years to the 
beginning of this project did not report evidence of intracellular growth of GAS in epithelial 
cells. However, a revealing study in 2006 showed that macrophages are the primary 
reservoir for viable intracellular GAS during invasive infection (Thulin et al., 2006). This 
suggested that GAS can resist or exploit host innate immune defense. To date, only two 
studies have provided tentative evidence that GAS can survive and replicate in human 
phagocytic cells (Medina et al., 2003; Hertzén et al., 2010). However, both studies lacked 
proper quantitative intracellular analysis and had considerable limitations, some of which 
are discussed in further detail below. Consequently, many experts in the field of 
streptococcal pathogenesis still consider GAS strictly an extracellular pathogen (Baruch et 
al., 2014). Since the role of macrophages during GAS infection remained unexplored, I 
decided to establish a reproducible infection system to quantify bacterial intracellular 
survival and/or replication within human macrophages on the single cell level. 
Monocytic cell lines of different degrees of differentiation are commonly used as models for 
macrophage biology since primary blood monocytes cannot be cultured ex vivo. Cell lines 
offer a significant advantage over primary monocytes due to their simple acquisition, 
genetic homogeneity, fast doubling time and short differentiation time (Chanput et al., 
2014).  A wide range of human monocytic cell lines were available for study, including U937, 
ML-2, THP-1, HL-60 and Mono Mac 6. THP-1 and U937 are the most widely used and were 
chosen having been used successfully with various intracellular pathogens such as 
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Chlamydia pneumoniae and M. tuberculosis (Virok et al., 2003; Theus et al., 2004; Ovalle-
Bracho et al., 2015). 
 
6.2 Previous reports of GAS replication in phagocytic cells 
The first report to suggest that M1 GAS can replicate inside human cells came in 2003, from 
a study carried out by Staali and colleagues using primary human neutrophils (Staali et al., 
2003). The authors reported that CFU counts steadily increased in neutrophils from 5 min to 
15 min, 30 min and 120 min p.u.  However, cells were infected with a MOI of 10 in the 
absence of antibiotic in the culture medium. Therefore, the increase in CFU counts could 
indicate ongoing phagocytosis and/or extracellular replication. Importantly, the author’s 
findings have not been confirmed in any follow up study to date.  
In a more recent study carried out by the Norrby-Teglund group in 2010, M1T1 GAS was 
reported to replicate intracellularly in primary human macrophages between 6 h and 10 h 
p.u. (Hertzen et al., 2010). An important caveat in this study is the absence of quantitative 
measurements of intracellular growth. Evidence for replication was highlighted in a single 
electron microscopy (EM) image showing evidence for septum formation of GAS in an 
infected cell. In addition, CFU counts from cell culture medium of infected cells 4 h post-
antibiotic removal was 10 fold higher compared with the same bacterial inoculum in cell 
culture medium without cells. The authors concluded that replication inside macrophages 
accounted for the 10 fold increase in the extracellular bacterial counts. However, it seems 
unlikely that bacteria will replicate more efficiently in host cells than in culture medium. 
Also, more bacteria will survive the initial killing with gentamicin in the presence of cells, 
since intracellular bacteria are protected from the effects of antibiotic, and therefore will 
replicate to higher numbers in the extracellular medium once released from the host cell. 
In summary, some aspects of experimental design in these studies appear to be flawed and 
the status of the intracellular population during infection of these cells remained to be 
defined unambiguously.  
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6.3 GAS fails to proliferate in THP-1 macrophages 
The formation of long chains during GAS growth in vitro represents a challenge to quantify 
the number of bacteria during infection. This aspect is likely to have caused discrepancies in 
the past in detecting intracellular growth. For instance, one CFU recovered on agar could be 
derived from either a single bacterial cell or a long chain. The presence of chains also 
complicates accurate quantification by microscopy.  Infections carried out in the THP-1 cells 
were difficult and required a significant degree of optimisation. To enrich for individual and 
small forming GAS chains in the infection inoculum, bacteria were subjected to a pre-
centrifugation step for 1 min at 1000 x g (Fig. 3.5). This allowed larger chains and clumps of 
bacteria to be pelleted and excluded from the infection inoculum. This simple procedure 
does not seem to have been described before. One group successfully disrupted chains into 
individual cells by sonication on ice (Braga et al., 2003). However, this technique was not 
adopted since it might adversely affect bacterial physiology before infection. The pre-
centrifugation step is much less stressful to the bacteria and proved a useful technique to 
count intracellular bacteria accurately over time.  
Microscopic quantification and CFU counts of intracellular M1T1 5448 GAS in THP-1 
macrophages failed to show any evidence of replication (Fig. 3.5). Conversely, a significant 
decrease in the percentage of cells containing 11+ bacteria was recorded over time. This 
decrease suggests that THP-1 cells can restrict the intracellular growth of GAS. Notably, a 
concomitant increase in the percentage of infected cells containing 1-2 bacteria was 
recorded. This effect could be derived by the reuptake of bacteria released from heavily 
infected cells, or by host cell killing over time. In addition, cells harbouring 1-2 bacteria 
could be more represented at later time points, since cells with a higher bacterial load could 
lyse or detach more frequently during infection or by washing and be unavailable for 
analysis.  
A recent study has also investigated the intracellular survival of GAS in THP1 cells (Bastiat-
Sempe et al., 2014).  Although the authors report an increase in the percentage survival of 
GAS from 2 h to 4 h post-uptake, this included both the intracellular and extracellular 
bacteria released into the cell culture medium after antibiotic removal. Thus, the observed 
CFU increase may well reflect unrestricted extracellular growth. 
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6.4 Bacterial invasion and growth in epithelial cells 
During my PhD studies, a group reported that GAS can replicate in epithelial cells (Barnett et 
al., 2013).  The study used Hep-2 cells and reported an increase by CFU for M1T1 5448 GAS 
in contrast to an M6 strain, which failed to replicate. HeLa and Hep-2 are the most common 
cell type used to investigate GAS invasion and intracellular survival. HeLa cells, as a model 
for GAS infection, are not as relevant compared to oropharyngeal keratinocyte cell lines 
(Cywes and Wessels, 2001; Love et al., 2012; Anderson et al., 2014). In fact, it has been 
hypothesised that the contradictory results on the survival of GAS in epithelial cells could be 
derived from differences in cell lines used (O’Seaghdha and Wessels, 2013).  
Since GAS failed to grow in THP-1 cells I wanted to determine whether the M1T1 5448 strain 
can replicate in epithelial cells, as reported by Barnett et al. However, this group used Hep-2 
cells, which are known to be contaminated with HeLa cells (Lavappa, 1978). This could be an 
important caveat to this study since they could have used an uncharacterised and 
contaminated cell type. As a result, HeLa cells were infected for two hours with M1T1 5448 
GAS (Fig. 3.6). Interestingly, I never observed the reported increase in CFU as Barnett et al. 
reported. Nonetheless, a significant increase in the percentage of cells containing 11+ 
bacteria was recorded, suggesting evidence for intracellular growth. In addition, many 
infected cells contained a high bacterial burden at late time points, which were not 
observed at 2 h p.i. These results provided confidence that the M1T1 5448 strain can 
replicate in human cells. 
However, the growth phenotype in HeLa cells was not further characterised.  GAS invasion 
rates are low  (Andreoni et al., 2014) and quantification of intracellular bacteria was difficult 
due to a high proportion of cells containing extracellular bound bacteria. Although 
gentamicin protection prevented extracellular growth in the cell culture medium, many 
bacteria remained attached to cells during infection and were difficult to remove by 
washing. It was also suspected that cells with surface attached bacteria could be slowly 
internalised throughout infection and may obfuscate microscopy counts.  
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6.5 Growth of GAS in U937 and MDMs 
U937 monocytes originate from tissue and are at a more mature stage compared to the pro-
monocytic THP-1 cell line (Kohro et al., 2004). Independent studies have shown that THP-1 
and U937 cells, when stimulated with phorbol esters such as PMA, have a macrophage 
phenotype that closely resembles native monocyte-derived macrophages (MDMs) (Baek et 
al., 2009; Daigneault et al., 2010). However, results obtained from macrophage-like cells 
might not always be extrapolated to primary MDMs. LPS stimulation of U937 cells gave 
vastly different responses compared to THP-1 and MDMs (Sharif et al., 2007). Recently, it 
was reported that THP-1 and U937 are more susceptible to Salmonella infection compared 
to MDMs (Kortmann et al., 2015). Overall, THP-1 and U937 cells could represent a useful 
model to investigate GAS-macrophage interactions, but primary macrophages remain the 
most relevant and accurate model to predict GAS behaviour in vivo. 
In U937 macrophages, M1T1 5448 underwent efficient intracellular growth, with up to 40% 
of infected cells containing 11+ bacteria at 6 h and 9 h p.u. (Fig. 3.7). It was observed at the 
later time points that many macrophages contained many long chains of intracellular 
bacteria. Some cells contained up to 100 cocci. Evidence for replication was much greater in 
U937 cells compared to HeLa cells. However, this result was in contrast to that obtained in 
THP-1 macrophages. To reconcile the conflicting observations in both macrophage cell 
types, the intracellular survival and replication of M1T1 GAS was investigated in primary 
macrophages, chosen as the most biologically relevant cell type and representative of an 
the in vivo situation (Fig. 3.8) 
Primary macrophages were derived from blood monocytes isolated by CD-14 positive 
selection and differentiated with M-CSF. In vivo, high levels of M-CSF induce an anti-
inflammatory macrophage state called ‘M2’, whereas GM-CSF has the opposite effect by 
inducing an pro-inflammatory phenotype referred to as ‘M1’ (Fleetwood et al., 2007). 
Macrophages of M1 or M2 type have different phenotypic and functional responses, and 
can behave differently in response to infection (Neu et al., 2013). During infection most 
bacteria drive macrophages into a pro-inflammatory state. However, GAS has been shown 
to activate markers of both the M1 and M2 state in murine macrophages (Goldmann et al., 
2007). Although GAS contain numerous superantigens which are potent inducers of the 
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proinflammatory response, biopsy tissue from patients with invasive disease revealed that 
the majority of intracellular GAS was found in tissue with low inflammation (Thulin et al., 
2006). Therefore, monocytes were differentiated with M-CSF to provide an activation state 
that is more representative of resting macrophages, including those macrophages that 
contain intracellular M1T1 GAS in vivo.  
Upon infection of MDMs with GAS, I observed strong evidence of bacterial replication (Fig 
3.8). The percentage of cells containing 11+ bacteria was significantly higher at 9 h p.u., 
compared to 0.5 h p.u. However, a high degree of variation was observed between 
experiments at the 6 h time point, perhaps due to donor variability. Interestingly, the 
infected population containing 3-5 bacteria decreased during infection, similar to that 
obtained in U937 cells. Therefore, it was concluded that GAS can replicate in primary 
macrophages and that the observations and kinetics of intracellular growth was comparable 
to that obtained in U937 macrophages. This justified the continued use of U937 cells. 
Many studies have shown that GAS is cytotoxic to cells (Tsai et al., 1999; Goldmann et al., 
2009). In macrophages, the toxic effect requires the internalisation of GAS and expression of 
SLO (Timmer et al., 2009). To investigate the growth phenotype in more detail, it was 
important to determine whether GAS triggers host cell death and then replicates in 
nonviable cells. PI was used a marker for cell viability during infection in U937 cells and it 
was observed that a significant proportion of GAS can replicate in PI-negative cells (Fig. 
3.10). As expected, some cells containing 11+ bacteria were also PI-positive at 6 h. This 
effect could be due to the transient effects of SLO. Although SLO can induce cell death and 
PI-uptake, some cells can repair the damage induced by the toxin and remain viable (Keyel 
et al., 2013). Therefore, PI-positivity does not always represent a ‘dead’ macrophage, and 
might suggest that the measure of bacterial growth in viable cells is underestimated. 
Overall, it was clear that M1T1 5448 GAS can exploit or resist host cell killing to replicate in 
viable PI-negative U937 macrophages.  
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6.6 Intracellular growth is not specific for the M1T1 hyperinvasive 
strain 
The previous studies that reported intracellular growth of GAS were restricted to M1 strains 
(Medina et al., 2003; Hertzen et al., 2010; Barnett et al., 2013). However, many different 
emm-types have been used in the past to investigate GAS-host cell interactions, including: 
M12 (Marouni and Sela, 2004), M89 (Thurston et al., 2009), M49 (Joubert et al., 2009), M3 
(O’Seaghdha and Wessels, 2013) M6 (Nakagawa et al., 2004), among many others. The 
study carried out by Barnett and colleagues reported that M1T1 5448 GAS replicates in HeLa 
cells whereas the M6 strain, used in studies by Nakagawa et al. (2004) and Sakaurai et al. 
(2010), failed to replicate. The authors stated that strains of GAS used in the past are not 
representative of the major serotypes associated with contemporary disease (Barnett et al., 
2013). However, this might be slightly misleading since M89 and M6 isolates are within the 
top 10 most common emm-types found in higher income countries (Fig.1.1) (Steer et al., 
2009a). 
The M1T1 clone is often referred to as hypervirulent and hyperinvasive and responsible for 
the resurgence of invasive GAS disease worldwide (Aziz and Kotb, 2008). However, the 
distinction between invasive and non-invasive isolates is often blurred since there exists a 
significant overlap in common emm-type isolates found in both invasive and non-invasive 
disease worldwide (Steer et al., 2009a). It has been proposed that the overrepresentation of 
the M1T1 isolates in invasive disease is not due to increased virulence, but rather 
widespread transmission (Rogers et al., 2007).  
With this in mind, several non-M1 strains were assessed for replication in U937 
macrophages (Fig. 3.11). Whereas the M12 and M49 NZ131 strains replicated similarly to 
M1T1 5448, the M28 and M49 CS101 strains replicated poorly, or failed to replicate at all. 
The M28 strain was the most cytotoxic to U937 cells and had the lowest percentage 
survival. Therefore, cytotoxicity could explain the low replication rate. In contrast, the M49 
CS101 strain caused less cytotoxicity but completely failed to replicate intracellularly. A lack 
of speB expression has been associated with failure to replicate in epithelial cells (Barnett et 
al. 2013). However, both M49 CS101 and NZ131 strains have been shown to expresss speB 
and are virulent in a mouse skin infection model (Chaussee et al., 1999; Wei et al., 2005; 
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Dmitriev et al., 2008). Therefore, it is apparent that there might be other considerable intra-
serotype differences that enable GAS to resist host cell killing and proliferate in 
macrophages. A future area of investigation could involve carrying out replication assays on 
a panel of serotype-specific strains, and then subject to WGS and gene expression analysis 
to identify differences between replication-proficient and -deficient strains. Predicted 
differences could be changes in two component signal transduction systems like CovRS, 
which controls many essential virulence factors. Likewise, mutation, deletion or acquisition 
of putative virulence factors may also be revealed in such a study.  Overall, these results 
suggests that replication in U937 macrophages is not specific to the M1T1 clone. 
 
6.7 Role of GAS virulence factors in promoting replication in U937 
cells  
At present over 200 distinct M (emm)-type strains have been identified (Steer et al., 2009a). 
The M protein is the major surface-exposed virulence factor of GAS and plays a major role 
during progression of invasive disease in mice (Ashbaugh et al., 1998). The M protein 
confers resistance to the antimicrobial peptide LL-37 and promotes survival in phagocytic 
extracellular traps (Lauth et al., 2009). Upon uptake by neutrophils, the M protein has been 
reported to promote intracellular survival, due to an inhibitory effect on the fusion of 
azurophilic granules to the phagosome (Bauer and Tapper, 2004). In macrophages, the M 
protein has been implicated in avoidance of phagolysosomal fusion (Hertzen et al., 2010). 
The WT 5448 strain used throughout this study was the isogenic WT strain from which the 
Δemm1 deletion mutant was derived, as used in the study by Hertzen et al. (2010). The 
Δemm1 mutant was slightly less cytotoxic than the isogenic WT strain (Fig. 3.12). The M1 
protein has not previously been shown to contribute to cellular toxicity in vitro, but is a 
mediator of a proinflammatory response in vivo (Herwald et al., 2004). In contrast to the 
results reported by Hertzen et al., I observed no difference in survival or replication 
between the WT and Δemm1 mutant in U937 macrophages. Unfortunately, due to time 
constraints I was unable to confirm this finding in primary macrophages.  
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SLO is another important virulence factor that displays cytotoxic activity and protects GAS 
from phagocytic killing in vitro and in vivo (Sierig et al., 2003). However, SLO-mediated 
cytotoxicity is dependent upon GAS uptake by macrophages (Timmer et al., 2009). Timmer 
et al. speculated that apoptosis is caused by SLO pore formation in the bacteria-containing 
phagosome. This hypothesis was later elaborated upon by Bastiat-Sempe et al., who 
showed that SLO-induced pore formation contributes to virulence in macrophages by 
preventing acidification of the phagosome and promoting intracellular survival (Bastiat-
Sempe et al., 2014).  
I obtained a strain deficient in SLO in the isogenic M49 NZ131 strain used previously (Fig. 
3.11). In U937 cells infected with Δslo mutant, cytotoxicity was considerably reduced 
compared to WT M49 infected cells (Fig. 4.1). Reduced cell death is characteristic of SLO-
deficient strains and was expected.  However, no difference in CFU was recorded between 
both strains and that result is in contrast to published studies (Fig. 4.1 B) (Timmer et al., 
2009; Bastiat-Sempe et al., 2014). However, the discrepancy in CFU counts could reflect 
differences in emm-type used or differences in the experimental conditions. Importantly, 
quantification by microscopy revealed that the Δslo mutant was significantly impaired for 
intracellular replication compared to the isogenic WT strain. In addition, the long chains of 
intracellular replicating bacteria were infrequently observed for the Δslo mutant. These 
heavily infected cells were easily identified by microscopy. Therefore, it was hypothesised 
that infected cells with a high bacterial burden would have higher fluorescence intensities 
than cells containing few bacteria. In agreement with the microscopy data, Δslo mutant-
infected cells displayed significantly lower geometric mean fluorescence intensity compared 
to WT-infected cells, indicating a defect in intracellular replication.  This technique was not 
only useful as an alternative measure of replication, but was more quantitative than 
microscopy since up to 50,000 infected cells were counted per experiment. These results 
show that the pore forming SLO toxin is required for replication of GAS in U937 
macrophages. 
The next part of my work focused on characterizing the effects of SLO in U937 cells and 
understanding how SLO promotes the intracellular growth of GAS. 
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6.8 SLO-mediated damage to the GCV 
As previously mentioned, several studies have reported that SLO can form pores in the 
phagosomal membrane which can trigger host cell death (Harder et al., 2009; Timmer et al., 
2009). In epithelial cells, some studies have also reported an SLO-dependant entry of GAS 
into the cytosol (Nakagawa et al., 2004; Sakurai et al., 2010). A study in 2010 reported the 
use of galectins as a useful tool to study vacuolar damage induced by cytosolic pathogens 
(Paz et al., 2010). I showed that upon uptake of GAS in U937 cells, both galectin 3 and 
galectin 8 are recruited to the GCV (Fig. 4.2). This recruitment was observed for both M1 
and non-M1 strains and was roughly correlated with toxicity (Fig. 4.4). It was also found that 
galectin recruitment was dependant on SLO since the Δslo mutant accumulated less galectin 
compared to the isogenic WT strain.  
Galectins have also been reported to bind directly to LPS from Klebsiella pneumoniae (Mey 
et al., 1996). Recombinant galectin 3 also has bacteriostatic activity on S. pneumoniae in 
vitro (Farnworth et al., 2008). It is speculated that galectin 3 can bind directly to the capsule 
of S. pneumoniae (Chen et al., 2014). However, this scenario is unlikely for GAS, since they 
do not contain galactose in the capsule (Ashbaugh et al., 1998). Therefore, it is very likely 
that galectins are recruited to the β-galactosides exposed on the inner leaflet of the 
damaged GCV. 
SLO-mediated damage to the GCV suggested that GAS is capable of escaping its vacuole in 
U937 macrophages. However, two independent studies carried out in primary macrophages 
and THP-1 macrophages failed to observe a cytosolic bacterial population (Hertzen at al., 
2010; Bastiat-Sempe et al., 2014). Whilst Hertzen et al. reported that GAS survived in 
vacuoles devoid of LAMP1 and negative for LysoTracker during infection, Bastiat-Sempe et 
al. showed that the GCV matures through the endosomal-lysosomal pathway but ultimately 
fails to acidify.  
Upon infection of U937 macrophages with isogenic WT NZ131 and Δslo mutant, a greater 
number of WT bacteria were absent from LAMP1-positive vacuoles, compared to Δslo 
mutant (Fig. 4.5). This suggested bacterial escape to the cytosol. Although 60% of WT 
bacteria remained associated with LAMP1 at 1 h and 2 h p.u., LysoTracker labelling revealed 
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that nearly 80% of WT GCVs failed to undergo acidification at the same time p.u. (Fig. 4.6). 
Therefore, SLO could carry out a dual function in macrophages, by preventing acidification 
of the GCV (Bastiat-Sempe et al., 2014) and mediating bacterial entry into the nutrient rich 
cytosol. 
It was also reported that GAS are not acidified in HL-60 neutrophils, due to impaired delivery 
of v-ATPase to the GCV (Nordenfelt et al., 2012). This effect was reversed with an isogenic 
Mga (multiple gene regulator of GAS) mutant strain lacking several virulence factors. Since 
Mga does not regulate SLO, its expression remained unaffected (McIver and Scott, 1997). 
This suggests that bacterial factors, other than SLO, could be involved in preventing vacuolar 
acidification. 
SLO is closely associated with SPN, a NAD-glycohydrolase enzyme that is dependent on SLO 
for its translocation into the host cytosol. SPN has been shown to induce cytotoxicity by 
depleting intracellular NAD+ and ATP levels. An SPN deletion mutant has been shown to be 
impaired for intracellular survival in epithelial cells (O’Seaghdha et al., 2013). In OKP7 cells, 
SLO damages the membrane of the GCV resulting in the activation of autophagy and 
sequestration of the bacteria in autophagosome-like compartments. Both SLO and NADase 
have been shown to delay fusion of this compartment to lysosomes, enhancing bacterial 
survival. Interestingly, SPN was not required for GCV rupture and escape into the host 
cytosol. Therefore, future work should also examine the contribution of SPN to the 
intracellular replication of GAS in human macrophages. Infecting macrophages with a SPN 
deletion mutant would likely result in much lower levels of cytotoxicity, as demonstrated in 
epithelial cells (O’Seaghdha et al., 2013). One could predict that in the absence of an 
apoptotic and/or pyroptotic host response to infection, GAS may replicate to even great 
numbers in the cytosol of U937 macrophages. Alternatively, the SPN-mediated depletion of 
NAD+ and ATP levels in the cytosol has been shown to impair the cells ability to repair 
membrane damage caused by SLO pores (Michos et al., 2006). Therefore, in the absence of 
functional SPN during infection, perhaps fewer bacteria would rupture the vacuole and 
escape into the macrophage cytosol.  
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6.9  Live imaging of vacuolar rupture 
Live cell experiments with GAS-infected MCherry galectin 3 U937 cells supported the 
hypothesis that GAS can escape its intracellular vacuole (Fig. 4.7). Time-lapse microscopy 
revealed that a significant proportion of GCVs rupture and this is followed immediately by 
bacterial replication in the cytosol. Exposure to the nutrient rich cytosol via diffusion 
through SLO pores could be sufficient to stimulate bacterial growth. Since GAS is non-
motile, the observation of complete dissolution of the GCV membrane is quite striking. The 
contribution of other bacterial and/or host factors that facilitate vacuolar lysis remain to be 
defined. However, the observation that a residual galectin signal is present at the poles of 
the expanding coccal chain could indicate that the force from the first division process leads 
to the physical rupture of the vacuole.  
Replication of GAS is different to that of many other Gram-positive cocci. GAS do not belong 
to the classical spherical cocci family like staphylococci, but rather exist as elongated 
ellipsoids (Zapun et al., 2008). Whereas staphylococci divide in three perpendicular planes 
resulting in irregular grape-like clusters of cells (Tzagoloff and Novick, 1977; Turner et al., 
2010), GAS divide in a single plane perpendicular to the long axis of the cell, resulting in a 
chain (Patterson, 1996). This is shown in a schematic - Fig. 6.1. 
In 31% of selected cells, a proportion of GAS hyper-proliferated in the cytosol and formed 
remarkably long coccal chains within macrophages (Fig. 4.7A). Some cells supported 
extensive bacterial replication (up to 100 cocci), before cell death became apparent, as 
these cells maintained their macrophage morphology and retained the cytosolic galectin 
signal. 
This study provides the first direct visualisation of vacuolar rupture and cytosolic replication 
of GAS inside human cells. To the best of my knowledge, formation of extensive chains of 
GAS during infection has not been reported in the literature. Therefore, the biological 
significance of these long intracellular chains is unknown. It would be interesting to 
determine if this phenotype can be observed in macrophages during in vivo infection or in 
ex vivo tissue from patients with invasive infection. 
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Figure 6.1 Differences in shape and division of GAS versus staphylococci.  
 
 
6.10   Evidence for cell-to-cell spread of GAS 
At late time points during live imaging the majority of cells containing long chains of bacteria 
remained attached to the surface of the dish. After the loss of macrophage morphology and 
galectin signal, some infected cells swelled and lysed releasing bacteria into the extracellular 
medium. This was consistent with a pyroptotic form of cell death (Fink and Cookson, 2005). 
In several cases, bacteria released from their intracellular environment, re-infected 
surrounding macrophages. Representative still images are shown in Fig. 6.2 and highlight 
the extensive intracellular replication in a macrophage from 2 h to 8 h p.u. By 9 h the cell 
became rounded and MCherry galectin signal was lost. At 10 h the cell boundary was 
compromised and the bacteria were released. Interestingly, a short chain consisting of up to 
5 cocci, separated from the main cluster and reinfected a neighbouring cell (shown by 
yellow arrow). Once internalised the bacteria associated with galectin and ruptured the 
newly formed vacuole, leading to death of the new host cell after 12 h.  
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Intracellular GAS was also observed to escape from primary macrophages and reinfect a 
new population of macrophages (Hertzen et al., 2010). Timmer et al. suggested that SLO-
induced cell death and bacterial egress promotes immune evasion and exacerbates GAS 
infection in mice. SLO is demonstrated to have immunomodulatory properties and can 
inhibit macrophage activation (Bebien et al., 2012). Interestingly, M. tuberculosis prevents 
apoptosis and triggers a form of necrotic cell death to avoid immune defense and reinfect 
surrounding cells (Behar et al., 2010). It was reported that LLO promotes bacterial cell-to-
cell spread by exploiting efferocytosis (Czuczman et al., 2014). Likewise, GAS may have an 
evasion mechanism similar to L. monocytogenes. One could imagine that SLO might have an 
important role in dissemination by triggering an immunologically silent form of cell death 
and/or exploiting efferocytosis to facilitate cell to-cell spreading. Unfortunately, only 3 such 
events were observed during live cell imaging. To study this phenomenon in detail would 
require a significant investment of time and was not pursued. 
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Figure 6.2 GAS reinfects a neighbouring macrophage after extracellular release. Live confocal 
imaging of MCherry-tagged galectin3 U937 cells infected with WT-pGFP1 at MOI 0.5. Elapsed time is 
highlighted at bottom left of each picture. Yellow arrows highlight an uninfected bystander cell and 
the intracellular bacteria. This region is magnified and shown in white boxes in the upper corner. 
This data is representative of 3 other infected cells in 4 independent live imaging experiments (scale 
bars, 5 µm).  
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6.11   Quantification of cytosolic replication 
The results from the live imaging suggest that GAS replicates in the cytosol after vacuolar 
rupture, although the extent to which cytosolic bacteria might contribute to overall 
replication is unknown. So far, two studies have shown qualitative evidence for GAS 
cytosolic entry, both by EM (Medina et al., 2003; Nakagawa e al., 2004). Another study used 
an anti-LAMP1 antibody as an indirect marker of cytosolic GAS (Sakurai et al., 2010). 
However bacteria which have entered the cytosol can become re-associated with LAMP1 if 
they are sequestered in an autophagosome and trafficked to lysosomes for degradation (Yu 
et al., 2010). 
However another technique for measuring the cytosolic population was provided by Barnett 
et al. (2013). This study showed that growth of GAS was abolished in Hep-2 (HeLa) cells by 
penicillin G treatment. The authors reported that cytosolic bacteria are the source of 
intracellular growth as penicillin is present only in the cytosol. However, I could not find 
convincing evidence from the references provided (Renard et al., 1987 and Camilli et al., 
1989) that penicillin G accumulates specifically in the cytosol. Likewise, the study by Renard 
et al. used mouse J774 macrophages to assess the internalisation of antibiotics. How 
penicillin might penetrate and accumulate in HeLa cells was not addressed by the authors.  
In addition, the penicillin negative selection assay reported by Camilli et al. does not suggest 
that penicillin selects for the cytosolic population only (Camilli et al., 1989).  Mutants 
defective for replication were isolated by penicillin, since this class of antibiotic targets 
replicating bacteria only. Moreover, the predominant theme in the literature, provided by 
many years of studies, suggests that penicillin has limited access to the intracellular space in 
eukaryotic cells (Johnson et al., 1980; Renard et al., 1987; Hand and King-Thompson, 1989; 
Carlone et al., 1991; Ahrén et al., 2002). Kaplan et al. also showed that the intracellular 
content from lysed HeLa cells, that were previously cultured in high concentrations of 
penicillin, did not inhibit the growth of GAS in vitro (Kaplan et al., 2006). 
Therefore, the published evidence showing GAS replication in the host cell cytosol is 
unconvincing. Another important point to highlight is that Barnett et al. (2013) reported 
that M6 strain was not found in the cytosol. This is in contrast to findings from Sakurai et al. 
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(2010) who showed an SLO-dependant role in promoting phagosomal escape for M6 GAS. 
Likewise, Nakagawa et al. (2004) also observed by EM that M6 GAS escaped the vacuole in 
HeLa cells. Therefore, it is unlikely that M6 GAS remain vacuolated throughout infection and 
one would expect to find a decrease in the CFU counts for M6 GAS during the penicillin 
assay (Barnett et al., 2013).  
I used a more direct tool for observing and measuring the cytosolic population of GAS in 
cells. In this study the application of digitonin permeabilisation has provided quantification 
of cytosolic GAS for the first time (Fig. 4.9). Other groups have used digitonin to selectively 
label cytosolic Salmonella, without affecting the integrity of intracellular endomembranes, 
including that of the SCV (Malik-Kale et al., 2012; Knodler et al., 2014). We found that nearly 
half of infected macrophages harbour cytosolic bacteria from 1 h p.u. This increased further 
at 6 h p.u., the time which replication is maximal. Interestingly, when infected cells 
containing 20+ bacteria were analysed, 84% of WT bacteria were cytosolic. This shows that 
cytosolic growth contributes significantly to the overall net replication in U937 
macrophages. 
 
6.12   Recognition by autophagy 
For several years, studies have consistently found that selective autophagy is efficient in 
recognising and eliminating GAS. The M6 (Nakagawa et al., 2004), M49 (Joubert et al., 2009) 
and M89 (Thurston et al., 2009) strains have all been shown to be recognised and efficiently 
removed by autophagy in HeLa cells. In autophagy-deficient cells lacking either Atg5, a 
critical regulator of autophagosome formation (Nakagawa et al., 2004) or the cargo receptor 
NDP52 (Thurston et al., 2009), GAS were able to proliferate. A more recent study found that 
whilst up to 85% of M3 GAS were localised within LC3-positive vacuoles at 2 h p.u., fusion to 
autolysosomes was delayed compared to an isogenic SLO mutant strain (O’Seaghdha and 
Wessels, 2013). SLO activity stimulated autophagy but prevented maturation of the 
autophagosome. However, this study used an unencapsulated mutant of M3-type GAS in 
OKP7/bmil/TERT immortalized primary human soft-palate keratinocytes (OKP7). Therefore, 
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the absence of capsule, differences in serotype and/or cell type may reflect differences 
obtained from other published work.  
Overall the M6 JRS4 strain is the most widely used model for investigating autophagy 
(Nakagawa et al., 2004; Yamaguchi et al., 2009; Sakurai et al., 2010; Nozawa et al., 2012). 
However, Barnett et al. (2013) reported that M6 JRS4 strain is defective for SpeB expression. 
Upon infection of HeLa cells with SpeB expressing M1T1 5448 strain, it was found that GAS 
avoided recognition of several important autophagy components, including NDP52 and p62 
and the autophagy marker LC3 (Barnet et al., 2013). Moreover, 5448 GAS avoided 
ubiquitination of the bacterial surface. This was due to the proteolytic activity of SpeB. As a 
result of impaired autophagic recognition, GAS could replicate in the cytosol of HeLa cells 
(Barnett et al., 2013). 
Given my previous findings that SpeB-expressing strains M1T1 5448 and M49 NZ131 
(Chaussee et al., 1999) replicate in U937 macrophages, one might expect that autophagy 
also fails to recognise cytosolic bacteria in this cell type. However, I found that between 40-
60% of cytosolic NZ131 bacteria, revealed by digitonin permeabilisation, were ubiquitinated 
or p62-positive throughout infection. Interestingly, the majority of the long replicating 
chains apparent at 6 h p.u., were ubiquitinated or associated with p62. A representative 
example is provided in Fig 4.10 
It is unknown whether GAS disrupts the autophagy pathway to facilitate its growth. If so, it 
is unlikely to involve the SpeB-mediated degradation of ubiquitin or p62, as reported in 
HeLa cells (Barnett et al., 2013). Nonetheless, I obtained the isogenic WT 5448 and ΔspeB 
mutant strain from the Nizet lab. Preliminary data suggested that WT and ΔspeB mutant 
replicated similarly in U937 cells. Likewise, in one experiment, ubiquitination of WT bacteria 
was frequently observed in U937 cells. Unfortunately, due to time limitations at the end of 
my PhD period these experiments were not completed. Therefore, the role of SpeB in 
evading autophagy recognition and promoting cytosolic replication in U937 macrophages 
remains to be determined and should be a focus of future investigations. 
The observation that many of the long replicating chains at 6 h were ubiquitinated or 
associated with p62, would suggest that autophagy, despite targeting bacteria for 
degradation, fails to restrict the growth of GAS. To test this, future work could involve 
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knockdown (KD) of the essential autophagy protein Atg5 in U937 cells, either by targeted 
siRNA or shRNA. Microscopic quantification of intracellular bacteria in WT and Atg5 KD cells 
would provide valuable insight on the contribution of autophagy to the intramacrophage 
fate of GAS. I speculated that if autophagy was active and bactericidal to GAS in U937 cells, 
then greater replication would be recorded in the absence of Atg5. Alternatively, the 
recruitment of ubiquitin and p62 to the GAS chains at 6 h, might suggest that autophagy 
promotes cytosolic replication. In that case then one might expect to see a decrease in 
replication of WT GAS in Atg5 KD U937 cells. Autophagy has been reported recently to 
facilitate the growth of cytosolic Salmonella (Yu et al., 2014) and C. burnetti (Campoy and 
Colombo, 2009). However, this remains a controversial topic in the autophagy field 
In conclusion, even though a significant proportion of cytosolic GAS are recognised by 
autophagy cargo receptors in U937 cells, antibacterial autophagy appears insufficient to 
fully restrict cytosolic replication of GAS. It remains to be determined if the cytosolic growth 
of GAS is due to incomplete recognition by autophagy modifiers (LC3/Atg8) or to bacterial 
interference in autophagosome and/or downstream events.  
This work might have broader implications for understanding how macrophages contribute 
to severe GAS infection. Moreover, the quantitative-based approach in measuring 
intracellular growth of GAS provides more support for the notion that intracellular GAS 
might contribute significantly to its overall pathogenesis. 
 
6.13   Link between chronic infection and persister formation 
GAS is a persistent coloniser of the oropharynx and the most common cause of pharyngitis 
(Cunningham, 2000). Appropriate diagnosis and antibiotic therapy are essential for the 
prevention of recurrent infection and acute rheumatic fever (ARF) (Herath and Carapetis, 
2015).  To this day, all GAS strains remain highly susceptible to β-lactams (Macris et al., 
1998). Penicillin and amoxicillin are the recommended drugs of choice in the treatment in 
pharyngotonsillitis (Shulman et al., 2012). However, failure to eradicate GAS with antibiotic 
therapy occurs in up to one-third of patients (Kuhn et al., 2001).  
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It has been proposed that interactions between GAS and the bacteria of the oropharyngeal 
flora could account for antibiotic failure. In one study it was shown that the respiratory 
pathogen Moraxella catarrhalis could be recovered in association with GAS in 22% of 
children with tonsillitis (Brook and Gober, 2006). It is now known that co-aggregation 
between both pathogens can enhance the adherence of GAS to epithelial cells (Schaar et al., 
2011). Moreover, it was found that M. catarrhalis can protect GAS from the effects of 
amoxicillin by secreting β-lactamase-containing outer membrane vesicles (OMVs) 
(Lafontaine et al., 2004).  
The discovery that GAS can trigger its uptake into epithelial cells represents an alternative 
explanation to explain chronic and relapsing infections. Evidence to support this theory was 
provided by Osterlund and Engstrand (1995) showing that GAS isolates obtained from 
patients with recurrent disease survived longer within HeLa cells, even up to 7 days, 
compared to strains from patients with non-recurrent disease (Osterlund and Engstrand, 
1995). In addition, the same group later showed that viable intracellular GAS was found 
within epithelial cells and macrophage-like cells from excised tonsil tissue of patients with 
recurrent tonsillitis (Osterlund et al., 1997).  
Increasing reports in the literature suggest that persister cells have a major role in the 
recalcitrance of recurrent infections and tolerance to antibiotic therapy (Zhang, 2014). 
Persisters are a subpopulation of cells that can enter a dormant, non-replicating state 
(Helaine and Kugelberg, 2014). This population is tolerant to the effects of bactericidal 
antibiotics, since antibiotics require active targets and cannot usually kill slow or non-
growing bacteria. One study found a correlation between increased drug tolerance and 
prolonged exposure to antibiotics in clinical isolates of M. tuberculosis obtained from 
patients with pulmonary tuberculosis (Wallis et al., 1999). Repeated exposure to antibiotics 
leads to selection of strains that produce increased amounts of persister cells, termed high 
persister mutants (hip) (Lewis, 2010). The long term application of antibiotics in patients 
with CF leads to the emergence of hip strains of P. aeruginosa with up to 100-fold increase 
in persister levels (Mulcahy et al., 2010).  
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Therefore my hypothesis was that clinical isolates of GAS from patients with recurrent 
tonsillitis might have increased tolerance to antibiotics compared to strains causing acute 
infections. 
 
6.14   Persister frequency of recurrent versus non-recurrent disease 
isolates 
Five different clinical serotype strains of GAS isolated from patients with acute throat 
infection, and four strains isolated from patients with a history of recurrent tonsillitis, were 
obtained from a UK hospital. The susceptibility to four different classes of antibiotics, 
commonly used to treat cases of tonsillitis (Shulman et al., 2012) was investigated. Each 
strain was susceptible to all antibiotics tested by classical MIC test (Fig. 5.1). Although the 
application of some of the antibiotics was in excess of 100 X MIC, a concentration unlikely to 
be achieved in vivo, the aim was to isolate and compare the fraction of highly tolerant 
persisters for recurrent and non-recurrent disease strains. 
The in vitro killing of GAS followed a typical biphasic pattern with an initial rapid killing 
subsequently followed by a slower phase of inactivation which eventually reached a plateau 
(Fig. 5.1). These kinetics have been shown for many other organisms such as E. coli 
(Bhagunde et al., 2011) and M. tuberculosis (Ahmad et al., 2009).  
Because no study at the time had investigated persister formation in GAS, I determined 
whether GAS produce a non-inheritable, antibiotic tolerant sub-population in response to 
antibiotic killing. As shown in Fig. 5.2, most of the non-recurrent disease isolates were found 
to produce persisters at high levels, with roughly 1% tolerant after 24 h drug treatment. 
Upon regrowth, a second round of antibiotic treatment killed 99.9% of the original surviving 
persisters, indicating that the surviving fractions are true persisters rather than resistant 
mutants. This is consistent with studies carried out for P. aeruginosa (Keren et al., 2004), S. 
aureus (Lechner et al., 2012) and S. mutans (Leung and Lévesque, 2012) where it was found 
that persisters are present in stationary phase cultures at frequencies between 10-2 and 10-
3. 
171 
 
Comparing the levels of persisters after 24 h of drug exposure for all GAS isolates, failed to 
reveal any significant difference between the recurrent and non-recurrent disease isolates 
(Fig. 5.3). In fact, the recurrent isolates seemed to form slightly less persisters overall. 
However, a more in-depth approach would be required to conclusively determine if GAS 
periodically form more persisters in vitro or not. In addition a bigger sample size for both 
recurrent and non-recurrent strains and a more detailed patient history would be required. 
For instance, hospital records do not reveal whether the GAS isolates from acute infection 
were successfully eradicated. In the future, this type of investigation may require a 
longitudinal study of clinical GAS isolates from chronically colonised patients followed over 
several months to perhaps years. This was done successfully by Mulcahy et al. (2010) in 
identifying hip mutants of P. aeruginosa from CF patients regularly treated with 
antimicrobials over 96 months. A more feasible approach could involve whole genome 
sequencing (WGS) of isolates obtained from patients that have regular relapse of tonsillitis. 
WGS was recently carried out on clinical isolates of Staphylococcus haemolyticus in 
European hospitals, to track the development of antibiotic resistance and adaptation 
(Cavanagh et al., 2014). Such an approach would help to identify GAS isolates which are 
responsible for chronic infection in patients. One study found that GAS isolates, recovered 
from patients during multiple onsets of pharyngitis, were different from the first onset in 
42% of cases (Ogawa et al., 2011b) Therefore, it is suggested that in some clinical cases a 
diagnosis of relapse may be mistaken for reinfection.  
 
6.15   TA modules and intracellular persisters 
There is increasing evidence that persister cells are formed by multiple, independent 
mechanisms, which may involve quorum sensing molecules, toxin/antitoxin modules and 
global transcriptional regulators. Quorum sensing molecules secreted into stationary phase 
cultures of P. aeruginosa and S. mutans have been demonstrated to enhance persister 
formation (Möker et al., 2010; Leung and Lévesque, 2012). However, there was no evidence 
to suggest the presence of a persister enhancing molecule in stationary phase supernatant 
of GAS (Fig. 5.4).  
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Recent publications, including work carried out in our Centre, have shown that persistence 
of E. coli and Salmonella depends on (TA) modules. Single deletions of various TA modules 
were shown to reduce persister frequency in Salmonella (Helaine et al., 2014), whereas 
successive deletions of multiple TA loci were required to demonstrate a decrease in 
persisters for E. coli (Maisonneuve et al., 2011), indicating that some TA’s might be 
redundant. This is almost certainly the case for M. tuberculosis which contains 79 TAs, some 
of which are induced in drug tolerant persisters (Sala et al., 2014). Investigating the role of 
TAs in GAS represented a much simpler and testable model since the majority of serotypes 
contain between four and eight TA modules (Fig. 5.5).  
Proteins of COG2856 are representative of the metzincin Zn-dependent protease family due 
to the presence of a conserved HEXXH motif (Makarova et al., 2009). The IrrE protein of 
Deinococcus radiodurans is a member of this family and a structural homolog of CogT1 and 
CogT2 (Fig. 5.5). Recently it was confirmed that IrrE is a metalloprotease that cleaves and 
inactivates the repressor protein DdrO which results in the upregulation of genes essential 
for bacterial survival after radiation exposure (Ludanyi et al., 2014). Likewise, the putative 
proteases CogT1 and CogT2 could be involved in the cleavage of Xre family of repressors 
involved in other stress response genes.  
According to published data, RelE toxin overexpression in E. coli resulted in growth arrest 
(Pedersen et al., 2002). This was also observed for overexpression of GAS RelE1 and RelE2 in 
E. coli (Fig. 5.6). CFU counts showed that upon induction at time zero, no growth occurred 
for RelE1- or RelE2-expressing E. coli strains. Co-induction of the RelB1 or RelB2 antitoxin 
could abolish toxicity of the cognate toxin, albeit only partially with RelE1. This may be due 
to the greater expression levels of RelE1 compared to RelE2. In contrast, CogT1 and CogT2 
overexpression did not affect bacterial growth in E. coli and Salmonella. It is possible that 
CogT1 and CogT2 are not bona fide toxins. Alternatively, targets for these toxins might not 
present within Gram-negative organisms and further work should test the impact of ectopic 
expression of these toxins in a Gram-positive organism. Moreover, both toxin genes were 
not codon optimised for E. coli, which may reflect the lack of toxicity. However, this 
possibility is remote, since both RelE1 and RelE2 were functional in E. coli.  
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Interestingly, a recent study examined the validity of putative toxin/antitoxin modules from 
the strain S. pneumoniae Hungary 19A-6 which also contained two uncharacterised TA 
modules classified as Cog 2856 (Chan et al., 2014). Both toxins from S. pneumoniae shared 
no sequence similarity to those found in MGAS5005 but were also predicted as zinc-
dependant metallopeptidases. However, when both toxins were overexpressed in E. coli or 
S. pneumoniae they failed to induce a detectable toxic effect. 
However, to accurately determine the contribution of GAS TA modules in in vitro and in vivo 
persister formation, single or multiple gene deletions should be carried out. Attempts were 
made unsuccessfully to generate individual knockout mutants for all four TA modules in a 
sequenced emm1 GAS clinical isolate. Two methods were chosen: insertion-duplication 
mutagenesis and precise in-frame allelic mutagenesis. Both methods involved the use of 
temperature sensitive shuttle vectors. Despite significant time invested in the optimisation 
of suitable electroporation conditions, using different plasmids, the sequenced emm1 strain 
was non-transformable. Due to time constraints, this area of investigation was no longer 
explored. Alternatively, future studies should attempt to generate TA knockout mutants in 
the highly transformable M49 NZ131 strain (McShan et al., 2008). However, no sequence 
data currently exists on the M49 serotype. Therefore, this strain would need to be 
sequenced and putative toxin/antitoxins would need to be identified using RASTA (Rapid 
Automated Scan for Toxins and Antitoxins in Bacteria) analysis. This is a publically available 
tool that allows fast and accurate identification of TA loci in sequenced prokaryotic genomes 
(Sevin and Barloy-Hubler, 2007). However, it is unknown whether M49 serotype strains 
contain the uncharacterised Cog2856 TA family, which is of high interest.  
It has been shown that upon uptake into host cells, Salmonella enters a viable but non-
replicative state in which bacteria are tolerant to host cell killing and antibiotic treatment 
(Helaine et al., 2014).  However, this has yet to be reported for GAS. Nonetheless, isolates 
from patients with recurrent disease have higher internalisation rates and longer survival 
times in epithelial cells compared to isolates which were successfully eradicated (Marouni et 
al., 2004). Therefore, I examined whether GAS form more persisters after uptake in 
macrophages and HeLa cells and compared persister induction levels between a recurrent 
and non-recurrent disease strain versus Salmonella as a positive control (Fig. 5.7).  
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Consistent with the previous report by Helaine et al. (2014), Salmonella formed significantly 
more persisters after 30 min phagocytosis in RAW and THP-1 macrophages, and HeLa cells. 
Interestingly, GAS failed to form more persisters after internalisation in all 3 cell types 
compared to the inoculum in THB. The intracellular Salmonella persisters are induced in 
response to acidification and depleted nutrients within the SCV (Helaine et al., 2014). 
However, data presented in Chapter 4 showed that a significant proportion of GAS damage 
or escape the vacuole shortly after uptake, suggesting that bacteria may not incur the same 
stress conditions as Salmonella. Conceivably, GAS might require longer incubation to enter a 
non-replicative state due to a delay in GCV maturation (O’Seaghdha and Wessels, 2013) or 
efficient recognition and recruitment of autophagosomes to the bacteria (Nakagawa et al., 
2004). 
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